Design, synthesis and characterisation of new protein folds by Porter Goff, Kate
                          
This electronic thesis or dissertation has been





Design, synthesis and characterisation of new protein folds
General rights
Access to the thesis is subject to the Creative Commons Attribution - NonCommercial-No Derivatives 4.0 International Public License.   A
copy of this may be found at https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode  This license sets out your rights and the
restrictions that apply to your access to the thesis so it is important you read this before proceeding.
Take down policy
Some pages of this thesis may have been removed for copyright restrictions prior to having it been deposited in Explore Bristol Research.
However, if you have discovered material within the thesis that you consider to be unlawful e.g. breaches of copyright (either yours or that of
a third party) or any other law, including but not limited to those relating to patent, trademark, confidentiality, data protection, obscenity,
defamation, libel, then please contact collections-metadata@bristol.ac.uk and include the following information in your message:
•	Your contact details
•	Bibliographic details for the item, including a URL
•	An outline nature of the complaint







Design, synthesis and characterisation 
of new protein folds 
 










A dissertation submitted to the University of Bristol in accordance with the 
requirements for award of the degree of PhD in the Faculty of Science. 
School of Chemistry, November 2018 
 
53941 words  









The primary sequence of amino acids in a polypeptide chain determines a proteins 3D shape, how 
it folds and its function. Understanding this process is known as the protein-folding problem. The 
loss of conformational entropy upon folding must be overcome by the formation of many weak, but 
cooperative, non-covalent interactions. Studying miniproteins reduces the complexity of the protein-
folding problem and allows us to systematically probe contributions to protein folding and stability.  
Recently in the Woolfson group, a 34-residue monomeric miniprotein, PP!, was made using a 
fragment-based design approach that borrowed sequences from two natural protein structures. This 
antiparallel construct comprises a polyproline-II helix, loop and ! helix.  PP! is stabilised by the 
interdigitation of proline from the polyproline-II helix into a stack of tyrosine residues presented by 
the ! helix. There remains much to be understood about the sequence-to-structure and sequence-to-
stability relationships in PP!. Further, such knowledge and understanding offers opportunities for 
using PP! as a reliable modular building block to design and engineer entirely new protein folds 
and functions. 
In chapter 3 of this thesis, the complete rational redesign of PP! is described, moving away from a 
fragment-based design towards a de novo framework. An optimised PP! topology is presented that 
has been analysed extensively by a variety of biophysical techniques including NMR spectroscopy. 
Optimised PP! has significantly improved thermal stability compared to the parent design. The 
enhanced stability is attributed to a number of factors including electrostatic steering effects and 
general tightening of the structure resulting in improved non-covalent interactions, specifically  
CH–π interactions. General and intimate side chain-side chain interactions are probed in chapter 4 
revealing sequence-to-structure/stability relationships for the miniprotein fold. 
With the knowledge of how to design robust PP! modules, chapter 5 explores designing two new 
topologies based on PP! that, to our knowledge, have not been observed before in nature. Firstly, 
through iterative rounds of design, we achieve a stable and well-folded ! helix:loop:polyproline-II 
helix topology (!PP). Subsequently, PP! and !PP are combined to give a PP!PP construct with the 
expanded topology polyproline-II helix:loop:! helix:loop:polyproline-II helix. Through 
mutagenesis studies it is shown that the PP! component of the PP!PP topology is the more dominant 
interface and when this is removed the stability of the topology is dramatically reduced. 
Two further strategies to improve the stability of PP! are discussed in chapter 6. Firstly, the chain 
length of optimised PP! is increased. Similar to previous observations for !-helical coiled coils, the 
stability of PP! increases with increasing chain length in a non-linear, cooperative manner. 
Secondly, successful enzymatic cyclisation of PP! using an engineered peptide ligase yields cyclic 




In summary, an optimised PP! has been designed and sequence-to-stability relationships for the 
miniprotein elucidated. The first steps towards expanded PP! topologies are presented.  These 
should pave the way for the development of more-advanced PP!-based protein folds with 
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Chapter 1! Introduction 
1.1! The protein-folding problem 
Max Pertuz and John Kendrew were awarded the 1962 Nobel Prize in Chemistry for their pioneering 
work using X-ray crystallography to determine the molecular structure of the globular proteins 
myoglobin and haemoglobin; the former of which was the first three-dimensional structure of a 
protein (Figure 1-1).1-2 They found that both molecules were built from Linus Pauling’s ! helices, 
but folded and packed together in intricate manners. Kendrew described the main features of 
myoglobin as its “complexity and lack of symmetry” adding “the arrangement seems to be almost 
totally lacking in the kind of regularities which one instinctively anticipates.”3 Their work raised the 
question of how protein structures are explained by physical principles and subsequently the notion 








The protein-folding problem is concerned with how a protein’s primary linear amino-acid sequence 
dictates its three-dimensional native structure. More specifically, protein-folding studies aim to 
understand the sequence-to-structure relationships that govern how proteins fold.4-5 Since the 
problem was first posed over half a century ago, Dill et al. describe the protein-folding problem as 
having grown from a distinct research question into a self-perpetuating field of science.6 
A landmark in protein science was the postulate that resulted from Christian Anfinsen’s experiments 
on the renaturation of Ribonuclease A.7 He hypothesised that the native structure of a protein is the 
thermodynamically stable state, and that this depends only on its amino-acid sequence and the 
solution conditions, not on the kinetic folding route.8 Further, folding does not depend on whether 
the protein is synthesised in vivo or in vitro. This led Cyrus Levinthal to pose the question of how 
Figure 1-1: Structures of myoglobin and haemoglobin (A) Drawing of the tertiary 
structure of myoglobin as deduced from the 6 Å fourier synthesis. (B) Haemoglobin 
model, haem groups indicated as disks. Images taken from Kendrew and Pertuz  
papers.1-2 
 




do proteins fold to their native state? The Levinthal paradox involves the consideration that a 
polypeptide chain cannot converge on its native state in real-time by a random search because the 
conformational space available to an unfolded polypeptide chain is too large.9-10 Levinthal reasoned 
that the protein must fold through a directed process, or protein folding pathways. 
Energy landscapes and folding funnels are used as a conceptual framework for understanding protein 
folding kinetics (Figure 1-2).11 A protein folds by taking steps that are generally incrementally 
downhill in energy towards a single stable low-energy native state. Folding can occur via multiple 
pathways in the conformational space landscape,12 hence why denatured peptides starting from 
different open conformations can refold to the same native structure. However, this is not always 
the case, there are exceptions in which the biologically active form is kinetically trapped, for 







The folded state of a protein is determined by the cooperation of many weak non-covalent 
interactions including hydrogen bonds, van der Waals interactions, electrostatic interactions and 
hydrophobic interactions.14 Hydrogen bonds are important because they form between backbone 
amide and carbonyl groups in nearly all secondary structure components including ! helices and $ 
sheets. Similarly, the atoms within a folded protein are tightly packed implying van der Waals 
interactions are also important.15 While some amino-acid side chains attract or repel one another as 
a result of negative and positive charges these groups are usually limited to the protein surface and 
so electrostatic interactions are unlikely to be the dominant interaction for folding.4, 16 Given that it 
is the side chains of amino acids that are responsible for the differences between proteins, and not 
the backbone hydrogen bonds, it is thought that hydrophobic interactions between non-polar side 
chains are the dominant driving force for folding. Supporting this view, globular proteins have 
hydrophobic cores where non-polar amino acids are buried from water. Also, studies have shown 
that there is a 1-2 kcal mol-1 benefit for sequestering a non-polar side chain from water into a 
hydrophobic oil-like media.17 
Figure 1-2: The funnel-shaped energy landscape of proteins has few low energy native 
like conformations and more unfolded structures. Image taken from an article by Dill and 
MacCullum.6  
 




Opposing the folding process is a large loss in conformational entropy as the protein collapses to its 
folded state. This penalty is only just outweighed by the enthalpy of forming the non-covalent 
interactions and as a result, native proteins are only marginally stable, approximately  
5-10 kcal mol-1 more stable than their denatured states.6, 14 This subtle balance between forces makes 
predicting the three-dimensional structure of proteins particularly challenging.18-19 One way to 
address the protein-folding problem is to study small folding motifs termed miniproteins. In these 
systems the number of factors that influence the folded state is reduced making them good platforms 
for probing contributions to protein folding and stability both in silico and in vitro.20-23 Larger 
proteins have generally evolved for function as opposed to for stability and so it is harder to 
deconvolute their sequences into the components that are responsible for stability over function. 
1.2! Miniproteins 
Miniproteins are defined as short peptides (approximately ≤ 40 amino acid residues) that usually 
have well-defined globular-like folds with sequestered hydrophobic cores.21 They comprise two or 
more elements of secondary structure and have cooperative folding. While single secondary 
structure components exist and can be cooperatively folded, for example single ! helices (SAHs), 
this is rare and they do not contain a hydrophobic core like globular proteins.24 While the entropic 
cost of folding is lower for miniproteins, their hydrophobic cores are smaller and there are fewer 
non-covalent interactions to stabilise the folded state. This means that many miniproteins rely on 
other methods of stabilisation including metal binding,25 covalent-crosslinking,26 un-natural side-
chain staples,27 cyclisation28 and oligomerisation.29 These miniproteins will be discussed briefly 
later. However, the focus of this thesis is on miniproteins stabilised by non-covalent interactions. 
As well as providing systems to probe various aspects of protein-folding specifically sequence-to-
structure and -stability relationships, miniproteins also have potentially useful applications. For 
instance, they provide scaffolds onto which functional domains can be grafted specifically motifs 
for catalysis, binding and recognition that interfere with protein-protein interactions. Also, 
miniproteins can be used as building blocks to design and engineer larger, more complex folds and 
systems.30-32 Furthermore, they offer a starting point from which to access the dark matter of protein 
space, that is, protein folds that have not been observed before in nature.33-34 
1.2.1! Miniproteins stabilised by metal binding and covalent crosslinking 
1.2.1.1! Zinc fingers 
Zinc fingers (ZnFs) are one of the most widespread protein-folding motifs involved in DNA binding 
and recognition. The most widely studied and engineered ZnF is the Cys2His2 (C2H2)-type.35 The 
C2H2-ZnF is a small independently folded domain with a compact globular structure in which two 
histidine and two cysteine residues coordinate in a tetrahedral manner to a Zn ion. The first NMR 
structure corresponding to a single ZnF from the Xenopus protein Xfin revealed a 25-residues 
peptide composed of a $ hairpin, a loop and an ! helix (Figure 1-3A). Just above where the Zn 
 




binds, Leu and Phe residues form a small hydrophobic pocket; the rest of the amino acids are solvent-
exposed.25 The four amino-acid residues located at the N-terminus of the ! helix participate in DNA 
recognition by interacting with hydrogen donors and acceptors exposed in the major groove of 
DNA.36 The modular assembly of metal-binding ZnF domains has allowed the engineering of 
artificial proteins and enzymes that recognise defined regions of DNA that can activate, repress or 
alter user-specified genes. These have been used in the field of targeted genome editing.37 While 
natural ZnFs require metal binding for folding, their $$! architectures have been engineered to fold 
in the absence of metal ions (see section 1.2.2.2). 
1.2.1.2! EF-hands 
The EF-hand calcium-binding motif plays an essential role in cell signalling.38 The motif, which is 
approximately 35-residues long, comprises two short ! helices separated by a metal-binding loop.39 
The Ca2+ ion binds to the loop in a preferred coordination geometry of seven ligands arranged in a 
pentagonal bipyramid. EF-hands usually occur in pairs to form discrete units in larger domains, most 
commonly containing two, four or six EF-hands. The EF-hand pair is stabilised through hydrophobic 
interactions between helices as well as "-" stacking interactions between single aromatic residues 
in the loop of each EF-hand. While stand-alone single-EF hands do exist, they are generally 
stabilised through dimerization (Figure 1-3B).38 
1.2.1.3! Cysteine knots 
Cysteine-knot miniproteins, often termed knottins, consist of approximately 30 – 40 amino acid 
residues.40 They have an unusual architecture where two disulfide bonds form a ring through which 
a third disulfide bond is threaded. The resulting structure has exceptional stability and resistance to 
proteolysis.41 A subset of these proteins are termed cyclotides, which, as well as having a knot 
framework, are characterised by their head-to-tail cyclised peptide backbone. Kalata B1 was the first 
cyclotide miniprotein to be structurally characterised (Figure 1-3C).42 It has three antiparallel $ 
strands stabilised by mainchain and side-chain hydrogen bonds and hydrophobic clusters. It also has 
a number of well-ordered tight turns stabilised by an extensive hydrogen bond network. A number 
of Gly residues are conserved in the turn regions of the cyclotide framework where adaptability of 
the backbone geometry is important. A Glu residue is also conserved that is involved in key 
hydrogen-bonding interactions. 
Cysteine knots play roles in various biological processes acting as enzyme inhibitors, hormones, 
growth factors, toxins, and host-defence molecules.43 Their exceptional stabilities and well-defined 
structures make them promising scaffolds for molecular engineering and pharmaceutical 
applications.26 While knottin cores are conserved, the loops between Cys residues are tolerant to 
mutation and have shown a broad range of sequence diversity thus making them suitable candidates 
for grafting bioactive epitopes.42For example, the Cochran lab have used directed evolution to 
engineer knottin peptides to bind with nanomolar affinity to integrin receptors which are 
overexpressed in a variety of cancers.44-45 
 




Overall, considerable progress has been made in the field of miniproteins stabilised by covalent-
crosslinking and metal binding. Naturally occurring pharmacologically active miniproteins have 
shapes that are highly complementary to binding pockets on their targets. These peptides combine 
the stability and cell permeability of small molecules with the binding affinity and target specificity 
of larger protein-therapeutics and therefore are attractive drug molecules.46-49 Consequently, effort 
has focused on reengineering naturally occurring miniproteins to generate new bioactive 
molecules.44 However, these approaches are hampered by the limited variety of naturally occurring, 
constrained miniproteins and the lack of global shape complementarity with the target. In response 
to this problem, the Baker group have recently developed computational methods for the accurate 
de novo design of miniproteins stabilised by disulfide crosslinks.50 12 experimentally determined X-
ray and NMR structures of miniproteins that are 18 to 47 residues long containing both canonical 
and non-canonical amino acids have been solved revealing very close matches to the 
computationally-designed models (Figure 1-4). These miniproteins span a broad range of topologies 
incorporating multiple secondary structure components. The miniproteins were designed using the 
Rosetta software suite.51 Large numbers of peptide backbones were randomly generated, 
combinatorial sequence design calculations were performed to identity sequences that stabilised 
each backbone conformation, and finally designed sequence/structures were assessed to determine 
which ones were in deep energy minima, that is, which ones had a large energy gap between the 
designed structure and alternative conformations.50 
 
 
Figure 1-3: NMR structures of miniproteins stabilised by metal binding and covalent 
crosslinking. (A) Single ZnF (PDB: 1ZnF). (B) Homodimeric EF-hand (PDB: 1CTA). (C) 
Kalata B1 cyclotide (PDB: 1NB1). Metal ions shown as pink spheres. Hydrogen bonds 
shown as dashed lines. Images generated using PyMol. 
 

















1.2.2! Miniproteins stabilised by non-covalent interactions 
The focus of this thesis is on non-covalently stabilised miniproteins. While the majority of 
miniproteins observed and studied are stabilised by covalent crosslinks and metal ions, it is non-
covalently stabilised miniproteins that will allow in depth examination of fundamental sequence-to-
stability relationships without the complications of stability aids or larger protein contexts. Over the 
past half-century the majority of non-covalently stabilised miniproteins described have been 
fragments of larger natural proteins that have undergone iterative rounds of redesign and 
optimisation to enhance stability or introduce functional motifs. This has resulted in general design 
rules for miniproteins and a greater appreciation for and understanding of the non-covalent 
interactions present in such structures. More recently, high-throughput methods have also been used 
to design miniproteins.52-53 
 
Figure 1-4: NMR and crystal structures of the hyper-stable constrained miniproteins 
designed by the Baker lab. (A-D) Backbone cyclised miniproteins. (E-G) Miniproteins 
incorporating both L- and D-amino acids. (H-L) Genetically encodable miniproteins. 
Note: (J) is an X-ray crystal structure (A-I,K,L) are NMR structures showing overlays of 
all states in each ensemble. Coloured blue to red from N to C terminus. Disulfide bond 
crosslinks shown in yellow. PDB codes: 5JG9, 2ND2, 2ND3, 5JHI, 5JI4, 5KVN, 5KWO, 
5KWP, 5KX2, 5KWZ, 5KX1, 5KX0. Images generated using PyMol. 
 




1.2.2.1! Pancreatic polypeptides 
The polyproline-II:loop:! helix topology was first observed in the X-ray crystal structure of the 
avian pancreatic peptide (aPP) dimer (Figure 1-5A).29 Pancreatic peptides are usually 36 residues 
in length and adopt a well-defined hairpin structure in water. The compact fold is stabilised by the 
interdigitation of Pro residues from the polyproline-II helix and aromatic residues stacked on the ! 
helix forming a hydrophobic core. aPP is a symmetric dimer stabilised by the intermolecular "-
stacking interaction between Tyr residues and is maintained in solution above micromolar 
concentrations.54-55 Indeed, most natural pancreatic peptides dimerise in solution. This has driven 
engineering and design of monomeric variants with a focus on developing miniprotein-based ligands 
as therapeutics. 
The Schepartz lab have used the aPP fold extensively as a scaffold to present !-helical and 
polyproline-II-helical recognition epitopes. For example, a synthetic monomeric aPP analogue 
named pGolemi was engineered that binds strongly (Kd 700 nM) to the Mena EVH1(enabled/VASP 
homology 1) domain of the Actin assembly-inducing protein (Acta) from Listeria monocytogenes.56-
57 EVH1 domains regulate actin filament dynamics and, similar to SH3 and WW domains, they 
recognise proline-rich sequences that are folded into polyproline-II helices. pGolemi was designed 
by grafting a polyproline-binding domain onto the N-terminal polyproline-II helix of aPP. As well 
as having high affinity for EVH1, 10-fold higher than the best previously known EVH1 ligand 
Acta11,58 pGolemi also discriminates between paralogs and reduces bacterial motility.  
A similar sequence-grafting strategy has been used for the aPP variant p007, which presents the !-
helical recognition epitope found on the bZIP protein GCN4 and binds DNA with nanomolar affinity 
and high specificity.59Also substitution of Arg residues for residues located on the ! helix of aPP 
help facilitate cell permeability without significant loss of helicity or thermal stability.60 
Furthermore, the bovine pancreatic peptide (bPP) has been designed as an artificial esterase to 
catalyse the hydrolysis of p-nitrophenyl esters. To do this His residues have been grafted onto the 
solvent exposed face of the ! helix.61 
1.2.2.2! $$! folds and metal free zinc fingers 
Small, independent $$! units are best exemplified by ZnFs as mentioned in section 1.2.1.1. While 
folding of natural ZnFs is driven by metal binding as opposed to the hydrophobic core, as noted 
above, several research groups have targeted this fold for metal free designs. In 1996, Struthers et 
al. obtained a 23-residue monomeric metal free $$! motif through an iterative design process in 
which amino acids were selected that would enhance the inherent secondary structure of the 
polypeptide.62 The final design incorporated a suitable turn that more effectively promoted $-hairpin 
formation, a D-Pro and a non-natural amino acid. The NMR structure revealed that the ! helix and 
$ hairpin are held tightly together by a defined hydrophobic core. Interestingly, the solution structure 
reveals the motif is more open than in the natural ZnFs. Struthers states this groove may be useful 
for catalysis or the design of enzyme mimics. Truncating the loop between $ hairpin and ! helix 
 




prevents the hairpin folding back on the ! helix exposing a hydrophobic surface and promoting 
homo-oligomerisation.63 
A year later, a computational design using only proteogenic amino acids was reported by Dahiyat et 
al.64 A combinatorial design algorithm was used to screen a combinatorial library of 1.9 % 1027 amino 
acid sequences for compatibility with the target $$! topology.65-66 The design was validated 
experimentally by NMR spectroscopy (Figure 1-5B). The backbone RMSD between the average 
NMR state and the design target was 1.98 Å. The peptide had a TM of 39 °C, with weakly cooperative 
and completely reversible unfolding curve. The broad melt transition observed is consistent with a 
low enthalpy of folding, which is to be expected for a peptide with a small hydrophobic core. 
1.2.2.3! Villin headpiece 
Another approach to  miniprotein design is to pare down larger natural proteins. Villin is an F-actin-
bundling protein involved in microvilli formation in absorptive epithelia.67 In 1997, NMR 
spectroscopy of the C-terminal 35 residues of the chicken villin (HP-35) in aqueous solution 
revealed a well folded peptide consisting of three !-helical segments with each helix contributing 
residues to the central hydrophobic core (Figure 1-5C).68-69 HP-35 is surprisingly thermostable with 
a TM of 70 °C. 
1.2.2.4! $ Hairpins and Trp-zippers 
Many research groups have explored β hairpin formation in naturally derived and designed systems. 
Early design efforts resulted in free-standing β structures based on natural fragments, which were 
only moderately folded in aqueous media.70-71 However since then more-folded structures have been 
attained through largely iterative processes as well as some combinatorial screening.72 Trp-zippers 
(12-16 residues in length) are well-studied examples of short β-hairpins with interlocked Trp 
residues showing edge-to-face packing against one another (Figure 1-6A).73-74 The β sheets are 
highly twisted and the peptide is also stabilised by capping residues at the termini to permit cross-
Figure 1-5: Structures of miniproteins. (A) X-ray structure of avian pancreatic peptide 
dimer (PDB: 1PPT). (B) NMR structure of metal free ZnF (PDB: 1PSV). (C) NMR 
structure of Villin Headpiece (PDB:1VII). Colour key: aromatic and hydrophobic residues 
(pink), "-" stacking between Tyr residues in aPP dimer (yellow), Pro (blue). Images 
generated using PyMol. 
 




strand hydrogen bonding. These miniproteins are highly folded monomers exhibiting exceptional 
thermal stabilities (TM 50 – 79 °C) and reversible cooperative unfolding curves. Chignolin is another 
example of a minimal β hairpin (10 residues) and is stabilised by the edge-to-face packing of Tyr 
and Trp residues.75 The peptide shows cooperative folding albeit with a broad thermal melt curve 
(TM 39 °C). The chignolin peptide has been used in phage display to identify a nanomolar binder of 
the Fc region of antibody immunoglobulin G.76 Trp-pocket β hairpins are stabilised by cation−π 
interactions in which Lys packs against a diTrp cleft on the opposite strand.77 Some Trp-pockets are 
near fully folded and can only be unfolded with high concentrations of denaturant or elevated 
temperatures.  
Overall, there has been substantial work in the field and as a result a number of general guidelines 
can be considered to ensure the successful design and stabilisation of monomeric β hairpins78: a 
hydrophobic cluster on one surface of the hairpin close to the loop region;79-80 inter-strand side-chain 
interaction with particular focus on Trp-Trp interactions;73, 81-82 high β-sheet and turn propensities;83 
and charged, aromatic residues or β-capping motifs at the termini.84 
1.2.2.5! Designed three-stranded $ sheets 
Initial designs of three-stranded $-sheets have been achieved by appending a third strand onto 
previously characterised $ hairpins.85-88 Most of these constructs however are largely unfolded in 
purely aqueous media and require  methanol to fold. One successful example, however, incorporates 
a Pro-Gly turn and N-methylated amino acids in the first and third strands to prevent amyloid-like 
aggregation.88 The 23-residue peptide is a soluble monomer and folds upon heating. No high-
resolution, structural data has been reported, the peptide is characterised by circular dichroism (CD) 
spectroscopy, size-exclusion chromatography and 1D NMR line shape analysis. 
A 20-residue peptide named Betanova has been designed that forms a monomeric, three-stranded, 
antiparallel $-sheet.85 The NMR structure reveals that the peptide is stabilised by an aromatic-rich 
hydrophobic cluster on one face of the $ sheet. However, subsequent more in-depth studies show 
that Betanova is only partially folded.89 This has led to the redesign of the fold through 
computationally informed point mutations that resulted in a more-stable structure.90 
The Gellman lab has designed a parallel triple-stranded $-sheet by incorporation of non-peptide 
linkers that connect pairs of strands in a parallel orientation.91 The solution structure reveals the 
desired peptide fold and CD spectroscopy shows a cooperative thermal unfolding transition. 
Enhanced folding is observed for the three-stranded-sheet relative to each two-stranded parallel 
hairpin component. 
WW domains are natural antiparallel three-stranded $-sheets and are one of the smallest naturally 
occurring folds. Their name reflects the conserved Trp residues in the first and third strands. WW 
domains mediate protein-protein interactions with short proline-rich motifs.92 The first structure of 
a WW domain was for human Yap65 in complex with its ligand.93 Following this, shorter WW 
 




domains have been isolated of 34 and 37 residues in length in absence of bound ligands.94 Based on 
a systematic analysis of conserved residues in the WW family, a 36-residue folded prototype WW 
sequence has been designed and an NMR structure determined (Figure 1-6B).94 It must be noted, 
however, that the prototype is less thermally stable than natural $-sheets (TM 44 °C ). WW domains 
have been re-engineered to incorporate different functions for example a DNA binding pocket that 







1.2.2.6! The Trp-cage 
The Trp-cage is a highly and cooperatively folded 20-residue miniprotein truncated from the 39-
residue extendin-4 (EX4) peptide found in Gila monster saliva. Original truncation of the C-terminal 
portion of EX4 resulted in a peptide that was only folded in the fold-promoting cosolvent 2,2,2-
trifluroethanol (TFE).96 However, a series of incremental sequence modifications has led to a well-
ordered fold comprising an N-terminal ! helix followed by a structured loop with a hydrophobic 
core centred on a single Trp residue surrounded by Pro side chains (Figure 1-7A).96 It is noted that 
the high Pro content may contribute to the stability of the peptide by limiting the conformational 
entropy loss associated with folding. In contrast to this, the peptide also has high Gly content – the 
most flexible and least rigid of all the natural amino acids. Gly flexibility may however allow the 
backbone to contort and further finetune the tertiary fold. Together, Gly, Pro and Trp form an 
organised fold with tightly buried side-chain interactions.97 Further mutations to the Trp-cage has 
seen increases in thermal stability with TMs up to 64 °C.98 Cyclisation of one variant gave a TM of 
95 °C.99 The Trp-cage has lent itself as a prime target for computational study as a result of its small, 
well folded nature and the large amount of structural data.20, 100 
1.2.2.7! $!$ Designs 
Extended βαβ repeats are widely observed in natural proteins, for example: TIM barrels consist of 
eight α helices and β sheets that alternate along the chain forming a closed barrel like structure;101 
the Rossmann fold is a structural motif found in proteins that bind nucleotides and forms an open 
Figure 1-6: Structures of miniproteins. (A) NMR structure of Trp-Zipper (PDB:1LE3). 
(B) NMR structure of the prototype WW domain (PDB: 1E0M). Colour key: aromatic 
residues (pink), Pro (blue). Images generated using PyMol. 
 




sheet structure;102 and Leu-rich repeats form a structural motif that resembles an α/β horseshoe.103 
The alternating secondary structures lead to parallel β sheets and parallel α helices. 
The first de novo design of a stand-alone water-soluble βαβ motif was reported in 2009 (Figure 
1-7B).104 The design comprises a 12-residue α helix, selected after a statistical analysis of the helix 
length in natural α/β proteins, paired with two five-residue β strands which were of corresponding 
length. Sequences were selected based on secondary-structure preferences. An amphipathic helix 
was designed with Leu and Ala on the hydrophobic face and electrostatic interactions between Glu 
and Lys were arranged on the opposite face. Ile and Val were placed on the parallel β sheet forming 
a hydrophobic pocket in the core of the miniprotein. Initial designs were molten globule. To obtain 
the stable folded state, a Trp-Trp pair in the β strands, similar to Trp-zippers, was introduced.73 An 
NMR structure of the final 36-residue design reveals face-to-face packing of the pair. The βαβ motif 
is highly thermally stable up to 90 °C. This is exceptional for a peptide containing only natural 
proteinogenic amino acids and without disulfide bonds or metal binding.  
1.2.2.8! TrpPlexus 
TrpPlexus is a 19-residue miniprotein with a β strand:loop:polyproline-II helix topology designed 
using a fragment-based approach (Figure 1-7C).105 The N-terminal β strand is rich in Arg residues, 
while the C-terminal polyproline-II strand is Trp rich with a WSXWX motif. Despite the name, the 
polyproline-II helix does not contain any Pro residues. The sequences for the β strand and 
polyproline-II helix are borrowed from a fibronectin type III (f3) binding domain and are connected 
with a D-Pro,Gly loop. The NMR structure of TrpPlexus shows the interdigitation of Trp and Arg 
residues, which leads to cation-" interactions. This network of solvent exposed cation-" interactions 
offers an alternative to hydrophobic-core packing. TrpPlexus is monomeric with a broad thermal 
unfolding transition. However, the unfolding transition sharpened when unfolding was measured as 
a function of guanidinium chloride concentration showing a two-state sigmoidal transition.  
Further work by the Kirshenbaum group synthesised a disulfide cyclised variant and showed its 
tolerance for N-substituted Gly and Pro resides in the polyproline-II helix.28 The ability to 
incorporate a broad variety of monomer types in the polyproline-II helix provides opportunities for 
developing peptide and peptidomimetic inhibitors that can target PXXP motif-binding proteins and 











1.2.2.9! High-throughput methods to miniprotein design 
In recent years, high-throughput methods have been used in miniprotein design. The Baker group 
have used parallel protein design on a large scale to build thousands of new miniprotein variants and 
determine what sequence motifs stabilise these small structures.52, 106 In their approach miniprotein 
structures were designed computationally using a fragment-based approach in Rosetta. Four target 
topologies are described - !!!, $!$$, !$$!, $$!$$ - of which only the !!! topology is observed 
in nature within their target size range of 40 to 43 amino acids. Libraries of amino-acid sequences 
were generated to fit best each of these structures. These proteins were obtained via high-throughput 
DNA synthesis and cloning. The resulting miniproteins were displayed on the surface of yeast so 
that every cell had many copies, with each protein genetically fused to an expression tag that was 
fluorescently labelled with an antibody and subsequently exposed to protease. Stable variants were 
distinguished from unstable variants based on their resistance to protease treatment. Protease 
cleavage of the miniprotein led to loss of the tag and loss of fluorescence. The cells that retained 
fluorescence after proteolysis were then isolated by fluorescence-activated cell sorting and identified 
by deep sequencing. The isolated miniproteins were characterised and their sequences analysed for 
sequence-to-stability relationships which could be fed back into the design cycle. Iteration between 
design and experiment improved design success rate from 6% to 47%. 
From sequence analysis of these new stably folded miniproteins Rocklin et al. highlight key 
sequence and structural features: firstly, the amount of buried non-polar surface area from 
hydrophobic amino acids. While this is well established, they quantify its importance showing that 
stable variants need at least 30 Å2 per buried residue. The study also revealed the importance of 
having charged side-chain residues at the termini of ! helices that balance the terminal partial 
charges of the helices. Overall, four high-resolution miniprotein structures of each target topology 
were obtained by NMR spectroscopy (Figure 1-8). 
Figure 1-7: Structures of miniproteins. (A) NMR structure of the Trp-Cage (PDB:1L2Y). 
(B) NMR structure of a $!$ motif (PDB: 2KI0). (C) NMR structure of TrpPlexus (PDB: 
n/a, see ref 105. Colour key: aromatic residues (pink), Pro (blue), Arg (green). Images 
generated using PyMol. 
 




1.2.3! Common features of miniproteins 
Whether the entropic cost of folding is less for small proteins or not, enthalpically favoured 
interactions still need to be made to form a stable, folded 3D structure. Inherent to their small size, 
miniproteins make fewer non-covalent interactions. Experimentally, this is apparent from the 
broader melt curves in CD spectroscopy, which are indicative of low enthalpies of folding.64 This is 
consistent with miniproteins having small hydrophobic cores. Therefore, to form stable miniproteins 
the non-covalent interactions that are made need to be optimal. 
The stable miniproteins described above have many common features in terms of both sequence and 
structure. These can be analysed to understand and refine the most important non-covalent 
interactions needed for creating stable miniprotein folds. A bioinformatics analysis of miniproteins 
in the PDB by the Woolfson group revealed that some classes of amino acids are more prevalent in 
miniproteins compared to larger proteins,21 including: electron-rich aromatics, in particular Tyr and 
Trp residues; long and charged amino acids for example Arg, Glu and Lys; and Pro residues. In 
contrast, it was found that small non-polar amino acids are more prevalent in larger proteins. This 
suggests that these aromatics and the longer charged residues may form more optimal non-covalent 
interactions such as CH-" interactions, cation-" interactions, "-" interactions and salt bridges. 
Furthermore, it is noted that CH-" interactions are six times more dense in miniproteins compared 
to larger proteins. The prevalence of Pro may be due to reducing conformational entropy. 
In the examples studied, the observed hydrophobic cores often have aromatic residues in contact 
with residues such as Pro and Arg leading to networks of CH-" and cation-" interactions, 
respectively. High proportions of Pro residues also likely reflects their ability to reduce the entropic 
cost of folding through their fixed torsion angle. Related to this, the backbones of miniproteins are 
more contorted and make better use of structured loops compared to larger counterparts. The 
Figure 1-8: Designed peptide from the Baker lab using high-throughput methods. (A) 
!!! topology (PDB: 5UOI). (B) $!$$ topology (PDB: 5UP5). (C) !$$! topology 
(PDB: 5UYO). (D) $$!$$ topology (PDB: 5UP1). Coloured blue to red from N to C 
terminus. Images generated using PyMol. 
 
 




contorted backbones likely helps sequester hydrophobic residues and pack them more tightly in their 
core. 
The ! helix secondary structure is a common building block in both miniproteins as well as larger 
proteins and are observed in similar proportions for each class. While examples of free-standing ! 
helices have been observed in nature and have also been designed they are more commonly observed 
in tertiary and quaternary structures, the most common of which is the !-helical coiled coil.24, 107 
1.3! Coiled coils: sequence, structure and function 
!-Helical coiled coils are ubiquitous folding motifs consisting of a two or more helices wrapped 
around each other to form supercoils.108 Constituting approximately 3 % of all protein-encoding 
regions of the known genome,109-110 coiled coils have a broad range of functions including structural 
roles, DNA binding and mediating protein-protein interactions.111-113 While predicting the structure 
of proteins from their primary amino-acid sequence is difficult for the majority of proteins, there are 
well-established rules and sequence-to-structure and -stability relationships for coiled coils. 
Arguably, it is the best understood of all protein structures. Furthermore, we are able to predict their 
structures and also design new sequences that fold into well-defined assemblies.114-117 The sequence 
and structural features of coiled-coil peptides are discussed below. 
The primary sequence of the majority of coiled-coil regions consists of a seven-residue repeat 
commonly known as a heptad repeat in which residues are labelled abcdefg. These repeats have 
hydrophobic (H) and polar (P) residues arranged in the pattern HPPHPPP; i.e. hydrophobics occupy 
the a and d positions of the a through g repeat. While there are variations on this pattern, generally 
consisting of different combinations of HPP and HPPP sequences, we will focus on the most 
common heptad pattern.118-119 The identity of the hydrophobic and polar amino acid residues dictates 
the final structure of the assembly, including helix orientation (parallel or antiparallel), 
oligomerisation state, and homotypic or heterotypic assemblies.120-124 
The primary sequence of a coiled coil folds into !-helical secondary structure elements which are 
stabilised by backbone hydrogen bonds between donor HN atoms at residue i and carboxyl oxygen 
atoms at residue i+4 (Figure 1-9A). These hydrogen bonds lie parallel to the helical axis.125 The 
canonical right-handed ! helix can be described by a number of parameters, including: the rise per 
residue, equal to 1.5 Å; the residues per turn, equal to 3.6; the helix radius, equal to 2.3 Å; and phi 
(&) and psi (') torsion angles, in the region of –63° and –43° respectively  









Other secondary structures found in folded proteins include: polyproline-II helices (discussed in 
detail in Section 1.4.1), $ sheets, 310 helices, and " helices. Their corresponding torsion angles are 






310 and " helices are stabilised by hydrogen bonds between peptide amide and carbonyl groups of 
residues (i, i+3) and (i, i+5) respectively. Both structures are rare, the 310 helix is usually found at 
the ends of ! helices, while the " helix has only been observed in a handful of structures persisting 
for, at most, only a couple of turns.128-129 The majority of designed 310 helices contain non-natural 
amino acids, in particular !-aminoisobutyric acid (AIB) residues which contain a second methyl 
group attached to the C! atom.130 Alongside ! helices, $ strands are the other major structural 
element found in globular proteins.131 $ strands are arranged adjacent to other strands and associate 
by hydrogen bonding to form a $ sheet-like structure which, in the majority of cases, is twisted. $ 






residue / Å 
Radius of 
helix / Å 
! helix +3.6 1.5 2.3 
310 helix +3 2 1.9 
" helix +4.3 1.1 2.8 
Polyproline-II –3.0 3.1 1.6 
$ strand –2.3 3.3 1.0 
Table 1-1: Examples of secondary structures and their parameters. 
Figure 1-9: The parameters that describe ! helix secondary structure. (A) ! helix showing 
hydrogen bonding between backbone NH and C=O groups of residues i to i+4 apart. (B) 
! helix showing the rise per residue and residue per turn parameters. (C) View down ! 
helix from the N-terminus highlighting helical axis and radius of the ! helix. 
 




Ramachandran space. They can interact in parallel or antiparallel orientations, each with a distinctive 
hydrogen-bonding pattern and side chains alternating above and below the sheet. 
Given that the ! helix repeats itself every 3.6 residues and hydrophobic side chains are spaced at 
combinations of three and four residues in the HPPHPPP sequence repeat, an amphipathic helix is 
formed when the heptad is projected onto a helical wheel (Figure 1-11A&B).132-133 The hydrophobic 
effect is a key driving force in most biological self-assembling processes. This phenomenon results 
in biological molecules in aqueous solution folding or self-assembling to minimize the hydrophobic 
surface area in contact with the bulk solvent. Therefore, in the context of coiled coils, amphipathic 
helices come together to bury their hydrophobic a and d residues (Figure 1-11C). 
When ! helices wrap around each other they form left-handed super-helical coiled coils. The 
supercoiling results from a mismatch in periodicity between the heptad repeat (H residues on 
average every 3.5 residues) and the ! helix (3.6 residues per turn) and thus an a/d hydrophobic seam 
winds slowly around the right-handed helix in a left-handed manner. Given the regular nature of 
coiled coils, their structures can be described by three geometric parameters, as first described by 
Crick in 1953134-135: radius, interface angle and pitch (Figure 1-11D). A range of software 
applications have built upon these parameters allowing for the parametric modelling of coiled coils. 
Hardbury et al. used the Crick equations to help design a right-handed coiled-coil tetramer,136-137 
Woolfson et al. modified the Crick equations to allow non-canonical repeats to be modelled138 and 
De Grado et al. has developed a method for fitting Crick parameters to known coiled-coil 
structures.139 More recently, CC-Builder and ISAMBARD have been developed for building and 
optimising models of coiled coils of a broad range of oligomeric states.140-142 Further, the 
Figure 1-10: Torsion angles and Ramachandran space. (A) section of an ! helix showing 
the torsion angles &, ', and (. The planarity of the amide bond restricts ( to be 180°. (B) 
Ramachandran plot highlighting ! helix region in orange and polyproline-II helix region 
in red. Modified from reference 126. 
 
 




ISAMBARD framework can be used to model any protein fold that is parameterizable; that is, folds 
that have a regular structure and can be described by mathematical parameters. 
When the ! helices of coiled coils wind around each other the side chains at the interface do not 
simply contact each other. Instead, the ! helices take part in intimate side-chain-packing 
interactions. A side chain referred to as a “knob” on one helix interdigitates with a diamond-shaped 
“hole” made up of four residues on a partnering helix. This type of intimate packing was first 
postulated by Crick and is termed “knobs-into-holes” (KIH) packing (Figure 1-11E&F).143 For 
example, in parallel coiled coils, an a knob docks into a dgad hole and a d knob docks into an adea 
hole. 
1.3.1! Oligomer-state specification 
The connection between sequence and KIH packing was first discussed in seminal work by Harbury 
et al.120, 144 In their experiments they found that mutating the core a and d positions of leucine-zipper 
peptide GCN4-p1 to combinations of Leu, Ile and Val residues resulted in changes to the oligomeric 
state of the assembly: when Ile and Leu were placed at a and d, respectively, a dimer was formed; 
Ile at both positions resulted in a trimer; and Leu at a and Ile at d gave a tetramer. This result was 
rationalised in terms of how the a and d side chains project towards their partner helix. In dimers, 
the a position projects out of the interface while the d position projects towards the interface. These 
projections change with changes in oligomerisation state. In dimers, a and d participate in parallel 
and perpendicular packing, respectively. Parallel packing is where the C!–C$ bond vector of the 
knob residue points parallel to the vector between the C! positions of the hole residues on the 
corresponding helix while in perpendicular packing the knob C!–C$ bond vector points 
perpendicular. In tetramers this packing is swapped over, while in trimers packing is somewhere 
between the two and is referred to as acute packing. Leu is most tolerated at perpendicular sites 
while beta-branched Ile (and Val) is preferred at parallel or acute sites. Perpendicular and parallel 
packing are discussed further in Section 4.1.1. 
Harbury’s experiments paved the way for future work in the field of coiled-coil design. Extensive 
work has since been carried out into the design and specification of both lower (< 5 helices in 
assembly) and higher-order coiled coils (>4 helices in assembly).32, 145-147 The oligomeric state of 
such coiled coils is determined by the interhelical interfaces present in their assemblies. The addition 
of helices from dimer through to tetramer leads to increased inclusion of peripheral residues (as well 
as a and d) within the hydrophobic core of the assembly. In particular, residues at g become knobs 
as well as just being part of the hole residues. These are referred to as Type I interfaces compared 
to the classical Type N interfaces, which are present in coiled-coil dimers (Figure 1-12). Increasing 
the hydrophobic core to include e knob residues as well leads to Type II interfaces and specifies 
pentamers through to heptamers. Type III assemblies have two distinct hydrophobic seams with a 
single intervening residue between them and specify even larger assemblies such as the 12-helix 
barrel of TolC.148 
 





Figure 1-11: Structure of !-helical coiled coils. (A) Projecting the heptad HPPHPPP 
repeat onto a helical wheel results in a seam of hydrophobic residues. Orientation of the 
leaf shape shows the direction of the C!-C$ bond vector. N refers to the helix terminal 
nearest the viewer. (B) Amphipathic helix. (C) Coiled-coil dimer showing hydrophobic 
seam in orange. View down the coiled-coil axis shown on right. (D) Geometric parameters 
describing coiled coils: Interface angle (°), radius (Å), and pitch (Å). (E) Knobs-into-holes 
packing in coiled coils. (F) Helical nets for two identical ! helices (left, N termini at the 
top, positions of C! shown as circles) and superimposed helices (right) to show tight KIH 
packing in a coiled-coil interface. The core a and d residues are highlighted as filled 
circles. 
 




Using these sequence-to-structure relationships as rules for protein design, a basis set of de novo 
designed peptides has been achieved for oligomeric states from dimer through to heptamer.32, 145 X-
ray crystal structures of these assemblies are shown in Figure 1-13. The higher-order coiled coils 
(>4  helices) have central open-ended channels and, therefore, are !-helical barrels. For these barrels 
the a and d sites are predominantly occupied by Leu and Ile residues. The residues at e and g 
essentially fine-tune oligomeric state selection: for CC-pent (five helices in the assembly) the 
flanking e and g residues are large Ile and Glu residues, respectively; in CC-Hex the e position is 
Ala and the g position is Glu or Ser; while in CC-Hept both e and g positions are Ala. Thus, in 
general, the smaller the residues at e and g the larger the helix-helix-helix interface angle and 
therefore the larger the barrel.  
These defined and well-characterised coiled coils have been used as building blocks for the reliable 
construction of more complex assemblies. Brodsky et al. used a homotrimeric coiled coil to promote 
folding of a recombinant bacterial collagen.149 Many collagen helices appear to require adjacent 
globular domains to assist folding. Brodsky et al. successfully replaced a natural trimerization 
domain with a de novo designed peptide. The coiled-coil “toolkit” has been engineered to make 
peptide fibres with detailed structural characterisation by cryoTEM.150 Further, using a peptide 
Figure 1-12: Coiled-coil interfaces. (A) Type N interface, found predominantly in 
dimers. (B) Type 1 interface found in trimers and tetramers. (C) Type II interface found 
in tetramers to heptamers. (D) Type III interface found in octamers and above. Coloured 
residues show “knobs” in KIH packing. Colour key: parallel packing (red), perpendicular 
packing (blue), acute packing (purple). The angle between two hydrophobic seams is 
highlighted in orange is termed the interface angle. Adapted from reference 113. 
 




origami approach, Jerela et al. have combined six coiled-coil pairs in a single polypeptide to direct 
the folding of a tetrahedron nanostructure.151 Functional residues can also be introduced into the 
lumen of the higher order coiled coils. A Cys-His-Glu catalytic triad was successfully introduced 
into the pore of CC-Hept and showed hydrolytic activity.152 This is the first example of a functional 
catalytic triad engineered into a de novo protein scaffold. 
1.4! Hybrid coiled-coil miniprotein: PP! 
Recently, the Woolfson group used a fragment based design approach to create a stable, monomeric 
coiled-coil-hybrid miniprotein named PP!.153 While coiled coils are stabilised by burying the 
hydrophobic residues in each amphipathic helix by oligomerisation, PP! is stabilised by the 
buttressing of an ! helix with a polyproline-II helix. Overall, PP! comprises an N-terminal 
polyproline-II helix, a loop region and a C-terminal ! helix. 
1.4.1! Polyproline-II helix secondary structure 
Polyproline-II helices have long been recognised as the dominant conformation in the collagen triple 
helix (Figure 1-14A).154 The characteristic structure is composed of a three-residue repeat Xaa-Yaa-
Gly sequence where Xaa and Yaa are often Pro and Hyp (hyroxyproline), respectively. The triple 
helix contains a one residue stagger, which allows Gly to pack in the core of the structure. More 
recently, the polyproline-II helix has emerged as a structural class not only of fibrous proteins but 
also of folded and natively unfolded proteins more generally. Bioinformatics analyses of the PDB 
show that 2 % of all residues in the PDB adopt polyproline-II conformation.155-158 While this is 
significantly lower than that of the ! helix and $ structure, it is comparable to that of 310 helices. 
Despite its name, the presence of Pro residues in polyproline-II helix is not a prerequisite (See 
Figure 1-13: X-ray crystal structures of the de novo designed basis set ranging in 
oligomeric state from two to seven helices. CC-Di (red, PDB 4DZM), CC-Tri (orange, 
PDB: 4DZL), CC-Tet (green, PDB: 3R4A), CC-Pent (teal, PDB: 4PN8), CC-Hex (blue, 
PDB: 3R3K), CC-Hept (purple, PDB: 4PNA). Images generated using PyMol. 
 
 




TrpPlexus, Section 1.2.2.8). Indeed, up to 46 % of polyproline-II helices in folded peptides and 
proteins do not contain Pro residues.159 
The polyproline-II helix is an extended left-handed helix defined by torsion angles in the region of 
& = –75° and ' = 145°. It has a rise per residue of 3.1 Å compared to 1.5 Å for ! helices and in the 
ideal form has three residues per turn; this number can vary slightly in natural structures (Figure 
1-14B).160 As a result of its extended character and the fact that the backbone amino and carboxyl 
groups point away from the helical axis, the polyproline-II helix does not support regular patterns 
of intrachain hydrogen bonds. Instead the helix is stabilised by main-chain hydrogen bonds with 
water molecules as well as side chain-main chain hydrogen bonds, specifically, the Gln side chain 
can participate in a hydrogen bonds with the backbone carboxyl oxygen of the preceding residue.156 
Also stabilisation is achieved through protein-protein interactions.159 Polyproline-II helices are more 
flexible in comparison to ! helices, although this flexibility is partially reduced when Pro is present 








Polyproline-II helices play an important role in both protein-protein as well as protein-nucleic acid 
interactions and mediate a wide range of molecular functions.161 They are considered the most 
widely spread binding motif in proteins. Their important role in binding is a result of their flexible 
structure and preferred location on the surface of proteins. The absence of intrachain hydrogen bonds 
means the helix is more flexible and can adjust its conformation to form hydrogen bonds to its target. 
Examples of recognition domains that bind ligands in the polyproline-II conformation include SH3, 
WW, EVH1, GYF, UEV and profilin domains.160 Specific examples are discussed in more detail in 
Section 1.2.1 and Chapter 6. 
Compared to ! helix and $ sheets, polyproline-II helices have not gained widespread interest. While 
this is mainly due to their low frequency of occurrence it is also because there are only a few methods 
Figure 1-14: Structure of collagen and polyproline-II helices. (A) Crystal structure of a 
collagen-like peptide (PDB: 1CAG). (B) Segment of a polyproline-II helix highlighting 
ideal residue per turn of 3 and a rise per residue of 3.1 Å. Images generated in PyMol. 
 




for polyproline-II assignment. The most widely used secondary structure assignment method, DSSP, 
which is used by the PDB does not assign polyproline-II helices. DSSP assigns secondary structure 
on the basis of particular hydrogen bonding patterns. Several secondary structure assignment 
methods that do include polyproline-II helices, for example XTLSSTR,162 PROSS,163 and 
SEGNO164 give divergent results. A new consensus assignment method (DSSP-PPII) however, 
based on the ‘coil’ class of DSSP, is in good agreement with earlier methods.165 DSSP-PPII assigns 
polyproline-II helices based on at least two consecutive residues being within the torsion angle range 
& = –75 ± 30° and ' = 145 ± 30°. 
1.4.2! PP! design and characterisation 
The PP! design borrowed components from two natural structures: the bacterial surface adhesin 
and antigen (AgI/II) in Streptococcus mutans, and the bovine pancreatic peptide hormone (Figure 
1-15).55, 166 In both structures a polyproline-II helix and ! helix combine to form a tertiary structure 
in which Pro residues on the former interdigitate with Tyr residues presented by the latter. 
Streptococcus mutans is the causative agent of human tooth decay and AgI/II has become a target 
for protective immunity. AgI/II is a cell surface localised protein adhesin that mediates adhesion to 
the tooth surface and influences biofilm formation. While a mechanistic understanding of the 
functional properties of the peptide is unknown, removal of AgI/II results in decreased virulence. A 
high-resolution (1.8 Å) crystal structure of the A3VP1 fragment of AgI/II revels an extended ! helix 
that is intertwined with a polyproline-II helix with a left-handed supercoil. The ! helix extends to 
approximately 155 Å in length. The bovine pancreatic peptide is a shorter peptide that is part of the 
pancreatic peptide family and forms dimers. 
Figure 1-15: Natural protein components used in the design of PP!. (A) Bacterial surface 
adhesin (AgI/II) from Streptococcus mutans (PDB: 3IOX) highlighting the variable 
region, the extended ! helix region (A3-repeat) and the polyproline-II helix (P1-repeat). 
(B) Surface structure of the ! and polyproline-II helices highlighting interdigitation of Pro 
and Tyr residues. The purple box shows the fragment used in the design of PP!. (C) 
Bovine pancreatic peptide (PDB: 1BBA). Region in purple is the loop region borrowed in 
the design of PP!. Images generated in Pymol. 
 




Two short segments of polyproline-II helix and ! helix were chosen from the bacterial surface 
adhesin (highlighted in purple in Figure 1-15B) for the PP! design. Segments were selected that 
best matched the different periodicities of the two secondary structure. Given that engineering loops 
in protein design is challenging, the two helices were connected with the loop from the bovine 
pancreatic peptide. A model generated for the topology was found to be stable over 100 ns of 
molecular dynamics (MD) simulation in water. A 34-residue peptide named PP!-Tyr, was 
synthesised and characterised in solution. CD spectroscopy showed that the peptide was folded and 
stable with approximately 50 % helicity at 5 °C and a TM of 39 °C. Sedimentation analytical 
ultracentrifugation (SE AUC) showed PP!-Tyr was monomeric in solution. NMR spectroscopy was 
used to determine the solution structure of PP!-Tyr. The NMR ensemble was consistent with the 
design model. KIH-type packing was observed between the two helices where Pro residues on the 
polyproline-II helix dock into a diamond shaped hole formed on the ! helix top and tailed by Tyr 
residues (Figure 1-16). 
1.4.3! CH-" interactions in PP! 
Close contacts were observed between the Tyr residues and the surrounding side chains prompting 
a search for potential CH–" interactions in the NMR ensemble. 45 CH–" interactions (2.25 per 
ensemble structure) were detected based on parameters from previous studies.167-168These were 
attributed as follows: 24 CH–" interactions between Pro and Tyr; 4 between Leu and Tyr; 15 
between Lys and Tyr; and 2 between Gly and Tyr. This suggested that beyond the hydrophobic 
effect and van der Waals’ forces from side-chain packing, PP!-Tyr is stabilised by CH–" 
interactions. To probe this hypothesis further stability studies were carried out in which a series of 
eight para-substituted phenylalanine mutants of PP! were synthesised, from electron rich p-
methoxyphenylalanine through to electron-poor p-nitrophenylalanine. Proteinogenic Trp and Phe 
Figure 1-16: Design of PP!. (A) Helical net of the polyproline-II helix component of 
PP!. (B) Helical net of ! helix component of PP!. (C) Overlay of the helical nets of the 
polyproline-II and ! helices showing KIH pacing of Pro residues into the diamond holes 
top and tailed with Tyr. (D) In silico model of PP!-Tyr after 100 ns of MD simulations in 
water. Adapted from Baker et al.153 
 
 




and His mutants were also synthesised. NMR structures of the three most stable mutants, PP!-OMe 
(p-methoxyphenylalanine substituents) and PP!-Me (p-methylphenylalanine substituents), showed 
folded polyproline-II:loop: ! helix topologies with intimate contacts and CH–" interactions between 
Pro and the modified aromatic rings (Figure 1-17).  
The TMs of the para-substituted phenylalanine variants were plotted against the corresponding 
Hammett constant (σp). The Hammett constant was used as a proxy for the electron density in the 
aromatic ring. It was observed that peptides with electron-rich aromatic " systems were more 
thermally stable than those with electron withdrawing substituents. This suggests there is an 
electronic contribution to the Pro-aromatic interactions. Furthermore, it provides evidence for  
CH–" interactions; electron density from the ring is redistributed into the CH bond and therefore 
these interactions are favoured by the electron-donating substituents in the series. The Hammett plot 
plateaued for PPα-φCN and PPα-φNO2 mutants consistent with cyano and nitro substituted benzene 
rings having reduced interaction energies with CH groups. Interestingly, PPα-φNH2 has a lower than 
expected TM for which there is no clear explanation. 
 
Thermodynamic parameters were calculated through a van’t Hoff analysis. A range of free energies 
of unfolding (ΔGunf) were determined, which varied linearly with σp. Interestingly, the ΔGunf values 
Figure 1-17: NMR ensemble structures and corresponding secondary structure 
assignments. (A) PP!-Tyr (B) PP!-φOCH3 (All Tyr residues substituted for p-
methoxyphenylalanine) (C) PP!-φCH3 (All Tyr residues substituted for p-
methylphenylalanine). Key: Polyproline-II helix (red); bend or hydrogen-boned turn 
(yellow); 310 helix (minimum length 3 residues, light blue); ! helix (minimum length 4 
residues, dark blue). Residue 0 = N-terminal acetyl cap. 
 




were spread over a 0.9 kcal mol-1 range which is similar to the literature estimate for CH–" 
interactions (1.5-2.8 kcal mol-1). Given that each ensemble structure from the NMR data had 
between two and three CH–" interactions, small differences in energy shift the equilibrium constants 
by nearly an order of magnitude. This implies that non-covalent interactions affect the energetics of 
folding and association significantly. 
A bioinformatics analysis of the PDB supported these conclusions: Pro-Tyr and Pro-Trp interactions 
are observed more frequently than expected by chance. In contrast, Pro-Phe interactions are 
underrepresented. Further, Pro-Tyr and Pro-Trp make many more CH–" interactions than any other 
side-chain interactions. Woolfson et al. state that these findings indicate that CH–" interactions 
which are traditionally considered as weak non-covalent interactions can considerably impact 




Figure 1-18: Folding and stability of PPα and mutants. (A) Electrostatic surface potential 
for para-substituted benzene side chains. Scale: ≤ -130 kJ mol-1 (electropositive, blue) to 
≥ 130 kJ mol-1 (electronegative, red). (B) Plot of TM against the Hammett σp parameter 
for the para-substituted aromatic substituents. (C) Free energy of unfolding (∆Gunf) at 
5°C vs. Hammett σp parameter for para-substituents of the PPα mutant series. Figure 
modified from reference 153. 
 




1.5! Scope of thesis 
Miniproteins reduce the complexity of the protein folding problem and allow us to probe 
contributions to protein folding and stability. Further, they provide stable, well-folded structures that 
can be used as modular building blocks in the design and engineering of larger and more-complex 
assemblies with the potential of accessing the dark matter of protein space. Recently, a fragment-
based approach has been used to design the PPα miniprotein with the topology polyproline-II 
helix:loop: α helix. There is much to be understood about the sequence-to-structure and sequence-
to-stability relationships in PP!. In this thesis, PPα has been completely redesigned, moving away 
from a structure based on natural sequence towards a de novo framework with enhanced thermal 
stability. General and intimate side chain-side chain interactions are examined revealing sequence-
to-structure relationships for the fold. Following iterative rounds of design, two new topologies are 
explored based on the PP! fold. Finally, further strategies to improve PP! are described, specifically 
chain elongation and cyclisation.




Chapter 2! Materials and methods 
2.1! General considerations 
Fmoc protected amino acids, N,N-dimethylformamide (DMF) and 6-Chloro-1-
hydroxybenzotriazole  (HOBt-Cl) were purchased from AGTC Bioproducts, (Hessle, UK). H-Rink 
Amide-Chemmatrix® resin was purchased from PACS BioMatrix Inc. (Sain-Jean-sur Richelieu, 
Canada). Hexafluorophosphate azabenzotriazole tetramethyl uronium (HATU) was purchased from 
Carbosynth Ltd. (Compton, UK) and morpholine from Merck Millipore (Burlington, USA). All 
other chemicals were purchased from Sigma Aldrich (Gillingham, UK) or Fisher Scientific 
(Loughborough, UK), and used without further purification. Solution phase biophysical 
characterization was undertaken in phosphate-buffered saline (PBS, 8.2 mM sodium phosphate, 
1.8 mM potassium phosphate, 2.7 mM potassium chloride, 137 mM sodium chloride, pH 7.4) in 
ultrapure water from a Synergy® UV water purification system (Merck Millipore).  
2.2! Peptide synthesis and purification 
2.2.1! Automated solid-phase peptide  synthesis 
Peptides were synthesized via standard Fmoc solid-phase peptide synthesis (SSPS) methods on H-
Ring Amide-Chemmatrix® resin on a 0.1 mmol scale using a CEM (Buckingham, UK) Liberty Blue 
microwave-assisted automated peptide synthesiser with inline UV monitoring. Fmoc-protected amin 
acids were used at 0.2 M in DMF. 
Fmoc deprotection was performed with 20% (v/v) morpholine in peptide-grade DMF, with the 
exception of sequences prone to aspartimide formation where 5% (v/v) formic acid was added to 
the deprotection solution. Peptides were synthesised in two stages. Stage one: single couplings under 
microwave conditions using N,N-Diisopropylcarbodiimide (DIC)/HOBt-Cl activation (0.5 M, 
DMF/ 1 M, DMF) for the !-helix component (i.e. for oPP! from residue 34 (Tyr) to residue 14 
(Pro), peptide synthesized from C to N terminus). Stage two: double couplings under non-microwave 
conditions using HATU/ N,N-Diisopropylethylamine (DIPEA) activation (0.45 M, DMF/ 0.6 M, 
DMF) for the loop and polyproline II helix (i.e. for oPP! from residue 13 (Thr) to residue 1 (Pro)). 
Microwave conditions for this region led to peptide degradation during synthesis.  
Following automated synthesis, the peptides were washed with DMF (4 x 5 mL), and N-terminally 
acetylated using an excess of acetic anhydride (0.25 mL), and pyridine (0.30 mL) in DMF (5 mL), 
with slow inversion for 20 min at room temperature (rt). The acetylated peptides were washed with 
DCM (4 x 5 mL) then cleaved from the resin and side chain deprotected using trifluoroacetic acid 
(TFA) / triisopropylsilane (TIPS) / H2O (95 : 2.5 : 2.5 , 15 mL) for 2 h. Following cleavage, the TFA 
solution was reduced in volume to ca. 5 mL under a positive flow of nitrogen. Cold diethyl ether 
(40 mL) was then added to precipitate the peptide, which was isolated by refrigerated centrifugation 




at 3 krpm, re-dissolved in water / acetonitrile (50 : 50, 10 mL) and lyophilised to yield the crude 











2.2.2! Peptide purification 
Crude peptides were purified by reverse-phase high performance liquid chromatography (HPLC) on 
a Phenomenex Luna C18 column (5 µm particle size; 100 Å pore size; 150 × 10 mm). A gradient of 
water (0.1 % TFA, buffer A) and acetonitrile (0.1 % TFA, buffer B) between 20 and 80 % or 20 and 
60% buffer B over 40 min at a flow rate of 3 mL min-1 with absorbance recorded at 220 and 280 nm 
was typically used. Pure fractions were identified by MALDI-TOF (matrix-assisted laser 
desorption/ionisation time-of-flight) mass spectrometry and analytical HPLC (vide infra), and were 
combined and lyophilised. 
2.2.3! MALDI-TOF mass spectrometry 
MALDI-TOF mass spectrometry was performed on a Bruker (Coventry, UK) UltrafleXtreme II 
MALDI-TOF mass spectrometer, operating in positive-ion reflector mode. Peptides were co-
crystallised on a ground-steel target plate using 2,5-dihydroxybenzoic acid (DHB) or !-cyano-4-
hydroxycinnamic acid (!-CHA) as the matrix. Representative mass spectra for each peptide are 
shown in Section 8.1. Theoretical masses are quoted as the average masses and were calculated 
using Peptide Synthetics’ online peptide mass calculator (http://www.peptidesynthetics.co.uk/tools/, 
Peptide Protein Research Ltd.). 
Figure 2-1: Overview of SPPS showing Fmoc deprotection, activation, peptide coupling, 









































































2.2.4! Analytical HPLC 
Peptide purity was confirmed by reverse-phase analytical HPLC on a JASCO 2000 series HPLC 
system using a Phenomenex® Kinetex C18 (5 µM particle size; 100 x 4.5 mm) column, monitoring 
at 220 and 280 nm wavelengths Typically, a gradient of water (0.1 % TFA, buffer A) and acetonitrile 
(0.1 % TFA, buffer B) between 20 and 80 % buffer B over 20 min was used. Representative 
analytical HPLC traces for each peptide is shown in Section 8.1. 
2.2.5! Peptide concentration determination 
Pure peptides were dissolved in ultrapure deionised water and concentrations were determined on a 
Thermo Scientific (Waltham, USA) Nanodrop 2000 UV / visible spectrophotometer. Concentrations 
were determined by absorbance of Tyr at 280 nm using the Beer-Lambert Law (Equation 2-1). 
ε280(Tyr) = 1280 mol-1 dm3cm-1. The extinction coefficient of oPP!-Phe and PPII was determined 
using a literature protocol based on the absorbance at 214 nm.169 Pure peptides and stocks were 
stored at -20 °C and thawed before use. 
! = ). $. % 
2.3! Solution phase biophysical characterisation  
2.3.1! Circular dichroism spectroscopy 
2.3.1.1! Introduction to circular dichroism 
Circular Dichroism (CD) measures the difference in absorbance of left and right circularly polarised 
light by a chiral molecule (e.g. peptides).170 Circularly polarised light is the result of two linearly 
polarised light waveforms that are perpendicular to one another and phase shifted by a quarter 
wavelength. CD spectroscopy can be used to determine the secondary structure present in peptides 
and proteins due to the distinctive spectra produced in the far UV (260 - 190 nm). Peptides produce 
two key CD signals as a result of the amide bond at ca. 220 and 190 nm. These signals arise from 
electronic transitions from the n to "* (n"*) and " to "* (""*) orbitals respectively. These spectral 
features are characteristic of random coiled peptides. The periodic alignment of amide bonds in the 
peptide backbone within regions of secondary structure modify these basic electronic transitions, 
giving rise to information about the conformation of the peptide.171 
!-Helical secondary structure give a characteristic “double dip” spectrum with minima at 208 and 
222 nm and a maximum at 190 nm. $-Sheets have a minimum at ca. 215 nm (n"*) and a maximum 
at ca. 195 nm (""*) and polyproline II helices have a minimum at ca. 197 nm and a maximum at 
220 nm (Figure 2-2).172 
 
Equation 2-1: The Beer-Lambert Law. A is absorbance, ) is the extinction coefficient 
(mol-1 dm3cm-1), c is the concentration (mol dm-3) and l is the pathlength (cm). 










Examination of CD spectra in the near UV range of 250 to 340 nm can provide useful information 
on the environment and conformation of aromatic side chains and consequently the structure of the 
peptide or protein. This is because the ""* transition on the aromatic rings of phenylalanine, tyrosine 
and tryptophan are responsive to their local surroundings.174 
2.3.1.2! Circular dichroism experimental details 
CD spectra were collected using a JASCO 815 or JASCO 810 spectropolarimeter fitted with a Peltier 
temperature controller. Peptide samples were prepared in PBS at pH 7.4. CD measurements were 
carried out in 1 mm (50 – 200 µM total peptide concentration, 250 µL total sample  volume), 5 mm 
(10 µM total peptide concentration, 1250 µL total sample volume) or 10 mm (near UV 
measurements, 100 µM total peptide concentration, 2500 µL total sample volume) pathlength 
cuvettes (Starna Scientific; Ilford, UK). For peptide concentrations greater than 500 µM a sandwich 
cell cuvette with pathlength 0.1 mm was used (100 µL total sample volume). CD spectra were 
baseline corrected and recorded as the average of five scans from 260 – 190 nm at 5 °C using a 
scanning speed of 100 nm min-1, a bandwidth of 1 nm, a 1 nm step size and a 1 s response time. 
Thermal denaturation curves were obtained from 5 to 95 °C and back to 5 °C (temperature slope = 
40 °C hr-1) by monitoring the absorbance at 222 nm (1 nm bandwidth) at 1 °C intervals with 16 s 
delay and 16 s response times. For near UV measurements 5 °C scans were recorded from 
250 – 340 nm and denaturation curves were obtained by monitoring at 276 nm. The midpoint of the 
denaturation curve (TM) was determined by taking the maximum value from the first derivative of 
the thermal transition. 
Data was buffer subtracted and then spectra were converted from ellipticities (mdeg) to mean residue 
ellipticities (MRE deg cm2 dmol-1 res-1) by normalising for peptide concentration, number  of peptide 
bonds and the cuvette pathlength as demonstrated in Equation 2-2. Representative spectra and 
thermal denaturation measurements for all peptides are shown in Section 8.2. 
 
Figure 2-2: CD spectra of protein secondary structure. !-Helical secondary structure 
(yellow, myoglobin), $-sheet secondary structure (green, $-Lactoglobulin) and 
polyproline-II helix (purple, bovine collagen type II). Spectra collected from Protein 
Circular Dichroism Data Bank.173 















2.3.2! Analytical ultracentrifugation 
2.3.2.1! Introduction to analytical ultracentrifugation 
Analytical ultracentrifugation experiments follow the sedimentation of macromolecules over time 
when a centrifugal force is applied. Two types of experiments are  conventionally carried out: 
sedimentation velocity (SV) and sedimentation equilibrium (SE). Each experiment gives 
information on the size of the macromolecule, while each also providing additional information.177 
2.3.2.2! Sedimentation velocity 
In SV experiments samples are spun at high rotor speeds (typically >40 000 rpm) leading to the 
depletion of peptide away from the centre of the rotor creating a pellet at the bottom of the cell. Data 
is collected across the radial distance of the cell following the sedimentation of the peptide over 
time. The data is fitted to the Lamm equations in a continuous c(s) distribution model returning a 
sedimentation coefficient profile.178 This allows for determination of the sedimentation coefficient 
(Svedberg units, S = 10-13 s) and the frictional coefficient (f/f0) of the peptide, both of which relate 
to the mass of the peptide being studied. f/f0 gives information about the shape of the peptide, a 
theoretical value of 1 would imply a totally spherical peptide. An advantage of the SV experiment 
is information on the homogeneity of the sample is obtained; multiple peaks are observed in the 






Equation 2-2: Conversion of mdeg (*) to mean residue ellipticity. c is the concentration 
of the sample (mol dm-3), l is the sample pathlength (cm) and b is the number of amide 
bonds in the sample. 
Equation 2-3: Percentage fraction helix at 222 nm. Where [MRE]coil = 640 – 45T = 415 
deg cm2 dmol-1 res-1 at 5°C. T is the temperature (°C); n is the number of bonds including 
the C-terminal amide.175-176 









2.3.2.3! Sedimentation equilibrium 
In SE experiments samples are spun at lower speeds and consequently the sedimentation of sample 
is balanced by its desire to diffuse back up the cell due to the creation of a concentration gradient. 
An equilibrium is established when no change in the concentration distribution of any component is 
detectable and when the opposing forces are balanced.179 When this is achieved, scans are taken 
over the radial distance of the sample at a range of different speeds. Unlike for SV, no distinct 
boundaries are observed; instead a smooth gradient is seen. The curves are fitted to an exponential 
equation, and the molecular weight of the peptide is returned. If, at the concentration of the peptide, 
multiple species are sampled then more complex models for associating system can be fitted (e.g. 







2.3.2.4! Sedimentation Velocity Method 
SV AUC experiments were conducted at 20 °C in either a Beckman XL-A or XL-I ultracentrifuge 
equipped with an An-60 or An-50 Ti rotor. 410 µL of solution at 100 µM peptide concentration in 
PBS were loaded in the sample channel, and the reference channel was loaded with 420 µL of PBS 
buffer. Samples were centrifuged at 50 krpm, with absorbance scans taken across the cell at a radial 
Figure 2-3: Representative SV data. Top: SV sedimentation coefficient distribution after 
fitting to continuous c(s) distribution. Sharp peak demonstrates homogenous sample. 
Bottom: Residuals for the above fit shown as greyscale, showing the difference between 
the raw and fitted data in bitmap format.  
Figure 2-4: Representative SE data and fit. Top: data measured at four centrifugal speeds 
(crosses) and fitted to single ideal species model curves (lines). Bottom: Residuals for the 
above fit. 














range of 5.8 – 7.3 cm at 5 min intervals to a total of 120 scans. Data was fitted to a continuous c(s) 
distribution model using SEDFIT (http://www.analyticalultracentrifugation.com) at a 95 % 
confidence level.180 The baseline, meniscus, frictional coefficient (f/f0), and systematic time-
invariant and  radial-invariant noise were fitted. Residuals for the c(s) distribution fit are shown as 
a bitmap in which the greyscale shade indicates the difference between fit and raw data. 
2.3.2.5! Sedimentation equilibrium method 
SE AUC experiments were conducted at 20 °C in either a Beckman XL-A or XL-I ultracentrifuge 
equipped with an An-60 Ti rotor and cells equipped with a 2-channel aluminium centrepiece and 
sapphire windows. Peptide solutions were made up in PBS at  80 – 130 µM (110 µl) peptide 
concentration. The reference channel contained 120 µl of PBS buffer. Samples were centrifuged 
from 44 – 60 krpm in increments of 4 krpm. Absorbance was measured at 280 nm across the cell at 
a radial distance of 5.8 – 7.3 cm at each speed after 8 h. To check the sample had reached equilibrium 
absorbance was measured again after a further hour to before moving onto the next speed. Data was 
fitted to a single ideal species model with Ultrascan II (http://ultrascan2.uthscsa.edu/).181 The partial 
specific volume (v̅ ) for peptides and the solvent density (1.0054 g mL-1) were calculated using 
Sednterp (http://www.jphilo.mailway. com/download.html). 95% confidence limits were calculated 
using Monte Carlo analysis of the obtained fits. All SE data, fitted curves and residuals are shown 
in Section 8.3. 
2.4! Nuclear magnetic resonance spectroscopy 
Peptide was prepared at 1 mM concentration in PBS. The pH was adjusted to pH 7.4 with 10 mM 
NaOH and the sample freeze-dried before being reconstituted in the appropriate volume of D2O 
(10%) in H2O (90%). The pH and concentration were confirmed. 
NMR data were acquired at 278 K on a Bruker Ascend spectrometer operating at 700 MHz equipped 
with a 1.7 mm micro-cryoprobe (BrisSynBio, University of Bristol). The peptides were assigned 
using standard 2D homonuclear spectra: TOCSY (60 ms mixing time) and NOESY (100 and 250 
ms mixing times). Both were acquired with spectral widths of 9,375 Hz, 4,096 complex points 
in f2 and 1,024 complex points in f1. To help with backbone and side-chain assignment, natural 
abundance 15N (96 (t1) × 1792 (t2) complex points) and 13C (124 (t1) × 2,048 (t2) complex points) 
HSQC spectra were also acquired.  
NMR data were processed by Dr Chris Williams (Crump Group, Bristol University) with NMRPipe 
and qMDD38, 68, 182. Peak picking and assignment were carried out in CCPNMR Analysis 2.4.1.183 
NOE  assignment and structure calculation were carried out with ARIA 2.3.1184 and CNS v 1.2185. 
The final structures were water refined using the standard ARIA protocol. Dihedral restraints for 
the α-helix were generated using DANGLE186 and validated with the NOE spectra before inclusion 
into the structure calculation. Three bond J couplings were extracted from a high resolution COSY 
and supplemented into the structure calculation during the final stages of refinement. The final 
refined ensemble was composed of 20 structures with the lowest energy and no violations (>5°) and 




validated using PSVS v1.5.187 All peptide structure images were rendered with Pymol 
(http://www.pymol.org).  
2.5! X-ray crystallography: peptide crystallisation trial methods 
Freeze dried peptides were resuspended in deionised water to a concentration of 15 mg mL-1 for 
sitting-drop vapour-diffusion crystallisation trials using standard commercial screens (JCSG, 
Structure Screen 1+2 MorpheusTM, ProPlex and PACT PremierTM; Molecular Dimensions 
(Newmarket, UK))  at 20 °C and 4 °C with 0.3 µL of the screening solution. 
2.6! Computational design and analysis 
ISAMBARD (Intelligent System for Analysis, Model Building And Rational Design) is an open-
source Python package with a suite of tools for biomolecular structure analysis, protein design, 
model building and evaluation.142  
2.6.1! Loop finder 
LoopFinder, a protein design tool within ISAMBARD, was used to extract loops from the Protein 
Data Bank (PDB) that fit between a pair of entering and exiting residues in the !PP topology. Loops 
were filtered based on the following criteria:  
-! Loops from crystal structures with ≤ 2 Å  resolution  
-! ≤ 3 Å fit RMSD between loop and !PP model backbone coordinates 
-! 3 – 6 residue loop lengths 
-! Loops that link ! and $ secondary structure 
-! Loops containing cysteine were omitted 
2.7! Bioinformatics 
2.7.1! CH–" interaction identification 
CH–π interactions were identified within the ISAMBARD framework.142 CH–π interactions were 
identified using parameters based on those used to find CH–π interactions involving carbohydrates 
in protein crystal structures168 and adapted to account for any CH protons interacting with an amino 
acid aromatic ring. This adaptation provides an update to a previous analysis of CH–π interactions.167 
CH–π interactions were determined between all amino acid CH bonds and the aromatic ring of Tyr. 
Interactions were classed as CH–π positive if the following conditions were met: CH–π distance 
(between the CH proton to centre of the aromatic ring) ≤3.5 Å; CH–π angle (between the vector of 
the CH bond and the normal to the plane of the aromatic ring) ≤ 55°; C projection distance (between 
the projection of the CH carbon to the plane of the aromatic ring and the centre of the ring) ≤ 2.0 Å 
for 6-membered Tyr (Figure 2-5). 
 










2.7.2! Solvent accessibility analysis 
Solvent accessible surface area (SASA) of both oPP! and PP! were calculated within the 
ISAMBARD framework using the programme NACCESS which uses the Lee and Richards method 
described in Section 1.4.6.188-189 SASA was calculated for the oPP! and PP! complex, loop region 
was ignored. SASA was then calculated for the individual ! helix and polyproline-II helix secondary 
structure components. SASA of the complex was then taken as a proportion of the total SASA of 
the individual components. This was done for all 20 structures in the NMR ensemble and then 
averaged. 
2.8! Molecular dynamics simulation 
2.8.1! Introduction to molecular dynamics  
Molecular dynamics (MD) is one of the principle tools for modelling proteins and probing their 
stability, folding and molecular recognition of other biologically important molecules. A molecule 
is described as a series of charged points (atoms) linked by springs (bonds). The potential energy 
function allows us to calculate the force experienced by any atom given the position of the other 
atoms in the system. How these forces affect the trajectories of atoms and molecules are determined 
by solving Newton’s equations of motion. 
2.8.2! Molecular dynamics simulation setup 
Models were constructed using Pymol and set up for MD simulation using the Gromacs 4.6.7 suite 
of tools.190-191 Hydrogen atoms were added consistent with pH 7.4 using pdb3gmx, and the TIP3P 
water model and Amber99sb-ILDN force field were chosen.192 A cubic periodic boundary box was 
set up with dimensions 2 nm greater than the longest dimension of the model with editconf. This 
box was filled with water molecules using genbox and 137 mM NaCl using genion. The system was 
energy minimized and position-restrained MD run for 200 ps as an NPT (normal pressure and 
temperature) ensemble at 278 K, 1 Bar using the Verlet cut-off scheme and under PME (Particle 
Figure 2-5: Parameters defining a CH–" interaction. CH–π distance (between the CH 
proton to centre of the aromatic ring, i.e. H–X, blue) ≤ 3.5 Å. CH–π angle (between the 
vector of the C–H bond and the normal to the plane of the aromatic ring) θ ≤ 55°. C-
projection distance (between the projection of the CH carbon to the plane of the aromatic 
ring and the centre of the ring, i.e. X – Cp, blue) ≤ 2.0 Å for 6-membered ring (Tyr). 




Mesh Ewald) boundary conditions as an initial relaxation and equilibration step. The restraints were 
then removed and a further 10 or 100 ns of MD was performed using 1 GPU and 6 cores of an X86 
workstation. Structures were saved every 10 ps. Post-simulation trajectories were processed using 
trjconv to remove periodic boundary condition effects and solvent and inspected using VMD.193 All 
atom and backbone RMSDs and RMSFs were calculated using Gromacs.




Chapter 3! Stabilising the PP! miniprotein by rational design 
The work described in this chapter was designed by the author of this thesis (KPG), Dr Emily Baker 
and Prof. Dek Woolfson. Bristol Chemical Synthesis CDT rotation student Frank Zieleniewski 
synthesised and preliminary characterised oPP!-E#K; full characterisation was followed up by 
KPG. Data collection and assignment of the oPP! NMR structure was done by Dr Chris Williams 
(Prof. Matthew Crump’s Group) and critical analysis of the structure was done by KPG. 
3.1! Chapter introduction 
Previously, the fragment-based design and characterization of a 34-residue miniprotein, PP!, has 
been described.153 PP! comprises a polyproline-II helix, loop and ! helix that are adapted from two 
natural proteins: an antigenic bacterial surface adhesin (AgI/II) from Streptococcus mutans166 and 
the bovine pancreatic polypeptide hormone.29 PP! is a monomer in aqueous solution and reversibly 
unfolds with a midpoint unfolding temperature (TM) of 39 ˚C. A Nuclear Magnetic Resonance 
(NMR) spectroscopy structure reveals that PP! is stabilized by the interdigitation of Pro and Tyr 
residues between the two helices and numerous CH–" interactions.  
We envisage using PP! as a building block to build larger and more-complex assemblies with 
applications in protein engineering and synthetic biology.194-195 PP! could provide a new component 
to the toolkit of peptides already developed to help make the engineering of biological systems easier 
and more accessible.151 Such building blocks should be predictable with respect to sequence, 
structure, and stability in order to be used reliably in a variety of systems while maintaining 
structural and functional integrity.32 As such, de novo designed building blocks of reduced 
complexity where the role of every residue in the sequence is understood provide advantages over 
more-complex sequences borrowed from nature. 
Arguably one of the best understood protein folding units in terms of sequence-to-structure 
relationships is the !-helical coiled coil where two or more amphipathic !-helices supercoil around 
a central hydrophobic core.132, 134, 196 !-Helical coiled coils with a range of oligomeric states have 
been de novo designed and fully characterised so that they can be used easily and reliably in different 
contexts.32, 145 In this chapter, we apply a similar strategy to PP! to garner a better understanding of 
the PP! topology. A rational redesign of PP! is described, that moves away from a fragment-based 
design towards a de novo framework. The extent to which the stability of PP! can be enhanced 
through this process is explored. An optimised and fully characterised PP! framework with 
significantly enhanced thermal stability compared to the first-generation design is delivered. 




3.2! Rational redesign of PP! 
One of the key defining features of the PP! topology is the interdigitation of Pro residues on the 
polyproline-II helix with Tyr residues on the ! helix. Furthermore, these residues are conserved in 
many natural examples of polyproline-II:! helix interfaces, such as the AgI/II bacterial surface 
adhesin and the pancreatic peptide family.29, 55, 166 Baker et al. previously mutated the residue Tyr to 
a series of other proteinogenic and non-proteinogenic amino acids and found that Tyr gave the most 
thermally stable PP! fold.153 Therefore, the Pro-Tyr interface was maintained in our PP! redesign 
with Pro placed at position 1 and Tyr placed at the d position of the polyproline-II and !-helical 
repeats respectively (Figure 3-1). Leu at the a position is also conserved in many related natural 
peptides and forms part of the diamond shaped hole into which Pro projects. Therefore, Leu at a 
was initially preserved in the new PP! designs. However, the mutability of this position is discussed 
in more detail in Chapter 4. 
The redesign of PP! was inspired by a number of !-helical coiled-coil design principles. At the 
heart of all coiled coils, the burial of hydrophobic surfaces in intimate side-chain packing termed 
knobs-into-holes (KIH) interactions197 provides the driving force for coiled-coil assembly and 
specification.113, 132, 196,198 Alongside this, additional electrostatic interactions can provide further 
stabilisation. Charged residues at the e and g positions that flank the hydrophobic core can form 
interhelical Coulombic interactions in natural systems.199-200 These have been used extensively to 
guide and stabilise de novo coiled-coil designs.132-133, 201-202 Lys-Glu pairs have been used to control 
either homomeric or heteromeric assembly in peptides with otherwise identical a and d core 
interfaces (Figure 3-1A).203 
By analogy, PP! might be stabilized by optimising similar interactions between the 2 and 3 positions 
of the polyproline-II helix and the e and g positions of the ! helix (Figure 3-1B). It is noted that the 
direction of the C!-C$ bond vectors of the side chains of the 2 and 3 positions in the polyproline-II 
helix point away from the ! helix. This may mean that formal salt bridges are not made between the 
2/e, and 3/g positions due to the distance between the opposite charge groups being outside of the 
range for salt bridging. Nonetheless, charged residues may still help stabilise and promote folding 
of PP! through electrostatic steering where long-range electrostatic forces specifically increase the 
rate of helix association without affecting the rate of dissociation.204-205 
There are two extreme possibilities for pairing charged residues in PP!: a Lys-based polyproline-II 
helix plus a Glu-based ! helix or vice versa (Figure 3-1C&D). To determine the optimal 
combination, both mutants (oPP! and oPP!-E#K) were considered (Table 3-1). While there are 
other possibilities for pairing charged residues with a combination of both Lys and Glu on the same 
helix we only investigated the two extreme and simplest cases.206-208 More elaborate charge pattern 
designs might be useful for creating orthogonal sets of PP! peptides that can be used together 
without any cross-interaction. 












With the initial ! helix foreground e, a, d and g positions of the starting sequences selected, focus 
turned to the remaining background positions (b, c and f positions). These residues were designed 
to contribute to the overall stability of the peptide by promoting ! helicity, without promoting 
aggregation. Therefore, helix propensity was optimised for the solvent-exposed face of the ! helix.  
Helix propensity is a measure of how the side chains of a particular amino acid affects the helix-to-
coil equilibrium; some residues have more of a preference for the !-helical conformation compared 
to others.209-211 Many different helix propensity scales have been developed based on different 
strategies and sources including statistical surveys,212-213 host-guest analysis214 and molecular 
dynamics calculations.215-216 One of the first helix propensity scales has been presented by Chou and 
Fasman and is based on the frequency of occurrence of amino acids in ! helices in proteins.217-218 
Later, DeGrado et al have designed an !-helical dimer in equilibrium with a random coil monomer. 
All 20 natural amino acids were substituted for a solvent exposed guest site on the helix and a list 
of free energy difference values (++G) for each amino acid were calculated.214 Perhaps the most 
comprehensive and widely used scale has been derived by Scholtz et al. based on experimental 
measurements of helix propensity in 11 systems including both proteins and peptides.209 From this 
analysis, the helix propensities of the amino acids are as follows (kcal mol-1): Ala 0, Leu 0.21, Arg 
Figure 3-1: Helical wheel representations of !-helical coiled coils and the PP! fold. Leaf 
tips point along the direction of the C!-C$ bond vectors. Lower case letters on the ! helix 
and numbers on the polyproline-II helix (left) indicate the helical register. C and N refer 
to the termini of the helices nearest the viewer. Interhelix Coulombic interactions (dashed 
lines) (A) Sequence of a heteromeric dimer highlighting interhelix Coulombic interactions 
between g and e positions.203 (B) Sequence of PP! with no interhelix Coulombic 
interactions. (C) Sequence of oPP! highlighting potential Coulombic or long-range 
electrostatic interactions between the 2 and 3 positions of the PPII helix and the e and g 
positions of the ! helix. (D) Sequence of oPP!-E#K highlighting alternative extreme 
arrangement of charged interactions.  




0.21, Met 0.24, Lys 0.26, Gln 0.39, Glu 0.40, Ile 0.41, Trp 0.49, Ser 0.50, Tyr 0.53, Phe 0.54, Val 
0.61, His 0.61, Asn 0.65, Thr 0.66, Cys 0.68, Asp 0.69, and Gly 1.  
The ! helix is stabilised mainly by favourable enthalpic contributions219 from the formation of 
backbone hydrogen bonds, whereas the random coil is favoured by conformational entropy.220 The 
1 kcal mol -1 difference in helix propensity between Gly and Ala is the result of the reduced phi-psi 
space available to residues when the H in Gly is replaced by a methyl group in Ala.221-222 The methyl 
group reduces the entropy of the backbone in the random coil however it does not lose side chain 
conformational entropy on folding to form an ! helix.215 All other residues experience an 
unfavourable change in side chain conformational entropy upon folding to form an  
! helix.209, 215, 220  
Based on this helix propensity scale, mutations to Ala at b and c and Lys at f for both oPP! and 
oPP!-E#K were made. While Leu has relatively high helical propensity it was avoided in the oPP! 
background positions to ensure the monomeric nature of PP! was preserved. Met was also avoided 
as it is susceptible to oxidation and so too was Arg as it can have undesirable side reactions during 
synthesis. Lys was placed at position f, that is, the position spatially between b and c, to prevent a 
two-residue hydrophobic Ala interface forming, which may cause oligomerisation of the topology. 
The length of the new PP! designs were maintained at three !-helical heptads so that a direct 
comparison in stability could be made between the new designs and parent PP!. Also, to allow 
comparison of the new PP! design with parent PP!, the same loop region from PP! was used. 
Furthermore, loop design is notoriously difficult, unlike for ! helices and $-strands, there are not 
well determined amino-acid preferences for forming well-ordered loops.223 
 
 
The residues at the initial e-f-g positions of the first heptad of oPP! and oPP!-E#K were different 
to those in the second and third heptad, P-E-K compared to E-K-E. This is because Pro and Glu 
were conserved as the N terminal residues in the ! helix of related natural sequences and have been 
shown to be good helix capping residues.224-225 
Table 3-1: Sequences for PP! variants. 
Peptide 
Sequence and helical register 
              efgabcd efgabcd efgabcd 
parent PPα153 Ac- PPTKPTKP GDNAT PEKLAKY QADLAKY QKDLADY -NH2 
o-α Ac-                PEKLAAY EKELAAY EKELAAY -NH2 
oPPα Ac- PPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY -NH2 
oPP!-E#K Ac- PPEEPEEP GDNAT PEKLAAY KKKLAAY KKKLAAY -NH2 
oPPα-Phe Ac- PPKKPKKP GDNAT PEKLAAF EKELAAF EKELAAF -NH2 




3.3! Biophysical characterisation 
3.3.1! Circular dichroism spectroscopy 
oPP! and oPP!-E#K were synthesized by solid-phase peptide synthesis, purified by reverse-phase 
HPLC, and confirmed by MALDI-TOF mass spectrometry (see Section 8.1). The peptides were 
characterised by circular dichroism (CD) spectroscopy (Figure 3-2). Both peptides were folded with 
approximately 50% !-helical structure at 5 °C, similar to parent PP!. Thermal denaturation 
experiments of the far-UV CD signal at 222 nm, which reports on the secondary structure present, 
revealed that oPP! had a cooperative and fully reversible thermal unfolding transition with a TM of  
51 °C. This is a substantial increase of 12 ˚C over the TM for PP!.  
However, oPP!-E#K was 10 °C less stable than oPP! with a TM of 40 °C, which is still more 
stable than parent PP!. It is noted that oPP!-E#K had a broader thermal unfolding transition 
compared to oPP!. The reduction in thermal stability can potentially be attributed to the large charge 
associated with the ! helix; +6 compared to -2 for oPP!.  
Consistent with PP!,153 oPP! was considerably more stable than the constituent ! helix (o-!). The 
! helix was 38 % folded and a TM could not be extracted from the thermal melt curve. This is striking 
given that almost half the oPP! sequence is loop region or polyproline-II helix both of which do not 
contribute to the CD signal but are included in the spectra normalisation. This demonstrates the 
significant stabilising effect of buttressing the ! helix against a polyproline-II helix. The folding and 
stability data is summarised in Figure 3-2. 
Next oPP! was characterised by near-UV CD spectroscopy, which reports on the tertiary structure 
of the peptide through the environment of the aromatic side chains, in this case Tyr (Figure 
3-2C&D). The thermal transition of oPP! monitored by near-UV CD spectroscopy gave unfolding 
and refolding curves coincident with the far-UV CD traces. While the degree of folding of both 
oPP! and PP! were similar at 5 °C in the far-UV region, the magnitude of the CD signal at 5 °C in 
the near-UV region was slightly greater for oPP!. This could indicate that the Tyr side chains of 


























3.3.2! Analytical ultracentrifugation 
Next, the constructs were investigated by analytical ultracentrifugation (AUC) to determine their 
molecular weights in solution. There are two standard AUC experiments usually used to determine 
molecular weight: sedimentation velocity (SV)  and sedimentation equilibrium (SE). In SV 
experiments samples are spun at very high centrifugal forces and sedimentation is measured over 
time. SV experiments reveal information about the size and shape of the peptide as well as the 
homogeneity of the system. SV experiments could not be performed on PP! variants, however, 
Peptide name MRE222 nm /  





PP! -18319 48 39 
o-! -13746 38 n/a 
oPP! -18319 48 51 ± 0.8 
oPP!-E#K -17810 47 40  ± 2.1 
Figure 3-2: Folding and stability of oPP! and variants. (A) CD spectra recorded at 5 °C 
in the far-UV range for parent PP!, oPP!,  oPP!-E#K and o-!. MRE is mean residue 
ellipticity. (B) Temperature dependence of the far-UV CD signal monitored at 222 nm. 
(C) Aromatic CD spectra recorded at 5 °C in the near-UV range. (D) Temperature 
dependence of the near-UV CD signal monitored at 276 nm. Conditions: 100 µM peptide, 
PBS, pH 7.4. Colour key: PP! (black, dash), oPP! (black), oPP!- E#K (orange), and o-
! (grey). (E) Table summarising CD data on the folding and stability for oPP! and 
variants. 
 




because rotational speeds > 60 krpm would be required for full peptide sedimentation and this 
exceeds the maximum speed limit of the analytical ultracentrifuge. Therefore, only SE experiments 
were performed where the sample is spun at lower speeds over longer times to allow an equilibrium 
to be set up between sedimentation and back diffusion. At equilibrium, information on the weight 
of the peptide can be extracted from the radial distribution of peptide concentration. For associating 
peptides, SE experiments can also provide association constants provided the dissociated and 
associated states are both accessed in the experimental data. 
SE AUC experiments were carried out on both variants. Experimental data readily fitted to single-
ideal species models returning molecular weights consistent with monomers (Figure 3-3). To ensure 
high confidence in the masses returned, residuals were plotted which indicate the difference between 







To probe and understand the structure of oPP! further, attempts were made to crystallise oPP! for 
structure determination by X-ray crystallography. Crystal trays were laid down as described in 
Section 1.5 using standard commercial screens at both 20 and 4 °C however no crystals have been 
observed to date. 
3.4! Characterisation using NMR spectroscopy 
As an alternative to X-ray crystallography, high-resolution NMR spectroscopy was used to 
determine the solution-phase structure of oPP!. Data for oPP! were acquired at both 600 and 700 
MHz. As a result of the low-complexity of the oPP! sequence there was significant overlap in the 
signals in the 1D 1H NMR spectrum (Figure 3-4). The peptide was assigned using standard 2D 
spectra: TOCSY, NOESY and HSQC. Previously assigned NMR spectra for PP! aided the 
Figure 3-3: Sedimentation-equilibrium AUC data (top, dots) and fitted (lines) single-ideal 
species model curves at 44 (blue), 52 (aqua), 56 (orange), and 60 (red) krpm for oPPα and 
oPPα-E#K. Residuals (bottom) for the above fit. (A) oPPα (v̅ = 0.748 cm3 g-1). The fit 
returned the following mass: oPPα, 3854 Da, (1.0 x monomer mass), 95% confidence 
limits = 3839 – 3869 Da. (B) oPPα-E#K (v̅ = 0.748 cm3 g-1). The fit returned the 
following mass: oPPα-E#K, 3545 Da, (0.9 monomer mass), 95% confidence limits = 
3511 – 3581 Da. 




assignment of those for oPP!. Data were collected and the NMR structure solved by Dr Chris 









3.4.1! Sequential assignment approach 
The sequential assignment approach consists of two stages.227-229 Firstly, spin systems associated 
with particular amino acids are identified. This is achieved by running TOCSY (or COSY) 
experiments. The second stage is the assignment of each spin system to a particular residue in the 
amino-acid sequence. TOCSY experiments cannot be used to do this since there is no coupling 
across the amide bond. Instead, assignments are made from through-space nuclear Overhauser 
effects (NOEs) from the NOESY spectrum (Figure 3-5). Regular secondary structures (e.g. ! 






Figure 3-4: 1D 1H NMR spectrum of oPP! acquired at 700 MHz showing the complexity 





























3.4.2! [1H-1H]-TOCSY: Total correlation spectroscopy 
Similar to a COSY experiment a TOCSY spectrum gives 1H-1H correlations due to scalar (through-
bond) couplings. Unlike a COSY spectrum where coupling is limited to protons up to three bonds 
apart (4J coupling constants are close to zero), a TOCSY experiment potentially correlates all H 
nuclei of the same spin system. There is no scalar coupling through the amide bond and so protons 
from different amino acids belong to different spins systems. Therefore, from the TOCSY spectrum, 
characteristic peak patterns for a spin systems can be assigned to a particular type of amino acid. 
The TOCSY spectrum for oPP! is shown in Figure 3-6 highlighting the aliphatic side chain protons. 
Resonance assignments have been omitted for clarity. 
 
  
Figure 3-5: Polypeptide backbone showing the though-space distances (d1, d2, and d3) 
used for the sequential resonance assignment (blue arrows). Through bond spin-spin 
coupling connectivities within amino acid residues are shown as red lines. 




3.4.3! [1H-1H]-NOESY: Nuclear Overhauser effect spectroscopy 
Cross peaks in a NOESY spectrum are the result of dipolar couplings resulting from interactions of 
spins via space and not through bonds as is the case for TOCSY experiments. The magnitude of 
these NOEs depends on the distance between interacting spins and therefore the NOESY spectrum 
contains all information about the spatial proximities of protons and consequently the 3D structure 
of the peptide.  
The amide region of the NOESY spectrum of oPP! is shown in Figure 3-7. Sequential HNi-HNi+1 
NOEs observed in the spectrum indicated a well-defined ! helix. To identity which amino acids 
these correlations belonged comparisons were made with the TOCSY spectrum. 
 
Figure 3-6: TOCSY spectrum of oPP! acquired at 600 MHz showing aliphatic side chain 
protons. Residual water band signal visible at 5 ppm on the f2 axis. 




3.4.4! HSQC: Heteronuclear single quantum coherence spectroscopy 
To help with backbone and side chain assignment, natural abundance 15N and 13C HSQC spectra 
were also acquired. The HSQC experiment shows one bond connectives, for example the 1H-15N 
HSQC shows peaks for all backbone amides and some side chain nitrogen atoms of Asn, Arg, Gln, 
His, Lys and Trp. Pro does not have an amide proton and so does not give cross peaks in the 
spectrum. 
An overlay of the 1H-15N HSQC spectra for oPP! and PP! is shown in Figure 3-8. Like PP!, oPP! 
appeared to be well folded as determined by the good chemical shift dispersion. There were 
similarities between the two spectra. For example, peaks corresponding to the loop region (which is 
the same for both peptides), either overlaid or appeared in very similar regions of the spectrum 
(residues G9, D10, N11, A12, and T13). Cross peaks from E15 which is present in both peptides 
and corresponds to the start of the N terminus of the ! helix also overlay well. 
Figure 3-7: NOESY spectrum of oPP! acquired at 700 MHz (250 ms mixing time) in the 
amide/aromatic region. Strong sequential HNi – HNi+1connectivities in the helical segment 
highlighted between K22 to Y34 (black lines). 




Unlike for PP!, clustering of peaks was observed for oPP!. This is a result of the repetitive and 
degenerate peptide sequence; there were a lot of the same residues in similar environments. This is 
particularly true for residues in the !-helical region, for example overlap is observed for residues 
A25 and A26, Y27 and E30, and L17, A18 and E23. 
In oPP!, residues K4 and K7 were shifted downfield in f1 and upfield in f2 relative to residues K3 
and K6. This is the result of the proximity of the K4 and K7 residues to the aromatic rings of Tyr27 
and Tyr20, respectively. 
 
 
Figure 3-8: Assigned natural abundance 1H-15N HSQC of oPP! (red) and parent PP! 
(black) acquired on a 700 MHz spectrometer. Pink and grey peaks are folded into the 
spectrum for oPP! and parent PP! respectively. Residues are labelled using their one-
letter codes. Coupling in carboxamide groups of Asp and Gln are specifically labelled. 




3.4.5! Analysis of the NMR structure of oPP! 
Despite the repetitive sequence, 95.8% of the 1H NMR resonances for oPP! were assigned. The 
core of the structure, in particular the interdigitating Pro and Tyr residues, was well defined, while 
some of the solvent-exposed residues were more dynamic. The most dynamic region of the structure 
was the loop. The RMSDs across the ensemble were 0.52 ± 0.13 Å (backbone) and 1.05 ± 0.15 Å 
(all atom). These backbone and all atom RMSDs are comparable to those for the 900 MHz NMR 
structure of PP!; 0.51± 0.12 and 0.83 ± 0.12 Å, respectively (Figure 3-9A). The NMR structure of 
oPP! was closely similar to the NMR structure of PP! (Figure 3-9B&C). A representative structure 
from the oPP!  ensemble (PDB 6GWX, model 8) matched PP! (PDB 5LO2, model 14) with 
RMSDs of 0.5 Å and 0.9 Å, respectively, measured over the backbone and all atoms.  
To explore the origins of the improved thermal stability of oPP!, the ensembles of structures for 
PP! and oPP! were compared in more detail. First, distances between the Lys and Glu residues 
introduced into oPP! (2:e and 3:g distances) were measured to determine whether interhelical salt 
bridges were present. An accepted definition of a salt bridge, defined by Barlow and Thornton, is 
based on a cut-off distance of 4 Å between N-O atom pairs.230 Overall across all 20 ensemble states 
the average distances between the N, of Lys and the Oε of Glu were 8.7 ± 1.8 Å and 11.5 ± 2.4 Å 
for 2:e and 3:g respectively and therefore outside of any accepted definition for formal salt-bridge 
interactions;231 thus, none of the potential salt bridges were made. However, while it is clear formal 
salt bridges do not stabilise oPP!, general electrostatic steering during folding likely contribute to 
stability.24, 204, 232-236 In the literature, Schreiber and Fersht show that long-range electrostatic 
interactions increased the association rate constant between two proteins, barnase (Bacterial 
Ribonuclease) and its intracellular inhibitor (barstar), while also helping orientate the two proteins 
Figure 3-9: (A) Overlay of all 20 states in the NMR ensemble of oPP!. (B) Overlay of 
PP! (PDB 5LO2, model 14) and oPP! (PDB 6GWX, model 8).  (C) Overlay of PP! 
(PDB 5LO2, model 14) and oPP! (PDB 6GWX, model 8) rotated through 90 ° along the 
axis of the ! helix compared to (B). Colour key: oPP! (purple), PP! (wheat). Note PDB 
6GWX is deposited in PDB but has not been released yet. 




for docking.204 Electrostatic steering has been shown to enhance the association rate between 
proteins in other studies too both experimentally and computationally.233, 237 
A key difference between the NMR structures was in the loop region and the orientation of the Pro8 
residue closest to the loop. In PP!, the loop kinks out causing Pro8 to be more solvent exposed 
compared to the equivalent Pro8 residue in oPP! (Figure 3-10A). In oPP!, Pro8 docked into the 
diamond-shaped hole on the ! helix more intimately than in PP!. The twisting out of Pro8 is likely 
result of the preceding residue, Lys7. In oPP!, Lys7 formed a long-range electrostatic interaction 
with Glu21 (Figure 3-10B). In PP!, there is no electrostatic steering effect between the two helices, 
instead a single interhelical salt bridge is made between Lys7 and Asp23 at 4.4 ± 1.3 Å with the 
knock on effect of Pro8 docking less tightly into the diamond shaped hole on the ! helix (Figure 
3-10C). We contend that electrostatic steering between the two helices has resulted in tightening of 
the oPP! NMR structure compared to PP!, which has contributed to the enhanced thermal stability. 
3.4.6! Analysis of solvent accessibility and side-chain burial in oPP! 
Next, we explored other factors that may have contributed to the enhanced stability of oPP! over 
PP!. The driving force for the assembly and stabilisation of the PP! fold is the interdigitation of 
Pro and Tyr residues and the burying of the hydrophobic interface. While polar hydrophilic residues 
are stabilised by interactions with water, hydrophobic side chains prefer to be buried and out of 
contact with water.238-239 The solvent accessible surface area (SASA) refers to the surface area of a 
biomolecule that is accessible to solvent, usually water. This is measured by rolling a probe of radius 
1.4 Å over the van der Waal’s surface of a macromolecule of interest, and the path traced out by the 
probe’s centre is the accessible surface.188 SASAs were calculated for both the oPP! and PP! NMR 
structures within the ISAMBARD framework using the programme Naccess.189 First, SASAs were 
calculated for intact oPP! and PP! complex (Figure 3-11A) with the loop region ignored in the 
calculations as it is the same for both the oPP! and PP! structures. SASAs were then calculated for 
the individual ! and PPII helix components for each structure (Figure 3-11B&C). 
Figure 3-10: Overlay of oPP! (PDB 6GWX, model 14) and PP! (PDB 5LO2, model 14) 
(A) Different orientations of residue Pro8 observed in PP! and oPP!. (B) Long-range 
electrostatic interaction (6.8 Å) between Lys7 and Glu21 in oPP!. (C) Salt bridge (2.7 Å) 
between Lys7 and Asp23 in PP!. Colour key: oPP! (purple), PP! (wheat). 




In order to be able to make reliable comparisons between the oPP! and PP! structures, the SASA 
of the complex was taken as  a proportion of the total SASA of the individual components. This is 






A low value for the relative SASA is indicative of the interface between the two helices being less 
solvent accessible and thus more buried compared to a high value for normalised SASA. In other 
words, a normalised SASA value of 0 indicates fully buried and a value of 1 indicates fully solvent 
exposed. 
Overall, the normalised SASA of oPP! was equal to that of PP! (oPP! 0.78 ± 0.006, PP! 0.78 ± 
0.010). While the overall SASA is the same for both structures, on a per residue basis there are some 
differences between the structures (Figure 3-12). There is a shift in SASA for some interface amino 
acids, for example, in oPP! Tyr20, Leu17 and Lys4 are considerably more buried than in PP!. 
However, overall the analysis suggests there is no significant difference in SASA between the two 
NMR structures and therefore the enhanced thermal stability of oPP! is not a result of higher side-
chain burial. 
Equation 3-1: SASA of the PP! or oPP! complex as a proportion of the SASA of the 
individual ! and PPII helix components. 
Figure 3-11: (A) oPP! complex with the loop removed. (B) ! helix component (C) PPII 
helix component. 




3.4.7! Analysis of CH–" interactions in oPP! 
Previous work shows that PP! is stabilized by CH–" interactions,153 therefore similar interactions 
were searched for in the oPP! ensemble. CH–" interactions were identified within the ISAMBARD 
framework.168-142 Interactions were classed as CH-positive if the following criteria were met: CH–π 
distance (between the CH proton to centre of the aromatic ring) ≤3.5 Å; CH–π angle (between the 
vector of the CH bond and the normal to the plane of the aromatic ring) ≤55°; H projection distance 
(between the projection of the CH bond to the plane of the aromatic ring and the centre of the ring) 






The analysis revealed 87 CH–" interactions across all 20 ensemble states in oPP! compared to 68 
interactions in PP!, equating to an increase of 28 %. This works out at an average of 4.35 CH–" 
interactions per structure for oPP! compared to 3.40 per structure for PP! (Table 3-2, Figure 3-14). 
Figure 3-13: Parameters defining a CH-" interaction. CH–π distance (between the CH 
proton to centre of the aromatic ring, i.e. H–X, blue) ≤ 3.5 Å. CH–π angle (between the 
vector of the C–H bond and the normal to the plane of the aromatic ring) θ ≤ 55°. C-
projection distance (between the projection of the CH carbon to the plane of the aromatic 
ring and the centre of the ring, i.e. X – Cp, blue) ≤ 2.0 Å for 6-membered ring (Tyr). 
 
Figure 3-12: Normalised SASA per residue in oPP! vs PP!. Colour key: oPP! (purple), 
PP! (wheat). Top line on x axis: oPP! sequence. Bottom line on x axis: PP! sequence. 




The greater number of CH–" interactions in the oPP! NMR structure, approximately one extra CH–
" interaction per ensemble state, likely contributes to the enhanced thermal stability observed for 











Interestingly, the dominant CH donors differed between the two ensembles: in oPP! fewer CH 
donors emanated from Pro side chains (oPP!: 5 interactions, PP!:, 22 interactions), but many more 
came from Leu (oPP!: 25 interactions, PP!: 4 interactions) and from the Lys residues (oPP!: 57 









Table 3-2: Table of CH–" interactions in oPP! compared to PP!. 
 oPP! PP! 
Pro donor: total CH–" interactions 5 22 
Pro donor: CH–" interactions per structure 0.25 1.1 
Leu donor: total CH–" interactions 25 4 
Leu donor: CH–" interactions per structure 1.25 0.2 
Lys donor: total CH–" interactions 57 15 
Lys donor: CH–" interactions per structure 2.85 0.75 
Gly donor: total CH–" interactions 0 20 
Gly donor: CH–" interactions per structure 0 1 
Acetyl group donor: total CH–" interactions 0 7 
Acetyl group donor: CH–" interactions per structure 0 0.35 
Total CH–" interactions 87 68 
Average CH–" interactions per structure 4.35 3.40 
Figure 3-14: Bar chart summarising CH–π interactions across oPP! NMR ensemble 
compared to PP!. Colour key: oPP! (purple), PP! (wheat). 




On closer inspection, in oPP! the side chains of Lys4 and Lys7 lie across the top faces of Tyr27 and 
Tyr20, respectively, leading to CH–π interactions between the C! and C$ protons of the former and 
the aromatic rings of the latter. The side chains of Leu24 and Leu31 sit on the underside of Tyr20 
and Tyr27 respectively, leading to CH–π interactions between the C$ protons of the former and the 
aromatic rings of the latter. Tyr residues appear to be anchored in place by CH–π interactions from 









The contrasting conformation of Lys side chains between structures is best emphasised on 
overlaying all NMR states for both PP! and oPP! (Figure 3-16). There is a change in conformation 
of the Lys4 residue between PP! and oPP!. In oPP!, Lys4 points more towards the interface of the 
two helices and lies across the face of Tyr27 to a greater extent than in PP!. In PP! Lys4 is more 
solvent exposed, consistent with the calculated SASA measurements for Lys4 (Figure 3-12). 
 
Figure 3-15: Representative models from the NMR structure ensembles of PP!  and oPP! 
highlighting CH–" interactions. (A) PP! (PDB ID 5LO2, model 14). (B) oPP! (PDB ID 
6GWX, model 8). Key: oPP! (purple), PP! (wheat), CH–" interactions(dashed lines). 
 











3.5! Further substitutions in oPP! 
Baker et al. show that the stability of PP! is influenced by the electron donating ability of the 
aromatic residue at the d position: peptides containing electron rich residues Tyr and Trp are more 
thermally stable compared to peptides containing electron poor residues Phe and His.153 To explore 
the importance of the CH-π interactions further, all of the electron-rich Tyr residues in oPP! were 
replaced by more-electron-poor phenylalanine (oPP!-Phe) (Figure 3-17). The electrostatic surface 
potentials of Phe and Tyr side-chains are shown in Figure 3-17D. As judged by CD spectroscopy, 
oPP! and oPP!-Phe had similar helicities at 5 °C. However, the thermal stability of oPP!-Phe 
dropped by approximately 20 °C compared to oPP! giving a TM of 33 °C. This drop is consistent 
with previous studies with PP! and thus indicates that while the identity of the CH–π donors is 




Figure 3-16: Overlay of oPP! and PP! NMR ensemble structures highlighting 
conformational change in Lys4 across the face of the aromatic ring in Tyr27 between 
structures. Key: oPP! (purple) and PP! (wheat).  





3.6! Chapter conclusion 
In conclusion, the PP! fold has been optimised by rational protein redesign to give oPP!, which has 
a completely de novo framework and significantly enhanced thermal stability. A solution-phase 
NMR structure supported by a range of biophysical techniques including CD spectroscopy and AUC 
confirms that, similar to the parent peptide, oPP! forms a stably folded monomeric and compact 
structure comprising a polyproline-II helix linked via loop to an ! helix. The two helices interact 
via KIH-like packing with the interdigitation of Pro and Tyr residues. CD spectroscopy reveals that 
oPP! unfolds reversibly with a midpoint unfolding temperature of 51 °C, a substantial increase of 
approximately 12 °C compared with PP!. Overall, 10 mutations are made to the PP! fold to yield 
the optimised sequence.  
Figure 3-17: Folding and stability of oPP!-Phe. (A) CD spectra recorded at 5 °C for oPP! 
(black), oPP!-Phe (blue) (B) Temperature dependence of the far-UV CD signal monitored 
at 222 nm. (C) AUC Sedimentation-equilibrium for of oPP!-Phe. Data (top, dots) and 
fitted single-ideal species model curves (lines) at 44 (blue), 52 (aqua), 56 (orange), and 
60 (red) krpm for oPPα peptides. Bottom: Residuals for the above fits using the same 
colour scheme. oPPα-Phe (v̅ = 0.756 cm3 g-1). The fit returned a mass of 3771 Da, (1.0 
monomer mass), 95% confidence limits = 3742 – 3801 Da. (D) Electrostatic surface 
potentials of the side chains of Phe (left) and Tyr (right). Scale: ≤ -130 kJ mol-1 
(electropositive, blue) through ≥ 130 kJ mol-1 (electronegative, red). Modified from 
reference 153. Conditions for CD: 100 µM peptide, PBS, pH 7.4. Conditions for AUC: 130 
µM peptide, PBS, pH 7.4. 
 




The increase in stability observed in oPP! compared to PP! is the result of a combination of factors. 
It was postulated that introducing Lys-Glu pairs between the 2 and 3 position of the PPII helix and 
the e and g position of the ! helix would result in the formation of interhelical Coulombic 
interactions that would help stabilise the miniprotein fold. This is a strategy used frequently in the 
de novo design of coiled coils to guide and stabilise assemblies.132-133 However, the distance between 
the Lys and Glu residues in oPP! indicated that salt bridges are not present in the NMR ensemble; 
distances are greater than the accepted cut-off for salt bridge interactions of 4 Å. While formal salt 
bridges may not stabilise oPP!, general electrostatic steering during folding likely contributes to the 
stability.204, 232 
Overall tightening of the oPP! NMR structure compared to PP! is observed, which will also 
contribute to the enhanced stability. The oPP! NMR structure reveals all Pro residues on the 
polyproline-II helix face and dock into diamond shaped holes top and tailed by Tyr residues forming 
KIH-like interactions. However, there is an anomaly in PP! where Pro8, the Pro residue closest to 
the loop region, kinks out and is more solvent exposed; it does not dock so tightly into the diamond 
hole formed on the ! helix. This is quantified by the higher SASA value for Pro8 in PP! compared 
to oPP!. 
This tightening of the structure improves the non-covalent interactions, specifically the frequency 
of CH–π interactions. Analysis of the oPP! NMR structure reveals a significant increase in the 
number of CH–" interactions in the ensemble compared to PP!; 87 CH–" interactions (4.35 per 
structure) in oPP! compared to 68 (3.40 per structure) in PP! i.e. one extra CH–" interaction per 
ensemble state. Interestingly, the dominant CH donor shifts from Pro in PP! to Lys and Leu in 
oPP!. Closer inspection of the NMR ensemble shows Tyr residues are stabilised by CH-" 
interactions from Lys above the aromatic ring and Leu below the ring. Lys appears to lie across the 
face of Tyr. 
Overall, the enhanced stability of oPP! can be attributed to electrostatic steering effects and overall 
tightening of the structure resulting in improved non-covalent binding, specifically an increase in 
the number of CH–π interactions. Further sequence-to-stability relationships need to be investigated 
to fully understand this miniprotein. In Chapter 4 such relationships will be discussed, in particular 
the effect of mutating the interface diamond-shaped-hole residues.
 




Chapter 4! Probing sequence-to-stability relationships in oPP! 
The work described in this chapter was designed by the author of this thesis (KPG), Dr Emily Baker 
and Prof. Dek Woolfson. Bristol Chemical Synthesis rotation CDT students Frank Zieleniewski and 
Jenny Samphire synthesised and preliminary characterised peptides oPP!-A@a, oPP!-I@a, 
oPP!-V@a, oPP!-E@a, oPP!-K@a. Full characterisation of these peptides was followed up by 
KPG. Molecular dynamics simulations were set up and analysed by KPG. 
4.1! Chapter introduction 
Chapter 3 described the redesign of PP! into a de novo framework. This resulted in an optimised 
PP! fold with significantly enhanced thermal stability. The increase in the thermal stability of oPP! 
can be rationalised by electrostatic steering from interhelix Lys-Glu pairs and improved non-
covalent interactions such as CH–" interactions as a result of the overall tightening of the structure. 
This chapter focuses on the interface residues involved in the KIH-like packing to further understand 
the PP! fold. 
We have a good understanding of sequence-to-structure relationships in !-helical coiled  
coils.132-133, 240 This has led to success in the rational design of lower order coiled coils32, 203 (both 
homo- and hetero- meric dimers trimers, tetramers) as well as more complex !-helical barrels with 
central channels.145 Successful rationally designed coiled coils are now being used as scaffolds onto 
which functions are being grafted152 and as building blocks for more complicated assemblies.241-242 
In a similar way, deeper understanding of the PP! fold should help pave the way for the successful 
design of more complicated assemblies based around the polyproline-II helix:loop:! helix topology. 
This chapter explores sequence-to-structure and -stability relationships in oPP! by probing the 
diamond shaped hole residues that accommodate the Pro knob residue. 
4.1.1! Knobs-into-holes packing 
As discussed in previous chapters, intimate side-chain interdigitation, named knobs-into-holes 
(KIH) packing, directs helix-helix interactions in coiled coils. Specifically, hydrophobic side chains 
at a and d on one helix act as knobs and dock into diamond-shaped holes of four residues on the 
adjacent helix. For parallel helices, two types of KIH interactions are possible depending on the 
identity of the knob residue: an a knob can dock into a hole formed by dgad residues while a d knob  
interacts with adea residues (Figure 4-1A).243 
As a result of the helical geometry, all the C!-C$ bonds of side-chains project out of the helix 
backbone along a defined vector.134 In parallel dimers a and d knob residues point towards the 
diamond shaped hole residues on the adjacent helix differently. The C!-C$ bond vector of the d knob 
residue points directly into the hole towards the opposite helix and is referred to as perpendicular 
 




packing.132 Whereas the C!-C$ bond vectors of a knobs point away from the helix-helix interface, 
which is termed parallel packing (Figure 4-1C).132, 143, 244 As a result, d residues favour non-$-
branched less bulky residues like Leu while a residues are more accommodating of different shaped 
side-chains and thus prefer $-branched Ile and Val.132, 245 
In the PP! fold, Tyr at d is critical for folding and stability153 and forms two sides of the diamond 
hole defined by side chains at successive dgad sites on the ! helix. Only position 1 (Pro) on the 
polyproline-II helix acts as a knob residue pointing at the diamond hole on the ! helix as a result of 









4.1.2! Related natural PP! peptides 
As described in the Introduction, the fragment based design of PP! borrowed from two natural 
proteins: pancreatic peptides29 and the antigenic bacterial surface adhesin166 (AgI/II). The pancreatic 
polypeptide family, consists of pancreatic peptides,29, 246-247 peptide YY248 and neuropeptide Y249 
and all have sequence similarities and some conserved residues (Table 4-1). The conservation of 




Figure 4-1: (A) Representation of knobs-into-holes packing for parallel coiled-coil 
dimers: (left) ‘d’ hole (right) ‘a’ hole. (B) Knobs-into-hole like packing in PP!. (C) 
Coiled-coil dimer (CC-Di, PDB: 4DZM) highlighting parallel and perpendicular packing. 
(D) oPP! (NMR structure, state 1) highlighting the a (cyan) and d (orange) sites. Key: 









Table 4-1, showing the sequences of the pancreatic polypeptide family, can also be interpreted 
visually as a sequence logo: a  graphical representation of an amino acid sequence alignment (Error! 
Reference source not found.).250-251 The logo consists of a stack of letters, one stack for each position 
in the sequence. The height of the letter within the stack indicates the relative frequency of each 
amino acid at that position. Letters at the top of a stack are the most frequent across all sequences. 
Both Table 4-1and Error! Reference source not found. show that Tyr at d and Pro at position 1 are 
highly conserved in related folds of natural proteins. Leu at position a is also conserved. The a 
position (residue24) is entirely Leu across all sequences for the middle !-helical heptad (heptad 2) 
while the frequency of other residues at the a position increases in heptads 1 and 3. For example for 
heptad 3, while Leu (residue30) is still the most frequent, other hydrophobic residues Ile and Val 
are present in some sequences. The g site is less conserved in related natural peptides and in the 








Table 4-1: Sequences of the pancreatic polypeptide family. 
Peptide name Sequence and helical register PDB 
Code                 321321               efgabcd efgabcd efgabcd  
oPP! Ac- PPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY    -NH2    6GWQ* 
Parent PP! Ac- PPTKPTKP GDNAT PEKLAKY QADLAKY QKDLADY    -NH2       5LO2 
aPP     GPSQPTYP GDDAP VEDLIRF YNDLQQY LNVVTRH RY -NH2 1PPT† 
bPP     APLEPEYP GDNAT PEQMAQY AAELRRY INMLTRP RY -NH2 1BBA 
hPP     APLEPVYP GDNAT PEQMAQY AADLRRY INMLTRP RY -NH2 - 
pPP     APLEPVYP GDDAT PEQMAQY AAELRRY INMLTRP RY -NH2 - 
nPY     YPSKPDNP GEDAP AEDLARY YSALRHY INLITRQ RY -NH2 1RON 
pYY     YPIKPEAP GEDAS PEELNRY YASLRHY LNLVTRQ RY -NH2 2DEZ 
AgI/II     PPVKPTAP  //   EAKLAKY QADLAKY QKDLADY PV 3IOX 
aPP (avian pancreatic peptide), bPP (bovine pancreatic peptide), hPP (human pancreatic 
peptide), pPP (porcine pancreatic peptide), nPY (neuropeptide Y), pYY (peptide tyrosine 
tyrosine), AgI/II (antigenic bacterial surface adhesin) residues 450-472 and 838-845. 
*NMR structure deposited in the PDB but will not be released to the public until 
publication. †All structures are NMR structures apart from aPP which is an X-ray crystal 
structure.  
 




As well as having sequence similarities, the pancreatic polypeptide family are also structurally very 
similar. Figure 4-3A shows overlays of the middle heptad of oPP!, parent PP!, avian pancreatic 
peptide (aPP), bovine pancreatic peptide (bPP), neuropeptide Y (nPY) and antigenic bacterial 
surface adhesin (AgI/II). All structures overlay well. The majority have similar side chain 
conformations for the dgad residues, in particular for the Pro and Tyr residues. There is some 
variation in the puckering of the ring in the Pro residues. 
nPY is slightly different. While it has sequence similarity to the other peptides it has different 
structural features. nPY has distinctly different side-chain conformations for the Tyr residues 
(Figure 4-3A) and in the NMR structure the ! helix does not interact with the polyproline-II helix; 
NOEs were not found between the ! and polyproline-II helices (Figure 4-3B).249 This can be 
rationalised by studies that have shown nPY is a dimer in solution with the two monomers 
interacting via their ! helices in an antiparallel fashion.252 From a biological perspective, nPY is a 
neurotransmitter acting on both the central and peripheral nervous systems and the self-associated 




Figure 4-2: Sequence logo of the related natural PP! like folds. (A) Sequence logo for 
aPP, bPP, hPP, pPP, nPY and pYY. (B) Sequence logo for aPP, bPP, hPP, pPP, nPY, pYY 
and AgI/II. Loop region omitted. (C) Sequence logo for an !-helical heptad repeat for 
aPP, bPP, hPP, pPP, nPY, pYY and AgI/II. (D) Sequence logo for the three residue 
repeating unit in the polyproline-II helices of aPP, bPP, hPP, pPP, nPY, pYY. Sequence 
logo for Sequence logos generated with Weblogo.250-251 Colour key: polar residues (blue), 
hydrophobic residues (black), Ala, Pro and Gly residues (green). 
 



























Figure 4-3: (A) Overlay of the middle heptad for aPP (pink), bPP (green), nPY (orange, 
only ! helix shown), AgI/II (wheat), oPP! (purple), parent PP! (pink) highlighting the 
similar conformations of the side chains in the diamond hole residue positions dgad. 
Structures aligned in Pymol. Note nPY PPII helix not present since peptide does not adopt 
PP! topology. (B) Overlay of all 26 states in the NMR ensemble of nPY (PDB: 1RON). 
 




4.2! Probing the diamond shaped hole residues in oPP! 
4.2.1! Mutations to the a position of oPP! 
While Pro and Tyr residues are essential for the formation and stability of the PP! fold the 
amenability of the a and g positions to mutation were investigated. First, to explore what other 
residues, if any, might substitute for Leu at a, a series of mutants (X@a mutants) in which all three 
sites were replaced by Ala, $-branched Ile or Val or  charged Glu or Lys residues were synthesised 
and characterised in solution (Figure 4-4). Non-bulky Ala was initially selected to determine the 
contribution of Leu to the stability of the peptide in a similar manner to alanine-scanning. $-branched 
Ile and Val were selected because the sequence logos above show they are present at the a position 
in the heptad repeats of natural related sequences while Glu and Lys were selected to determine the 










4.2.1.1! Characterisation of the X@a series by CD spectroscopy 
These peptides were first analysed by CD spectroscopy to determine the effect of a position 
mutations on the overall structure and stability of the peptides (Figure 4-5). CD spectra and thermal 
unfolding curves revealed a broad range of stabilities for the X@a variants ranging in helicity from 
5 to 48 % at 5 °C and ranging in TM from < 5 °C to 51 °C. Of all the X@a mutants, Leu at a was 
the most stable, which is consistent with it being the naturally preferred residue at the a position. 
Peptide name Sequence and helical register 
       321321       efgabcd efgabcd efgabcd  
oPP! Ac- PPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY -NH2          
oPP!-I@a Ac- PPKKPKKP GDNAT PEKIAAY EKEIAAY EKEIAAY -NH2                    
oPP!-V@a Ac- PPKKPKKP GDNAT PEKVAAY EKEVAAY EKEVAAY -NH2                     
oPP!-E@a Ac- PPKKPKKP GDNAT PEKEAAY EKEEAAY EKEEAAY -NH2                       
oPP!-K@a Ac- PPKKPKKP GDNAT PEKKAAY EKEKAAY EKEKAAY -NH2                     
oPP!-A@a Ac- PPKKPKKP GDNAT PEKAAAY EKEAAAY EKEAAAY -NH2                
Figure 4-4: (A) Helical wheel representation of the series of mutations at the a position 
(X@a mutations). (B) Sequences of the series of peptides with mutations to the a position. 
 















The stability of the oPPα-A@a variant was drastically compromised with respect to oPPα. The CD 
spectra at 5 °C showed 23% α-helical character, less than half that of oPPα, despite the favourable 
increase in helical propensity of Ala compared to Leu. Thermal stability was also substantially 
compromised. We attribute this to the non-bulky nature of the methyl functional group eliminating 
any preferable side chain interactions. Further, this implies that Leu at a plays an important role in 
the folding and stability of the peptide and contributes to the interface.  
oPPα variants with $-branched residues at a, oPPα-I@a and oPPα-V@a, were well folded, albeit 
with reduced thermal stabilities compared to oPPα with TMs values of 40 °C and 34 °C vs 51 °C 
respectively. This is perhaps unsurprising given the similar size and isomeric nature of Ile and Leu. 
Furthermore, both Ile and Val are present in the third heptad of some natural sequences (Table 4-1) 
hinting at their amenability at the a position. The reduction in TM values suggests that the extra steric 
bulk of the $ carbon may hinder access of the Pro knob to the hole. However, it must also be noted 
that this cannot be disconnected from the fact that the !-helix propensities of Ile and Val are 
appreciably lower than that of Leu.209  
 
Peptide name MRE222 nm /  





oPP! -18319 48 51  ± 0.8 
oPP!-I@a -16493 43 40  ± 0.1 
oPP!-V@a -14854 37 34  ± 1.4 
oPP!-K@a -12448 33 19  ± 2.3 
oPP!-A@a -8522 23 - 
oPP!-E@a -1642 5 - 
Figure 4-5: Folding and stability of oPP! and X@a variants. (A) CD spectra recorded at 
5 °C for oPP! variants: oPP!-E@a (red), oPP!-A@a (sky blue), oPP!-K@a (blue), 
oPP!-I@a (green), oPP!-V@a (orange), and oPP! (black) for comparison. (B) 
Temperature dependence of the far-UV CD signal monitored at 222 nm for the X@a 
mutants, same colour scheme as in (A). (C) Table summarising the MRE at 222 nm at  
5 °C, the % helicity and also the TM for all the X@a peptide variants. Conditions:  
100 µM peptide, PBS, pH 7.4. 
 
 




The least folded variant, oPPα-E@a, was unfolded showing no α-helical characteristics at 208 and 
222 nm. We postulate this is due in part to the proximal glutamates at the e position if the ! helix 
were folded, but also the bulky nature of the Glu side-chain may potentially prevent Pro from 
docking so tightly into the diamond hole. This is despite a potentially positive interaction with the 2 
position. Also the helical propensity of Glu is slightly lower compared to Leu which will contribute 
to the reduced stability. This result suggests large negatively charged side chains are not compatible 
at the a position. In comparison, oPPα-K@a gives a partially folded peptide with a TM of 33 °C. Lys 
likely forms a favourable i!i+4 interaction with Glu at the e position contributing to stability.24 
However the close proximity to Lys at position 2 will reduce electrostatic steering effects between 
the two helices thus hampering stability. It is encouraging nevertheless that larger positively charged 
residues can be accommodated. 
To summarise, Leu at a gave the most folded and thermally stable variant. However, other residues 
such as hydrophobic Ile, Val and positively charged residue Lys can also be tolerated. This is 
encouraging for future applications of oPPα where the sequence will need to be amenable to 
mutation to allow for function to be introduced. 
4.2.1.2! Characterisation of the X@a series by AUC 
To determine the oligomeric states of the X@a peptide series in solution SE AUC experiments were 
carried out. For all peptides in the series, apart from oPPα-E@a, experimental data readily fitted to 
single-ideal species models returning molecular weights consistent with monomers (Figure 4-6). 





























4.2.2! Probing a fully hydrophobic interface 
To further assess the optimal interface, the g position of the ! helix was also investigated. In oPP!, 
polar residue Glu at g contributes to electrostatic steering between the ! and polyproline-II helices. 
Therefore, any mutations at g could be detrimental in this respect so Glu was installed at the c 
position to maintain charge complementarity between the two helices. This allowed the identity of 
the g position to be explored. Note also that Glu at the c position results in a potential Glu ! Lys 
i!i+4 side chain salt bridge with the f position (Figure 4-7). 
The ! helix also needed to be considered since in oPP! the first heptad is different to the following 
two heptads and starts with the residues P-E-K at e-f-g. As mentioned in Chapter 3, this is because 
Pro and Glu are conserved as the N-terminal residues in the ! helix of related natural sequences 
(Table 4-1, Error! Reference source not found.). This is likely because Pro and Glu have been shown 
to be good helix capping residues with high frequency of occurrence at the N1 and N2 positions 
Figure 4-6: AUC Sedimentation-equilibrium data (top, dots) and fitted single-ideal 
species model curves  (lines) at 44 (blue), 52 (aqua), 56 (orange), and 60 (red) krpm. (A) 
oPP!-A@a (v̅ = 0.733 cm3 g-1). (B) oPP!-K@a (v̅ = 0.742 cm3 g-1). (C) oPP!-V@a (v̅ = 
0.743 cm3 g-1). (D) oPP!-I@a (v̅ = 0.748 cm3 g-1). The fit returned the following masses: 
oPPα-A@a, 3510 Da (1.0 % monomer mass), 95% confidence limits = 3495 – 3526 Da; 
oPPα-K@a, 3692 Da, (1.0 % monomer mass), 95% confidence limits = 3680 – 3703 Da; 
oPPα-V@a, 3702 Da, (1.0 % monomer mass), 95% confidence limits = 3683 – 3722 Da; 
oPPα-I@a, 3074 Da, (1.0 % monomer mass), 95% confidence limits = 3037 – 3111 Da. 
Conditions: 130 µM peptide, PBS, pH 7.4. 
 




respectively in ! helix motifs.224-225, 253 Pro lacks the flexibility of other residues because its 
backbone dihedral angle . is constrained at ≈ –70° similar to an ideal helix.224 Lys was selected to 
balance the charge associated with Glu. Therefore, the first turn of the ! helix following the loop 
region was maintained across mutants of oPP!. The g position was therefore not mutated in the first 
heptad but only mutated for heptads two and three. 
4.2.2.1! Leu at the g position 
The g site was initially mutated to Leu with Leu maintained at the a position since our analysis 
above shows Leu offers the greatest stability. This resulted in a fully hydrophobic diamond hole and 




The CD spectra at 5 °C showed that oPP!-L@a-L@g had approximately the same helicity as oPP! 
(Figure 4-8A). However, a much broader transition in the thermal denaturation curve was observed 
with a TM of 76 °C (Figure 4-8B). This is a substantial increase over the TM of oPP! (51 °C). The 
broad nature of the thermal melt is unlike the melt curves of other oPP! mutants. The different 
unfolding behaviour suggests that the interactions in oPP!-L@a-L@g are potentially different to 
what has previously been observed. 
Peptide name Sequence and helical register 
       321321       efgabcd efgabcd efgabcd  
oPP! Ac- PPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY -NH2          
oPP!-L@a-L@g Ac- PPKKPKKP GDNAT PEKLAEY EKLLAEY EKLLAEY-NH2                    
Figure 4-7: (Top) Sequence of peptide with a fully hydrophobic diamond hole (oPP!-
L@a-L@g). (B) Helical wheel representation of oPP!-L@a-L@g.  
 






















Figure 4-8: Folding and stability of oPP!-L@a-L@g. (A) Far-UV CD spectra recorded 
at 5 °C for oPP!, oPP!-L@a-L@g. (B) Temperature dependence of the far-UV CD signal 
monitored at 222 nm. For both (A) and (B) spectra overlaid for concentrations 5, 10, 50, 
100 and 200 µM. The lines for each concentration range in colour from light blue (low 
concentration) to dark blue (high concentration). (C) Near-UV CD spectra recorded at 5 
°C for oPP!, oPP!-L@a-L@g. (D) Temperature dependence of the near-UV CD signal 
monitored at 276 nm for oPP! and oPP!-L@a-L@g. (E)  AUC Sedimentation-
equilibrium data (top, dots) and fitted single-ideal species model curves (lines) at 44 
(blue), 52 (aqua), 56 (orange), and 60 (red) krpm for oPPα-L@g-L@a. Bottom: Residuals 
for the above fits. oPPα-L@a-L@g v̅ = 0.754 cm3 g-1  The fit returned a mass of 4912 Da 
(1.2 % monomer mass), 95% confidence limits = 4899 – 4926. Colour key: oPP! (black), 
oPP!-L@a-L@g (blue). Conditions: 100 µM (CD Spectroscopy) and 130µM (SE AUC) 
peptide, PBS, pH 7.4. 
 




To investigate this further, near-UV CD spectroscopy experiments were also performed (Figure 
4-8C&D). The magnitude of the CD signal in the near-UV region is very similar compared to oPP! 
indicating similar stability at 5 °C. Monitoring the thermal transition showed unfolding and folding 
curves that were coincident with those recorded in the far-UV with a TM of 76 °C. 
The broad melt curve combined with the fully hydrophobic diamond hole interface perhaps suggests 
that there is non-specific association of the two helices. The two hydrophobic faces of the 
polyproline-II and ! helices come together driven by the hydrophobic effect but perhaps do not 
interact so precisely as in PP! and oPP!. In addition, some possible self-association may be 
occurring.  
To test this oligomerisation hypothesis, CD spectra were run at a range of different concentrations 
to determine whether there was any concentration dependence to the CD signal. Concentration 
dependence of the CD signal is indicative that the peptide could be oligomerising into a higher order 
oligomeric state.226, 254-256 As well as running CD spectroscopy experiments at 100 µM, experiments 
were also run at 5, 10, 50 and 200 µM (Figure 4-8A&B). A range of peptide helicities and TMs were 
observed (Table 4-2). CD spectra at 5 and 10 µM were consistent with one another however were 
less folded compared to oPP!-L@a-L@g at 100 µM exhibiting lower helicity at 5 °C and a lower 
TM of 71 °C. The CD signal at 50 µM was between 10 and 100 µM with a TM of 72 °C while at 200 
µM the TM value was 77 °C, slightly higher than at 100 µM. This concentration dependence of the 





To further examine the oligomeric state of oPP!-L@a-L@g SE AUC experiments were performed 
(Figure 4-8E). SE AUC determined that the peptide had a mass of 1.2 % the mass of the monomer. 
This non-discrete value combined with the concentration dependence of the CD signal suggests that 
oPP!-L@a-L@g is not fully monomeric and is in equilibrium with a higher order species, 
potentially a dimer. 
 
 
Table 4-2: Concentration dependence of CD signal for oPP!-L@a-L@g 
Concentration 
/ µM 
MRE222 nm /  
deg cm2 dmol-1 res-1 
% Helicity175-
176 
TM / °C 
5 -14065 37 71 
10 -14259 37 71 
50 -15265 40 72 
100 -17333 46 76  ± 1.2 
200 -16525 43 77 
 




4.2.3! Probing which position is more dominant: a or g 
Leu is conserved at the a position in related natural sequences. Leu at both a and g results in a higher 
midpoint of unfolding however the discrete monomeric nature of the miniprotein is lost. The broad 
transition in response to temperature may also be the result of non-specific association.  
While it is clear Leu at both a and g is not preferable, the preference for one position over the other 
has not been investigated. To make a direct comparison between the preference for Leu at either the 
a or g positions the following two peptides were synthesised (Figure 4-9). Again, Glu was installed 
at the c position to maintain complementary electrostatic interactions between the two helices. PEK 
was also retained which limited mutations to the second and third heptads of the ! helix. In 













Peptide name Sequence and helical register 
       321321       efgabcd efgabcd efgabcd  
oPP!-L@a-A@g Ac- PPKKPKKP GDNAT PEKLAEY EKALAEY EKALAEY-NH2                     
oPP!-A@a-L@g Ac- PPKKPKKP GDNAT PEKLAEY EKLAAEY EKLAAEY-NH2                     
Figure 4-9: (Top) Peptides sequences for oPP!-L@a-A@g  and oPP!-A@a-L@g. 
(Bottom) Helical wheel representations of oPP!-L@a-A@g (A) and oPP!-L@g-A@a  
(B). Diamond holes formed in the second and third heptads of oPP!-L@a-A@g (C) and 
oPP!-A@a-L@g (D). 
 






















Figure 4-10: (A) Folding and stability of oPP!-L@a-A@g and oPP!-A@a-L@g. (A) 
Far-UV CD spectra recorded at 5 °C for oPP!-L@a-A@g and oPP!-A@a-L@g. (B) 
Temperature dependence of the far-UV CD signal monitored at 222 nm. (C) Near-UV CD 
spectra recorded at 5 °C for oPP!-L@a-A@g and oPP!-A@a-L@g. (D) Temperature 
dependence of the near-UV CD signal monitored at 276 nm. (E&F)  AUC Sedimentation-
equilibrium data (top, dots) and fitted single-ideal species model curves (lines) at 44 
(blue), 52 (aqua), 56 (orange), and 60 (red) krpm for oPPα-L@g-L@a. Bottom: Residuals 
for the above fits. (E) oPP!-L@a-A@g v̅ = 0.745 cm3 g-1.  The fit returned a mass of 4019 
Da (1.0 % monomer mass), 95% confidence limits = 4006.9 – 4030.6. (F) oPP!-A@a-
L@g v̅ = 0.745 cm3 g-1  The fit returned a mass of 4101 Da (1.1 % monomer mass), 95% 
confidence limits = 4089.0 –  4113.3. Conditions: 100 µM (CD Spectroscopy) and 130µM 








oPP!-L@a-A@g was significantly less folded than oPP! at 5 °C with 29% helicity and a TM of  
21 °C (Figure 4-10A&B). Surprisingly, oPP!-A@a-L@g was more folded compared to  
oPP!-L@a-A@g (38 % helicity at 5 °C), albeit less so than oPP! . The thermal melt curve of  
oPP!-A@a-L@g was slightly broader compared to oPP! and a lower TM of 43 °C was calculated. 
Near-UV CD spectra at 5 °C for oPP!-L@a-A@g showed a less intense signal compared to oPP!-
A@a-L@g indicative of less rigid and more mobile Tyr side chains.226 The thermal unfolding curves 
in the near-UV range for both were consistent with traces in the far-UV range and TMs were 
coincident (Figure 4-10C&D). 
oPP!-L@a-A@g and oPP!-A@a-L@g were both monomeric in solution by SE AUC (Figure 
4-10E&F) yielding masses of 1.0 and 1.1 % monomer mass. 
These results suggest that, with Glu at c, Leu is best placed at the g position compared to the a 
position. This is surprising given that Leu is very conserved at the a position in related natural folds. 
It is also surprising given that on mutating Leu at a to Ala it would be expected that this would result 
in the loss of CH-" interactions between Leu and Tyr that are observed in both PP! and oPP! and 
stabilise the structure. However other interactions must compensate for this. 
4.2.4! Swapping the a and g positions 
Based on this result, the effect of Leu at g in the context of oPP! was investigated by synthesising 
oPP!-a#g where the a and g positions were swapped (Figure 4-11). The e and c as well as the b 
and f positions were also swapped so as to keep both peptides equivalent and comparable. 
Introducing complementary or unfavourable charged interactions in the ! helix of oPP!-a#g that 






Peptide name Sequence and helical register 
       321321       efgabcd efgabcd efgabcd  
oPP! Ac- PPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY-NH2                     
oPP!-a#g Ac- PPKKPKKP GDNAT PEKLAAY AALEKEY AALEKEY -NH2                     
Figure 4-11: (Top) Peptide sequence of oPP!-a#g. (Bottom) Helical wheel of oPP! (A) 
and oPP!-a#g (B). 
 




oPP!-a#g was less folded at 5 °C compared to oPP! and yielded a TM value of 19 °C, a substantial 
decrease compared to the TM of oPP!. The near UV CD spectra was consistent with what is observed 
in the far-UV range. SE AUC experiments found oPP!-a#g to be monomeric in solution. 
This result is inconsistent with what is observed when probing Leu at both a and g in isolation 
(oPP!-L@a-A@g and oPP!-A@a-L@g), which showed that Leu at g appeared to provide greater 
stability compared to Leu at a. This highlights the difficulties in probing non-covalent interactions 
even in the context of miniproteins. The diamond hole residues work in combination to provide 
stability to the peptide and looking at individual contributions of Leu at a or g does not accurately 
reflect the effect this has on stability in the context of oPP!. Comparing oPP! with oPP!-a#g 












































Figure 4-12: (A) Folding and stability of oPP!-a#g (A) Far-UV CD spectra recorded at 
5 °C for oPP!-a#g and oPP!. (B) Temperature dependence of the far-UV CD signal 
monitored at 222 nm. (C) Near-UV CD spectra recorded at 5 °C for oPP!-a#g and oPP!. 
(D) Temperature dependence of the near-UV CD signal monitored at 276 nm. (E&F)  
AUC Sedimentation-equilibrium data (top, dots) and fitted single-ideal species model 
curves (lines) at 44 (blue), 52 (aqua), 56 (orange), and 60 (red) krpm for oPP!-a#g. 
Bottom: Residuals for the above fits. (E) oPP!-a#g v̅ = 0.748 cm3 g-1  The fit returned a 
mass of 4079 Da (1.1 % monomer mass), 95% confidence limits = 4065 – 4093. 
Conditions: 100 µM (CD Spectroscopy) and 130µM (SE AUC) peptide, PBS, pH 7.4. 
Colour key: oPP! (black), oPP!-a#g (green. 
 




4.3! Molecular dynamics simulations of oPP! and variants 
Obtaining experimental structures was not possible for all of the oPP! variants because of their 
reduced stabilities. Therefore, molecular dynamics (MD) simulations in water were used to explore 
the root causes of the difference in stabilities in the oPP! variants. MD simulations are one of the 
principle tools in the theoretical study of biological molecules to assess their time-dependent 
behaviours. MD simulations can provide information on protein stability, conformational changes, 
protein folding, molecular recognition and ion transport in biological systems.257-258 
4.3.1! MD simulations of the X@a series of oPP! peptide 
Point mutations were made to conformer eight of the NMR structure of oPP! in Pymol to generate 
models for the X@a mutants. A cubic periodic boundary box was set up and the box was filled with 
water molecules and 137 mM NaCl to mimic experimental conditions. Simulations were run using 
the Gromacs suite of tools and the Amber99sb-ILDN force field. After an initial relaxation and 
equilibration period each model peptide underwent a further 100 ns of MD. Simulations were 
performed in triplicate for each X@a model from the same starting structure to ensure as much 
conformational space was sampled. However without infinite simulation time the quality of 
sampling in simulations will always be limited. Theoretically, with an infinitely long MD run time, 
the overall global thermodynamic energy minimum can be reached. Simulations were also run for 
the oPP! NMR structure (state 8).  
All-atom RMSDs were calculated across the MD simulation; each structure from the trajectory was 
compared to the reference structure at the 0 ns timepoint. RMSDs were used to give an indication 
of how stable the model peptide was. RMSDs that fluctuate most across the time course were 
deemed less stable relative to RMSDs that did not fluctuate so much and were more consistent across 
the time course. 
Firstly, the oPP! NMR structure was simulated and was found to be stable over three 100 ns 
simulations showing no significant fluctuations in the RMSD over the trajectory. For the oPPα X@a 
variants, the RMSDs of the model structures through the MD trajectories correlated crudely with 
the observed experimental thermal stabilities. oPPα and oPPα-I@a, which have the highest TMs, 
were stable with little fluctuation throughout all simulations as judged by RMSD. Whereas, all of 
the other variants deviated progressively from the initial structures as the simulations ensued as 














Figure 4-13: RMSD analyses of molecular dynamics trajectories. All atom RMSD vs. 
simulated time for oPP!-X@a variants run in triplicate. RMSDs calculated relative to 0 
ns time point. Colour key: oPP! (black), oPP!-I@a (green), oPP!-V@a (orange), oPP!-
K@a (blue), oPP!-A@a (sky blue), oPP!-E@a (red). 
 
 




To quantitatively compare the MD structures, the RMSD between the 0 and 100 ns structures were 
calculated for each repeat, averaged and the standard deviation determined (Figure 4-3).  Again, 
there was a rough trend in which the all atom and backbone RMSDs increase as the stability of the 
peptide decreases (i.e. as the TM of the peptide drops). Also, as well as an increase in RMSD for the 
less stable peptides, there was an increase in the standard deviation too. This suggests that the less 





As well as calculating RMSDs between the 0 and 100 ns structures, root mean square fluctuations 
(RMSFs) were also determined. The RMSF calculates, for each residue, the fluctuation about the 
average position. While the average structure is not that informative the fluctuations gives insight 
into the flexibility of different parts of the peptide and correspond to crystallographic b-factors. The 
RMSF and average structure for each mutant in the X@a series are represented in Figure 4-14. The 
colours of the structures are distributed over the b-factors values where blue represents the most 
stable and red represents the most fluctuating regions. The bulges in the cartoons emphasise regions 
of high fluctuation in b factors in the structure.  
For each oPP! mutants the interface a, d and g positions were the most stable, in particular the 
residues Tyr20, Tyr27, X@a24, and Pro5  showed the least fluctuation around the average structure 
and were the most rigid. For oPP! and oPP!-I@a, flexibility was limited mainly to the loop region 
and all Tyr, Leu and Pro residues were rigid. oPP!-V@a showed some fraying towards the N-
terminus of the ! helix. Significant fraying of both the N and C terminus was observed for oPP!-
K@a and oPP!-E@a. Notably, only slight fraying of the C-terminus of oPP!-A@a was observed 
however large fluctuations in the loop region and the Pro8 residue were noted. 
 
 
 Backbone RMSD / Å 
 
All atom RMSD / Å 
 
TM / °C 
oPP! 1.28 ± 0.21 2.49 ± 0.26 51 
oPPα-I@a 1.43 ± 0.10 2.62 ± 0.11 40 
oPPα-V@a 2.44 ± 0.19 3.31 ±0.25 34 
oPPα-K@a 2.80 ± 1.22 3.82 ± 1.17 19 
oPPα-A@a 2.43 ±0.26 3.45 ± 0.38 - 
oPPα-E@a 2.78 ±1.02 3.78 ± 0.97 - 
Table 4-3: RMSD between 0 and 100 ns timepoints for oPP!-X@a Series. 
 
















Snapshots of each mutant were also overlaid at 0 and 100 ns timepoints to compare the gross change 
in structure from the start to the end of the simulation (Figure 4-15). For oPP! and oPP!-I@a the 
snapshots were very similar and the 100 ns structures overlaid well with the initial structures. oPP!-
V@a overlaid well however slight fraying of the C-terminus of the ! helix was observed, consistent 
with the RMSF. Significant fraying of both the N-terminus of the PPII helix and C-terminus of the 
! helix was observed for oPP!-K@a and oPP!-E@a. No KIH interaction between Pro and the dagd 
residues is observed in the final heptad of the oPP!-E@a structure. Also bulging of the ! helix in 
oPP!-E@a was observed across the trajectories. While, only slight fraying of the C-terminus of 
oPP!-A@a is observed unfolding of the N-terminal !-helix towards the loop region is seen. 
Figure 4-14: Average structures of each X@a mutant highlighting RMSFs. (A) oPP! (B) 
oPP!-I@a (C) oPP!-V@a (D) oPP!-K@a (E) oPP!-A@a (F) oPP!-E@a. Colour 
gradient: blue (most stable) through to red (most fluctuating). 
 


















Figure 4-16 shows the diamond shaped holes of the second (middle) heptad of the oPP!-X@a 
variants at 0, 20, 40, 60, 80, and 100 ns timepoints. The overlays highlight the difference in stabilities 
of the diamond holes for each mutant model. oPP! and oPP!-I@a show the least variation and 
residues at the d, a, g and 1 positions overlay relatively well with little change in conformation. 
Interestingly, while there is some more variation in the conformation of the Tyr side chains for 
oPP!-K@a and oPP!-E@a compared to the other mutants, there is not a significant difference in 
the diamond holes for all mutants.  
 
 
Figure 4-15: Overlays of the 0 and 100 ns snapshots from the MD simulations of the 
oPP!-X@a mutants. (A) oPP! (B) oPP!-I@a (C) oPP!-V@a (D) oPP!-K@a (E) oPP!-
A@a (F) oPP!-E@a. Structures shown in grey are of 0 ns timepoints. 
 















4.3.1.1! Correlation between the BUDE score and TM in oPP!-X@a mutants 
BUDE (Bristol University Docking Engine) predicts the free energy of binding (kJ mol-1) between 
two molecules using an empirical free-energy force field and can perform protein-protein docking 
in real space, virtual screening and ligand binding site identification on protein surfaces.140, 259-260 It 
was hypothesised that there may be a correlation between the BUDE259-260 score of the peptide after 
MD and the stability (TM) of the peptide. To assess the fit of the polyproline-II helix with the ! helix 
the former was treated as the ligand and the latter as the receptor. It was hypothesised that peptides 
which had a higher TM and were deemed more thermally stable would also exhibit a better (i.e. more 
negative) BUDE score. BUDE scores for each oPP!-X@a model was implemented within the 
ISAMBARD framework.142 
 The BUDE scores for the oPP!-X@a series are shown in Figure 4-17. Unfortunately, there appears 
to be no correlation between BUDE score and peptide stability; all models have very similar BUDE 
scores. It appears that the subtle differences in the a position are not significant enough for BUDE 
to accurately determine relative stabilities. BUDE overweights charge-charge interactions and so a 
mutations may not be enough to disentangle these non- covalent interactions. 
Figure 4-16: In silico models for designed oPP! variants after 100 ns of molecular 
dynamics simulation in water. Structures highlight a position mutations and corresponding 
‘knobs-into-holes packing’ for the middle heptad within the !-helix sequence. (A) oPP!, 
(B) oPP!-I@a, (C) oPP!-V@a, (D) oPP!-K@a (red). (E) oPP!-A@a (F) oPP!-E@a. 
 
























 TM / °C BUDE score 
before MD 
Average BUDE 
score after MD 
oPP! 51 -391.9 -369.8 ± 4.5 
oPPα-I@a 40 -377.4 -366.4 ± 13.5 
oPPα-V@a 34 -375.7 -341.7 ± 16.0 
oPPα-K@a 19 -385.8 -374.7 ± 15.8 
oPPα-A@a - -359.0 -367.8 ± 18.1 
oPPα-E@a - -374.2 -373.0 ± 43.7 
Figure 4-17: (Top)  Table of BUDE scores of the oPP!-X@a models before and after 
100 ns of MD. (Bottom) Bar chart showing BUDE score after MD for each oPP!-X@a 
model. 
 




4.3.2! MD simulations examining Leu at a and g positions 
Point mutations were made to the NMR structure of oPP! in Pymol to also generate models for  
oPP!-L@a-L@g, oPP!-L@a-A@g, oPP!-A@a-L@g and oPP!-a#g. Simulations were 
performed in triplicate for each model and all atom RMSDs were calculated across the MD 
simulations (Figure 4-18).  
 
There were no significant fluctuations in the RMSD over the time course for both oPP!-L@a-L@g 
and oPP!-L@a-A@g and this is reflected in the low all atom RMSDs between the 0 and 100 ns 
time points; 2.92 ± 0.11 and 2.58 ± 0.40 respectively (Table 4-4). Whereas oPP!-A@a-L@g and 
oPP!-a#g showed much greater variation across the ensembles with all atom RMSDs of 4.51 ± 
1.61 and 2.91 ± 0.70 respectively. In particular the high standard deviation in the RMSD for oPP!-





Backbone RMSD / Å All atom RMSD / Å 
 
oPPα-L@a-L@g 1.75 ± 0.10 2.92 ± 0.11 
oPPα-L@a-A@g 1.57 ± 0.50 2.58 ± 0.40 
oPPα-A@a-L@g 3.36 ± 1.83 4.51 ± 1.61 
oPPα-a#g 1.51 ± 0.45 2.91 ± 0.70 
Table 4-4: Comparison of average RMSDs between 0 and 100 ns timepoints. 
 
Figure 4-18: RMSD analysis of molecular dynamics trajectories. RMSDs calculated 
relative to 0 ns time point. Colour key: oPP!-L@a-L@g (teal), oPP!-L@a-A@g 
(purple), oPP!-A@a-L@g (pink) and oPP!-a#g (sky blue). 
 
 




The RMSF and average structure were again determined and are shown in Figure 4-19. For  
oPP!-L@a-L@g and oPP!-L@a-A@g fluctuations were limited mainly to the loop region. The 
interface a, d and g positions were the most stable. oPP!-A@a-L@g and oPP!-a#g showed 













Snapshots of each mutant were overlaid at 0 and 100 ns timepoints to compare how the structures 
changed overtime. For oPP!-L@a-L@g and oPP!-L@a-A@g the 0 and 100 ns structures overlaid 
well whereas there was much more deviation as a result of fraying termini for oPP!-A@a-L@g and 





Figure 4-19: Average structures of each mutant highlighting RMSFs. (A) oPP!-L@a-
L@g (B) oPP!-L@a-A@g (C) oPP!-A@a-L@g (D) oPP!-a#g Colour gradient: blue 
(most stable) through to red (most fluctuating). 
 


















Figure 4-21 shows the diamond shaped holes of the second (middle) heptad of the oPP! variants at 
0, 20, 40, 60 , 80 and 100 ns timepoints. The overlays highlight the difference in stabilities of each 
mutant model. oPP!-L@a-L@g shows the least variation and residues at the d, a, g and 1 positions 
overlay relatively well with little change in conformation. Overall the time points for oPP!-L@a-
A@g overlay well, there is more movement in the polyproline-II helix across the ! helix compared 
to oPP!-L@a-L@g. oPP!-A@a-L@g and oPPα-a#g show the most variation between timepoints. 
There is substantial variation in the conformation of the Tyr residues for oPP!-A@a-L@g and both 





Figure 4-20: Overlays of the 0 and 100 ns snapshots from MD simulations. (A) oPP!-
L@a-L@g (B) oPP!-L@a-A@g (C) oPP!-L@a-L@g. (D) oPP!-a#g. Structures shown 
















Figure 4-21: Overlay of MD structures at 0, 20, 40, 60, 80 and 100 ns time points. 
Structures highlight ‘knobs-into-holes packing’ for the middle heptad within the !-helix 










Table 4-5: Combined solution-phase biophysical characterisation of oPP! and mutants. 
a MRE222 from CD spectroscopy at 5 °C and 100 µM peptide in PBS. b The point of inflection in sigmoidal thermal denaturation curves, calculated from the maxima 
of the first derivative of the thermal transition. c Oligomeric state calculated from SE AUC experiments. 
Entry Name Sequence and register 
 321321       efgabcd efgabcd efgabcd 
MRE222 (deg cm2 
dmol-1 res-1) a 
% Helicity TM / °C b Oligomeric 
State c 
1 Parent PP! Ac- PPTKPTKP GDNAT PEKLAKY QADLAKY QKDLADY -NH2 -18319 48 39 0.9 
2 oPP! Ac- PPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY -NH2 -18319 48 51  ± 0.8 1.0 
3 oPP!-E"K Ac- PPEEPEEP GDNAT PEKLAAY KKKLAAY KKKLAAY –NH2 -17810 47 40  ± 2.1 0.9 
4 oPP!-Phe Ac- PPKKPKKP GDNAT PEKLAAF EKELAAF EKELAAF -NH2 -18105 47 33  ± 0.6 1.0 
5 oPP!-I@a Ac- PPKKPKKP GDNAT PEKIAAY EKEIAAY EKEIAAY -NH2                    -16493 43 40  ± 0.1 1.0 
6 oPP!-V@a Ac- PPKKPKKP GDNAT PEKVAAY EKEVAAY EKEVAAY -NH2                     -14854 37 34  ± 1.4 1.0 
7 oPP!-K@a Ac- PPKKPKKP GDNAT PEKKAAY EKEKAAY EKEEAAY -NH2                       -12448 33 19  ± 2.3 1.0 
8 oPP!-A@a Ac- PPKKPKKP GDNAT PEKAAAY EKEAAAY EKEKAAY -NH2                     -8522 23 - 1.0 
9 oPP!-E@a Ac- PPKKPKKP GDNAT PEKEAAY EKEEAAY EKEEAAY -NH2                -1642 5 - - 
10 oPP!-L@a-L@g Ac- PPKKPKKP GDNAT PEKLAEY EKLLAEY EKLLAEY -NH2 -17333 45 76  ± 1.2 1.2 
11 oPP!-L@a-A@g Ac- PPKKPKKP GDNAT PEKLAEY EKALAEY EKALAEY -NH2 -10849 29 21 1.0 
12 oPP!-A@a-L@g Ac- PPKKPKKP GDNAT PEKLAEY EKLAAEY EKLAAEY -NH2 -14365 38 43 1.1 
13 oPP!-a"g Ac- PPKKPKKP GDNAT PEKLAAY AALEKEY AALEKEY -NH2 -12477 33 19  ± 1.3 1.1 
86 
C
hapter 4: Probing sequence-to-stability relationships in oPP! 
 




4.4! Chapter conclusion 
oPP! is stabilised by KIH-like packing between the ! and polyproline-II helices. Pro residues on 
the polyproline-II helix dock into diamond shaped holes formed by successive dagd residues on the 
! helix. Mutations were made to the diamond hole to determine sequence to stability relationships 
for oPP!. 
Firstly, the a position was mutated to a series of hydrophobic, polar and charged residues. Ile and 
Val are tolerated at the a position yielding well folded peptides with TM values of 43 and  37 °C 
respectively. Lys at a is tolerated to some extent while Ala and Glu are not tolerated. Therefore, as 
observed in related natural peptides Leu at a appears to be the most favoured. 
A fully hydrophobic diamond hole was also probed by placing Leu at both a and g. The behaviour 
of this variant in response to temperature was altered and gave a broad CD melt curve with a TM of 
76 °C. Concentration dependence of the CD signal was indicative of peptide oligomerisation which 
was confirmed by SE AUC returning a molecular mass equivalent to 1.2 " the monomer mass of the 
peptide. Collectively this indicated that non-specific association of the helices is occurring, 
consistent with a broader hydrophobic seam. 
A direct comparison between the preference for Leu at either the a or g positions was made by 
comparing oPP!-L@a-A@g with oPP!-A@a-L@g. Despite nature selecting Leu at the a position 
oPP!-A@a-L@g was more stable with a higher TM value. This led to investigating the effect of Leu 
at g in the context of oPP! with Glu at the a position; the a and g positions were switched. oPP!-
a#g was substantially less folded than oPP! with a TM of 19 °C. This result suggests that the 
diamond hole residues work in combination to provide stability to the peptide and observing 
individual contributions of Leu at a or g does not accurately reflect the effect this has on stability in 
the context of oPP!. 
MD studies of the X@a peptide series show a crude correlation between TM and RMSD across the 
trajectory. Analysis of the MD simulations revealed that instability of the model peptide mutant 
mainly manifested itself as fraying of the N and C termini. While MD is a powerful computational 
technique for studying biological systems there are some limitations to it. Firstly, the output of a 
simulation is the result of the atomic force field and so results will only be realistic if the force field 
mimics the forces experienced by ‘real’ atoms. Designing a good forcefield is very challenging. A 
balance must be struck between the accurate representation of real atoms within a forcefield, a 
simple enough forcefield to speed up evaluation, and a forcefield that is applicable to many systems. 
While the AMBER forcefield is accepted as one of the best forcefields for studying proteins and 
nucleic acids, there is still room for improvement. Secondly, time limitation is a major problem with 
MD simulations. It is currently not feasible to run simulations longer than the nanosecond timescale 
using standard MD simulations. This may not be long enough to observe the process of  protein 
folding. 
 




Overall, Leu is the most preferred residue at the a position, however Ile, Val and Lys are also 
tolerated. Preference for Leu at the a position over the g position in oPP! is also observed. A fully 
hydrophobic diamond hole results in increased thermal stability of the peptide at the cost of a discrete 
monomeric structure. 
The optimised and thermally stable PP! structure and the sequence-to-stability relationships 
determined herein can now be used as a foundation on which to build larger and more complex 
assemblies based on the PP! fold.
 




Chapter 5! Towards larger oPP! topologies 
5.1! Chapter introduction 
The previous chapters have described the successful redesign of PP! and subsequent sequence-to-
stability studies for the optimised topology. This chapter describes attempts to use this optimised 
PP! as a building block in the construction of larger and more-complex de novo assemblies. 
Towards this goal, expanding the PP! assembly to incorporate additional secondary structure 










We hypothesised that optimal PP! and !PP components might be combined to give these constructs. 
With an optimised PP! component already in hand, efforts turned towards designing an !PP 
component. The !PP topology differs from the oPP! topology since the ! helix is N terminal in the 
former. We anticipated that finding an appropriate loop to join the ! and polyproline-II helices 
together would be important. To test this hypothesis the two secondary structure components of 
oPP! were synthesised individually and their interactions investigated (Figure 5-2A). CD 
spectroscopy was performed on a 1:1 mix of the peptides corresponding to the ! and polyproline-II 
helices and the resultant CD spectra were compared to the theoretical average spectrum of the non-
interacting helices (Figure 5-2B&C). 
 
Figure 5-1: Cartoon representations of the PP!PP and !PP! folds broken down into their 
constituent components: PP! and !PP. Colour key: Polyproline-II helix (light blue), ! 
helix (dark blue). Arrows represent orientation of helices. 
 




If the ! and polyproline-II helices were not interacting then the resultant CD spectrum at 5 °C would 
overlay exactly with the theoretical average spectrum of the two individual helices. The polyproline-
II helix CD spectrum resembled that of a polyproline-II helix with a minimum at approximately 
197 nm and a maximum at approximately 220 nm while the ! helix was 38 % !-helical. The 
resultant CD spectrum of the 1:1 mixture gave an ! helicity of 34 % while the theoretical average 
of the non-interacting helices was 26 % !-helical (oPP! was 48 % folded at the same concentration). 
The thermal melt curves for the 1:1 mix of the ! and polyproline-II helical components and the 
theoretical average of the two were also very similar. Together, these results indicated that in the 
absence of the loop, the peptides corresponding to the ! and polyproline-II helices showed very 
limited interaction and the !:polyproline-II complex was much less folded and stable than the single 
chain oPP!. Furthermore, this demonstrated that selecting an appropriate loop to join the secondary 










5.2! Designing an !PP topology 
The !PP topology was designed to maintain the interface between the two helices as in oPP! 
(Figure 5-3A-C). The NMR structure of oPP! revealed close contacts between the N-terminal PP-
cap and C-terminal Tyr, therefore a PP-cap was installed at the now C-terminal polyproline-II helix 
Peptide name Sequence and helical register 
    efgabcd efgabcd efgabcd 
! component Ac-PEKLAAY EKELAAY EKELAAY-NH2 
Polyproline-II component Ac-PPKKPKKPG-NH2                     
Figure 5-2: CD spectra of ! and polyproline-II helices. (A) Sequences of ! and 
polyproline-II helical components. (B) CD spectra at 5 °C for ! helix, polyproline-II helix, 
1:1 mix of ! and polyproline helices and theoretical average of non-interacting helices. 
(C) Temperature dependence of the CD signal monitored at 222 nm. Conditions: 100 µM 
each peptide, PBS, pH 7.4. Colour key: ! helix component (green), PPII component 
(pink), 1:1 mix of the peptides corresponding to the ! and PPII helices (blue), theoretical 
mix of helices (blue dash), oPP! (black).  
 




and Tyr at the N-terminal ! helix. This required the !-helical register to be shifted by one residue 
to maintain Tyr at d and Leu at a. The resulting heptad runs d through c. Loop design is notoriously 
difficult and therefore, as a starting point, the natural loop used in PP! was initially also used for 










Loop design is challenging for a number of reasons: firstly, the backbone hydrogen-bonding 
potential of a loop is not automatically satisfied as it is for ! helices and $ sheets.223 For a loop to 
adopt a low-energy discrete conformation the backbone/side-chain polar groups need to be hydrogen 
bonded to other groups either in the loop, the rest of the protein, or be solvent exposed and able to 
hydrogen bond with water. However, if too much of the loop is exposed to water then the loop may 
not adopt a unique conformation. Secondly, unlike for ! helices and $ sheets where there are general 
rules and sequence-to-structure relationships for forming well-folded secondary structures,83, 261-262 
the relationships for forming an ordered loops are less clear. Most ordered loops have diverse 
sequences that form specific and hard-to-predict interactions within the loop and with the rest of the  
protein.223, 263 
Peptide name Sequence and helical register 
       321321       efgabcd efgabcd efgabcd  
oPP! Ac- PPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY-NH2                     
    defgabc defgabc defgabc defgabc       123123123 
!PP-GDNAT         Ac-YEKELAA YEKELAA YEKELAA GDNAT PKKPKKPPG–NH2 
!PP-GDNAT-4 Ac-YEKELAA YEKELAA YEKELAA YEKELAA GDNAT PKKPKKPKKPPG–NH2 
Figure 5-3: (A) NMR structure state 1 of PP! (B) Model of !PP generated within the 
ISAMBARD framework. (C) Overlay of PP! and !PP. The region between the two black 
dashed lines represent the interface region that is the same in both structures. The region 
above the top grey line and below the bottom grey line are different between the oPP! 
and !PP topologies. (D) Sequences of initial !PP designs compared to oPP!. 
 




A Gly residues was included at the C-terminus of !PP so that a Pro residue was not adjacent to the 
Rink Amide resin during peptide synthesis. When Pro was positioned at the C-terminus a single Pro 
residue was deleted during synthesis.  
The !PP-GDNAT peptide was first characterised by CD spectroscopy. !PP-GDNAT was 
significantly less folded than oPP! with an !-helicity of 32 % compared to 48 % for oPP! (Figure 
5-4A). Interestingly, the minimum at 208 nm is substantially lower than at 222 nm for !PP-GDNAT. 
As discussed in Section 2.3.1 a distinctive !-helical peptide is characterised by minima at 208 and 
222 nm of approximately equal intensities. While the ratio of these two minima is sometimes used 
as an additional gauge of !-helicity the origin and effect of peptide sequence on this ratio remains 
ill-defined.264-266 It is likely the difference in MRE values is linked to the less folded nature of the 
peptide and the increased random coil. !PP-GDNAT was also significantly less thermally stable 
than oPP! and a TM could not be extracted from the data (Figure 5-4B). SE AUC data confirmed 
that the peptide was monomeric in solution (Figure 5-4C). 
While the ! helix:polyproline-II helix interface in !PP should be the same as in oPP!, the peptide 
is significantly less folded and stable. This suggests that although the ! helix:polyproline-II helix 
interface provides the key driving force for peptide folding the role of the loop region is also critical 
for folding and cannot be overlooked. While the natural loop adopts conformations optimal for 
joining the secondary structure components in oPP! the loop is not optimised for !PP. 
!PP-GDNAT was also extended and synthesised as a four heptad variant to determine the effect of 
increased length on the stability of !PP. !PP-GDNAT-4 was significantly more folded and 
thermally stable than !PP-GDNAT with an !-helicity of 50 % and a TM of 49 °C. The stability of 
four heptad variant !PP-GDNAT-4 is comparable to oPP! (three heptads). Further, from work 
discussed in Section 6.2, !PP-GDNAT (three heptads) is comparable in stability to shortened oPP! 
variant oPP!-2 (two heptads). This further suggests that the GDNAT loop is not optimised for !PP. 
The first heptad after the loop potentially compensates for the suboptimal loop resulting in fraying 
or unfolding at the C terminus of the ! helix component. Subsequently, this leads to loss in helicity 
and stability of the peptide topology. The effect of chain length on oPP! will be discussed in more 
depth in Section 6.2. 
 















As a control, a simple and more flexible Gly-Ser loop was selected of the same length to join the ! 
and polyproline-II helices together (Figure 5-5A).151, 267 !PP-GSGSG was slightly more folded 
than !PP-GDNAT with an !-helicity of 36 % however this was still not comparable to the folding 
observed for oPP! (Figure 5-5B). Further, an imbalance in the minima at 208 and 222 nm was 
observed. A TM of 20 °C was extracted from the thermal unfolding curve of !PP-GSGSG, 
compared to 51 °C for oPP! (Figure 5-5C). SE AUC experiments revealed the !PP variant was 





Figure 5-4: Folding and stability of !PP-GDNAT and !PP-GDNAT-4 compared to 
oPP!. (A) CD spectra recorded at 5 °C for !PP-GDNAT and !PP-GDNAT-4. (B) 
Temperature dependence of the CD signal monitored at 222 nm. (C-D) AUC 
Sedimentation-equilibrium data (top, dots) and curves fitted single-ideal species model 
(lines) at 44 (blue), 52 (aqua), 56 (orange), and 60 (red) krpm for αPP-GDNAT. Bottom: 
Residuals for the above fits. (C) !PP-GDNAT: v̅ = 0.743 cm3 g-1. The fit returned a mass 
of 3860 Da (1.0 " monomer mass), 95% confidence limits = 3849.7 – 3870.4 Da. (D) 
!PP-GDNAT-4: v̅ = 0.747 cm3 g-1. The fit returned a mass of 4979 Da (1.0 " monomer 
mass), 95% confidence limits = 4955.8 – 5001.8 Da. Conditions: 100 µM peptide, PBS, 
pH 7.4. Colour key: !PP-GDNAT (green), !PP-GDNAT-4 (red), oPP! (black). 
 

















While the flexible linker allowed the loop to adopt a broad range of conformations, including ones 
favourable for the antiparallel !PP topology, the lack of rigidity potentially meant the loop did not 
adopt a single unique conformation. The reduced folding of both !PP-GDNAT and !PP-GSGSG 
implied a more structured loop optimised for the !PP topology was required and thus a more 
sophisticated approach to loop design was needed. 
5.2.1! Capping Motifs 
There are other factors as well as an optimal loop that may help improve the stability of the !PP 
topology including capping motifs. We note that loops and capping motifs were investigated 
simultaneously but for the purpose of this chapter they are discussed separately. 
Peptide name Sequence and helical register 
    defgabc defgabc defgabc       123123 
!PP-GSGSG Ac-YEKELAA YEKELAA YEKELAA GSGSG PKKPKKPPG–NH2 
Figure 5-5: Sequence and biophysical characterisation of !PP-GSGSG compared to 
oPP!. (A) Sequence of oPP!-GSGSG. (B) CD spectra recorded at 5 °C for !PP-GSGSG. 
(C) Temperature dependence of the CD signal monitored at 222 nm. (D) AUC 
Sedimentation-equilibrium data (top, dots) and curves fitted single-ideal species model 
(lines) at 44 (blue), 52 (aqua), 56 (orange), and 60 (red) krpm for αPP-GSGSG. Bottom: 
Residuals for the above fits. v̅ = 0.744 cm3 g-1. The fit returned a mass of 3864 Da (1.0 " 
monomer mass), 95% confidence limits = 3851.1 – 3877.5 Da. Conditions: 100 µM 
peptide, PBS, pH 7.4. Colour key: !PP-GSGSG (blue), oPP! (black). 
 




Capping residues at the N termini of ! helices are important for stabilising helix formation. A 
bioinformatics study of an early subset of ! helices in the PDB shows preferences of amino acids 
for particular positions at the ends of ! helices (Figure 5-6).225 Specifically, there is a strong 
preference for Asn at the N-cap position. This is because Asn can form a hydrogen bond from its 
O% position to the backbone NH group of residue N3, which is the third residue after the N-cap and 
is exposed in the first turn of the ! helix. There is also a strong preference for Pro at position N1. 
One reason for this is because the backbone dihedral angle (&) of Pro is fixed at approximately 70° 
and therefore, with only one rotatable angle, the loss of entropy on forming an ! helix structure is 
lower than for other amino acids.224 The study notes side-chain hydrogen bonds to the backbone 
NHs of N2 and N3 but almost never to N1. It has been hypothesised that another important 
contribution to why Pro is preferred at N1 is simply to occupy a position which would otherwise 
have an exposed NH group.268 Pro is often thought of as a “helix breaker” because it is not often 
found in the interior positions of ! helices however, given its preference at position N1, a better 
description of Pro may be as a helix initiator.268 A preference for charged residues at N2 is also 
noted, in particular Asp and Glu.24 Overall, an important theme to help stabilise the terminal ends 
of ! helices is the need to satisfy potential hydrogen bonds. 
 
In !PP the N-cap of the ! helix is Tyr, the N1 position is Glu and the N2 position is Lys. While Glu 
is the second-most preferred residue at the N1 position, Tyr and Lys are significantly less 
favourable.225 Therefore, we propose that the addition of favourable residues at the N-terminus of 
the ! helix of !PP may help stabilise the overall topology. A series of peptides were synthesised 
with various N-terminal capping residues added (Table 5-1).  
 
 
!PP-NP was first synthesised with Asn at the N-cap position and Pro at the N1 position. This peptide 
was significantly more folded and thermally stable than the corresponding peptide with the same 
loop region (!PP-GDNAT) but without the Asn-Pro cap. !PP-NP had an ! helicity of 39 % 
compared to 32 % for !PP-GDNAT and a measurable TM of 15 °C. The next peptide synthesised in 
Table 5-1: Sequences of !PP variants with various capping residues. 
Peptide name Sequence and helical register 
           defgabc defgabc defgabc       123123 
!PP-NP Ac-NP     YEKELAA YEKELAA YEKELAA GDNAT PKKPKKPPG–NH2 
!PP-NPE Ac-NPE    YEKELAA YEKELAA YEKELAA GDNAT PKKPKKPPG-NH2 
!PP-NPELAA Ac-NPELAA YEKELAA YEKELAA YEKELAA GDNAT PKKPKKPPG-NH2 
Figure 5-6: Summary of some of the position specific amino acid preferences in ! helices. 
Top entry is the position in the ! helix and the bottom entry is the amino acid preference 
at that position. 
 




the series, !PP-NPE, had a Asn-Pro-Glu cap. Glu was chosen at the N2 position over Asp since Glu 
is much more prevalent in the !-helix sequence of oPP! and has higher !-helical propensity 
generally.209 This is despite the fact that Asp is the most preferred residue at this position with Glu 
the second most preferred.225 This additional Glu residue enhanced the folding and stability further 
to an !-helicity of 42 % and a TM of 22 °C. 
In an attempt to make a seamless transition between the Asn-Pro-Glu capping residues and the first 
heptad in the !PP sequence the residues Leu-Ala-Ala were added after Asn-Pro-Glu. In effect, a 
truncated heptad (NPELAA) with enhanced helix capping potential was added onto the N-terminus 
of !PP. While this peptide does not represent a realistic !PP variant, it was synthesised to determine 
how much helicity and  stability could be garnered from a helix cap. !PP-NPELAA was slightly 
more folded than !PP-NPE with an !-helicity of 44 % however the TM was approximately 20 °C 
which is slightly lower than for !PP-NPE. All peptide variants were monomeric in solution as 
determined by SE AUC. The biophysical characterisation data of these peptides are shown in Figure 






Interestingly, as the folding of the peptides in this series increased the ratio between the 208 and 
222nm minima become closer to equal intensities. This series of peptides demonstrates the 
importance of residues close to the N-terminus which will impart stability to the peptide. The optimal 
cap in terms of enhancing thermal stability appears to be Asn-Pro-Glu. This cap was therefore used 







Table 5-2: Table summarising the MRE222 at 5 °C, the % helicity and the TM for the series 
of peptides with helix caps. 
Peptide name MRE222 nm  





oPP! -18319 48 51 
!PP-GDNAT -12046 32 n/a 
!PP-NP -14910 39 15 
!PP-NPE -16020 42 22 
!PP-NPELAA -17057 44 20 
 























Figure 5-7: Biophysical characterisation of !PP variants with various capping motifs. (A) 
CD spectra recorded at 5 °C for !PP-NP, !PP-NPE, !PP-NPELAA. (B) Temperature 
dependence of the CD signal monitored at 222 nm. (C-E) AUC Sedimentation-
equilibrium data (top, dots) and curves fitted to a single-ideal species model (lines) at 44 
(blue), 52 (aqua), 56 (orange), and 60 (red) krpm. Bottom: Residuals for the above fits. 
(C) !PP-NP: v̅ = 0.740 cm3 g-1. The fit returned a mass of 3936 Da (1.0 " monomer mass), 
95% confidence limits = 3920 – 3951 Da. (D) !PP-NPE: v̅ = 0.738 cm3 g-1. The fit 
returned a mass of 4296 Da (1.0 " monomer mass), 95% confidence limits = 4284 – 4308 
Da. (E) !PP-NPELAA: v̅ = 0.742 cm3 g-1. The fit returned a mass of 4646 Da (1.0 " 
monomer mass), 95% confidence limits = 4628 – 4664 Da. Conditions: 100 µM peptide, 
PBS, pH 7.4. Colour key: !PP-GDNAT (green), oPP! (black), !PP-NP (yellow), !PP-
NPE (blue), !PP-NPELAA (pink). 
 




5.2.2! Optimising loop region in !PP 
With the new helix cap improving !PP folding and stability, efforts turned to the more challenging 
task of finding an optimal loop to connect the ! helix and polyproline-II helix components. For 
reasons discussed earlier in this chapter, de novo loop design is significantly more challenging than 
designing regular elements of secondary structures like ! helices and $ strands. Therefore, loops 
were taken from proteins in the PDB. LoopFinder, a protein design tool within ISAMBARD, was 
used to extract loops from the PDB that fitted between the residues that ‘entered’ and ‘exited’ the 
loop. The entering residue was defined as the last residue of secondary structure entering the loop 
and by the same logic the exiting residue was defined as the first residue of secondary structure 
exiting the loop.  
In oPP! a five-residue loop was optimal to bridge the gap between the polyproline-II and ! helices. 
Based on this, it was hypothesised that a loop of similar length would be adequate for !PP. 
Therefore, only loops of between three and six residues were extracted from the PDB. Loops were 
filtered based on the following criteria: Firstly, loops were only selected from NMR or crystal 
structures with a resolution ≤ 3 Å. A resolution greater than this was not deemed reliable enough to 
ensure an accurate fit between the residues entering and exiting the loop and the loop residues 
selected. Also, this constraint helped refine and reduce the number of loops returned. Secondly, only 
loops with ≤ 2 Å RMSD fit between loop and entering and exiting residue backbone coordinates 
were selected. This ensured the transition in backbone coordinates from !PP to the loop were 
continuous. To ensure the loops selected fitted well with the secondary structure elements either side 
of the loop, the DSSP defined secondary structure of the entering and exiting residues were restricted 
to ! and $, respectively. The $ secondary structure element was chosen since polyproline-II helix is 
not formally defined by DSSP. Loops containing cysteine residues were also omitted for ease of 
handling; the thiol group can readily undergo oxidation if not handled with care. 
Based on these criteria, 2212 loops were extracted from the PDB by LoopFinder. Of these, over half 
were three-residue loops, a quarter were four and five residues, and only 28 loops were 6 residues 
long (Figure 5-8). 
 






Figure 5-8: (A) Overlay of the top 100 five-residue loops i.e. those that have the lowest 
RMSD. (B) Frequency of loops of ranging lengths selected from the PDB using 
LoopFinder. 
 




Subsequently, loops were refined and selected for ease of synthesis and low RMSD with !PP. Loops 
with amino-acid sequences that were particularly hydrophobic were avoided because the loop in 
!PP is solvent exposed. Also, only loops with the ! and $ helices in an antiparallel orientation, 
similar to !PP, were selected. The loop sequences chosen are shown in Table 5-3. 
 
 
The loops selected for joining the constituent components of !PP are shown in their native protein 
environments in Figure 5-9. All loops are proximal to the surface of the protein as opposed to being 
buried within the core and thus are relatively solvent exposed. While the conformation that a loop 
adopts depends on the surrounding protein environment, the fact that these loops are solvent exposed 












Table 5-3: Sequences of !PP peptides with ranging loop lengths. 
Peptide name Sequence and helical register 
        defgabc defgabc defgabc        123123 
!PP-NPE-3 Ac-NPE YEKELAA YEKELAA YEKELAA GKP    PKKPKKPPG–NH2 
!PP-NPE-4 Ac-NPE YEKELAA YEKELAA YEKELAA NPQG   PKKPKKPPG–NH2 
!PP-NPE-5 Ac-NPE YEKELAA YEKELAA YEKELAA NGGQG  PKKPKKPPG-NH2 
!PP-NPE-6 Ac-NPE YEKELAA YEKELAA YEKELAA QAKDQQ PKKPKKPPG-NH2 
Figure 5-9: Loops selected for !PP in their natural protein environment. (A) 3 residue 
loop, GKP, from PDB: 1T9A. (B) 4 residue loop, NPQG, from PDB: 3T7D. (C) 5 residue 
loop, NGGQG, from PDB: 3QWA. (D) 6 residue loop, QAKDQQ, from PDB: 4RHE. 
Colour key: Loop (light), entering and exiting secondary structure (dark), surrounding 
protein (grey). 
 




5.2.3! MD Studies 
To give an indication of the stability of the series of !PP peptides with varying loop lengths, 100 ns 
MD simulations were performed for each variant (Figure 5-10). Note that for this MD study models 
of the peptides were generated without the Asn-Pro-Glu capping residues however this did not 
interfere with determining the effectiveness of the loop region. 
!PP-NPE-3 with the three-residue GKP loop was least stable across the MD trajectory resulting in 
the proline residues on the polyproline-II helix flipping to the solvent-exposed surface and no longer 
interdigitated with the tyrosine residues on the ! helix. It appears the loop was too short to keep the 
polyproline-II helix in the correct orientation against the ! helix and the interface between the ! and 
polyproline-II helix was lost. Consistent with this, the RMSD across the trajectory showed the 
greatest deviation. In contrast, !PP-NPE-4 (with the four-residue NPQG loop) was stable across the 
trajectory and the initial and 100 ns snapshots overlay well, in particular the Pro and Tyr interface 
residues. This suggests the four-residue loop was a good fit and allowed the interface between the 
two helices to be maintained. !PP-NPE-5 and !PP-NPE-6 were also relatively stable across their 
trajectories. While the Tyr and Pro residues from the 0 and 100 ns timepoints do not overlay as well 
as compared to !PP-NPE-4, the interface between the two helices is maintained and Pro and Tyr 
are still interdigitated. As a result of this MD study !PP-NPE-3 was not taken forward for synthesis. 
Subsequently, only the !PP variants with four, five and six residue loops were synthesised. These 
peptides were then characterised by CD spectroscopy to determine their folding and stability in 
Figure 5-10: Snapshots of MD simulations at 0 and 100 ns, and fluctuations in all-atom 
RMSD across the trajectory. (A) !PP-3 (loop:  GKP) (B) !PP-4 (loop: NPQG) (C) !PP-
5 (loop: NGGQG) (D) !PP-6 (loop: QAKDQQ). Colour key: initial 0 ns snapshot (grey), 
100 ns snapshot (blue, red, green and purple). 
 




solution. All peptides in the series exhibited very similar !-helicities at 5 °C (approximately 40 %), 
however they showed a broader range of thermal stabilities. The variant with the shortest length 
loop, !PP-NPE-4,  was the least thermally stable in the series with a TM of 18 °C. Interestingly, 
!PP-NPE-4 was less thermally stable than !PP-NPE, which has the natural GDNAT loop. The 
variant with the five-residue loop, !PP-NPE-5 was the most thermally stable in the series with a TM 
of 28 °C. The variant with the longest loop, !PP-NPE-6 fell between the two with a TM of 20 °C. 
All the peptides in this series were monomeric in solution as determined by SE AUC. The CD and 
AUC biophysical data are shown in Figure 5-11 and the folding and thermal stability of these 





While none of the peptides were as stable as the PP! counterpart the !PP-NPE-5 variant with the 
NGGQG loop had the greatest thermal stability. Therefore, this loop was taken forward to create a 
PP!PP design and combine PP:! and !:PP interfaces. It was hoped that the presence and well folded 
behaviour of the PP! component may help template the folding of the C-terminal second 




Peptide name MRE222 nm  





oPP! -18319 48 51 
!PP-NPE -16020 42 22 
!PP-NPE-4 -15395 40 18 
!PP-NPE-5 -15789 41 28 
!PP-NPE-6 -15190 39 20 
Table 5-4: Summary of the !-helicity at 5 °C and thermal stability of the series of 
peptides with varying loop length. 
 























Figure 5-11: Biophysical characterisation of !PP variants with varying loop lengths and 
composition selected using LoopFinder. (A) CD spectra recorded at 5 °C for !PP-NPE-4, 
!PP-NPE-5, !PP-NPE-6. (B) Temperature dependence of the CD signal monitored at 222 
nm. (C-E) AUC Sedimentation-equilibrium data (top, dots) and curves fitted to a single-
ideal species model (lines) at 44 (blue), 52 (aqua), 56 (orange), and 60 (red) krpm. Bottom: 
Residuals for the above fits. (C) !PP-NPE-4: v̅ = 0.741 cm3 g-1. The fit returned a mass of 
4172 Da (1.0 " monomer mass), 95% confidence limits = 4160 –4184 Da. (D) !PP-NPE-
5: v̅ = 0.737 cm3 g-1. The fit returned a mass of 4180 Da (1.0 " monomer mass), 95% 
confidence limits = 4166 – 4195 Da. (E) !PP-NPE-6: v̅ = 0.739 cm3 g-1. The fit returned 
a mass of 4562 Da (1.0 " monomer mass), 95% confidence limits = 4548 – 4576 Da. 
Conditions: 100 µM peptide, PBS, pH 7.4. Colour key: oPP! (black), !PP-NPE-4 (red), 
!PP-NPE-5 (green), !PP-NPE-6 (purple). 
 




5.3! Expanding the PP! topology: PP!PP  
With both an oPP! and !PP component in hand efforts turned towards combing the two topologies 
in an attempt to create a PP!PP topology (Figure 5-12A). In !-helical barrels, each helix interacts 
with the adjacent helix via a hydrophobic seam. There are three main types of interfaces as discussed 
in Section 1.3.1: the two hydrophobic seams share one residue (type I interface), the two seams are 
adjacent (type II interface) or the seams are separated by one intervening residue (type III 







The a, d and g positions (Leu-Tyr-Glu) that make up the diamond shaped hole on the ! helix of 
oPP! were maintained in the design of PP!PP. An extra Leu-Tyr-Glu interface was placed on the 
previously solvent-exposed face of oPP! ! helix at the c, f and b positions. Lys was placed at the e 
position to balance charge on the ! helix. Also, a potential i!i+3 salt bridge could form between 
Lys at e and Glu at b which would help stabilise the ! helix. The natural GDNAT loop was used to 
connect the PP! components of the topology while the NGGQG loop from !PP-NPE-5 was used to 
connect the !PP component. Overall the sequence for the design of PP!PP is shown in Table 5-5. 




Table 5-5: Sequence of the PP!PP Design. 
Peptide  Sequence and helical register 
name      321321       efgabcd efgabcd efgabcd       123123 
oPP! Ac-PPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY-NH2                     
PP!PP Ac-PPKKPKKP GDNAT PYKLELY KYELELY KYELELY NGGQG PKKPKKPPG -NH2 
Figure 5-12: (A) Cartoon representation of the PP!PP topology with the polyproline-II 
helices shown in light blue and the ! helix shown in dark blue. Arrows demonstrate the 
orientation of the helices. (B) Helical wheel representation of PP!PP with overlaid 
peptide sequence highlighting the interhelical interfaces. Colour key: hydrophobic seams 
(purple), Glu (red), Lys (blue). C and N represent the termini of the helices nearest the 
viewer. 
 





















PP!PP was significantly less folded at 5 °C in the far-UV region compared to oPP! with an !-
helicity of 33 %. However, the thermal stability of PP!PP was only slightly lower than oPP! with 
a TM of 48 °C. The reduced folding of PP!PP is the result of the presence of the extra polyproline-
II helix which will have limited contribution to the CD signal at 222 nm. Therefore, to give a better 
indication of the effect of the extra polyproline-II helix on the stability of PP!PP, the CD data were 
Figure 5-13: Folding and stability of PP!PP. (A) CD spectra recorded at 5 °C for oPP! 
and PP!PP. (B) Temperature dependence of the far-UV CD signal monitored at 222 nm. 
(C) CD spectra recorded at 5 °C normalised for expected number of !-helical residues. 
(D) Temperature dependence of the far-UV CD signal monitored at 222 nm normalised 
for expected number of !-helical residues. (E) Aromatic CD spectra recorded at 5 °C. (F) 
Temperature dependence of the near-UV CD signal monitored at 276 nm. Conditions: 100 
µM peptide, PBS, pH 7.4. Colour key: oPP! (black), PP!PP (blue). 
 




renormalised for !-helical residues only in both topologies (Figure 5-13C&D). Upon 
renormalisation the !-helicity of PP!PP at 222 nm matched that of oPP!.  
There is also a significant difference in the ratio of the minima at 208 and 222 nm. This is again 
likely a result of the additional polyproline-II helix. Polyproline-II helices have a deep minimum at 
approximately 197 nm which will contribute to the signal at 208 nm for PP!PP. (See Section 2.3.1). 
PP!PP was also monitored by near-UV CD spectroscopy to monitor the aromatic environment. The 
thermal transition of PP!PP by near-UV CD spectroscopy showed unfolding and refolding curves 
that were consistent with the far-UV CD traces. The TM when measured through the aromatic CD 
signal at 276 nm was 48 °C which is the same as the TM when measured through the far-UV CD 
trace. 
To probe further the contributions of each helix interface to the overall stability of the PP!PP 
topology each interface was knocked out in turn. An interface was removed by mutation of all the 
Pro residues on the polyproline-II helix to Gly residues. The sidechain of Gly is a single hydrogen 
atom and therefore should not contribute to helix packing. Each interface was knocked out 
individually leading to two peptides: PP!PG and PG!PP (Figure 5-14).  
 
 
Both peptides were analysed by CD spectroscopy (Figure 5-15). The CD spectra of PP!PG 




Peptide  Sequence and helical register 
name      321321       efgabcd efgabcd efgabcd       123123 
PP!PP Ac-PPKKPKKP GDNAT PYKLELY KYELELY KYELELY NGGQG PKKPKKPPG -NH2 
PP!PG Ac-PPKKPKKP GDNAT PYKLELY KYELELY KYELELY NGGQG GKKGKKGGG -NH2 
PG!PP Ac-GGKKGKKG GDNAT PYKLELY KYELELY KYELELY NGGQG PKKPKKPPG -NH2 
Figure 5-14: Sequences and helical wheel representation of PP!PG and PG!PP. (A) 
PP!PG (B) PG!PP. (C) Sequences of the PP!PG and PG!PP peptides. 
 






















PP!PG was well folded with the same helicity at 5 °C as observed for PP!PP. The thermal stability 
of PP!PG was slightly reduced with a TM of 46 °C compared to 48 °C for PP!PP. Conversely, the 
folding and thermal stability of PG!PP was dramatically reduced. The peptide showed only 14 % 
Figure 5-15: Folding and stability of PP!PG and PG!PP. (A) CD spectra recorded at 5 
°C for oPP!, PP!PP, PP!PG and PG!PP. (B) Temperature dependence of the far-UV CD 
signal monitored at 222 nm. (C) CD spectra recorded at 5 °C normalised for !-helical 
residues. (D) Temperature dependence of the far-UV CD signal monitored at 222 nm 
normalised for !-helical residues. (E) Aromatic CD spectra recorded at 5 °C. (F) 
Temperature dependence of the near-UV CD signal monitored at 276 nm. Conditions: 100 
µM peptide, PBS, pH 7.4. Colour key: oPP! (black), PP!PP (blue), PP!PG (red), and 
PG!PP (green). 
 




!-helicity at 5 °C and a TM could not be extracted. A summary of the folding and stability of these 





The slight reduction in thermal stability of PP!PG compared to PP!PP suggests the !PP interface 
plays a lesser role in the overall stability of the topology while the PP! interface is the most 
dominant. Further, the significantly reduced folding and stability of PG!PP suggests that without 
the PP! interface the PP!PP topology will not form. Taken together this implies it is the PP! 
component of PP!PP that reduces the energy for second polyproline-II helix by providing a 
template. 
It was anticipated that the PP! interface within the PP!PP topology would be the most dominant 
given we have previously shown oPP! to be more folded and stable compared to !PP. However, 
the fact that the PG!PP peptide was essentially unfolded was unexpected. 
Interestingly, the minima at 208 and 222 nm are of equal intensities for PP!PG, this is in contrast 
to what is observed for PP!PP. This may be explained by the fact that without the proline residues, 
a polyproline-II helix conformation is not adopted; instead just random coil. While the CD spectra 
of random coil and polyproline-II helices are similar there are some slight differences. One such 
difference is that the minima at 197 nm in the CD spectra of polyproline-II helices is reduced in 
magnitude and redshifted.172 The effect of this in the context of PP!PG would result in the signal at 
208 nm to also be reduced in magnitude and therefore result in an intensity that matches the signal 
at 222 nm. 
The oligomeric states of PP!PP, PP!PG and PP!PPP were determined by SE AUC (Figure 5-16). 
Both PP!PP and PP!PG were monomeric in solution and fitted well to single ideal species models. 
PG!PP precipitated at approximately 50 kprm and therefore the oligomeric state of the peptide could 
not be determined. The presence of precipitation emphasised the unfolded and less predictable 
nature of the peptide. 
 
Peptide name MRE222 nm  





oPP! -18319 48 51 
PP!PP -12818 33 48 
PP!PG -12939 33 46 
PG!PP -5283 14 n/a 
Table 5-6: Summary of the folding and thermal stabilities of PP!PP and variants. 
 










5.4! Chapter conclusion 
In conclusion, an iterative design process has been used to design a stable and folded !PP topology. 
Through the iterative design process it became apparent that simply maintaining the interface 
between the two helices of the foregoing oPP! design and using either a flexible (!PP-GSGSG) or 
suboptimal loop region (!PP-GDNAT) to connect the ! and polyproline-II helices is not enough to 
form a stable !PP topology. Subsequently, two important factors were considered for generating a 
well folded !PP topology: introducing N-terminal capping motifs and an optimising the loop region. 
N-terminal capping motifs help initiate helix formation and stabilise the !-helix component. Based 
on work by Richardson et al., which gives amino acid preferences for specific locations at the ends 
of helices, an Asn-Pro-Glu motif was added to the N terminus of the ! helix of !PP.225 This resulted 
in an improvement in the folding and thermal stability of the !PP topology compared to the initial 
design with an increase in TM from < 20 to 22 °C. 
MD simulations suggest that a three-residue loop is too short to connect the ! and polyproline-II 
helices effectively but a loop of length four to six residues should be sufficient. Therefore, 
LoopFinder was used to extract loops ranging from four to six residues from the PDB that would fit 
between a pair of entering and exiting residues of the !PP topology. The best loop selected from 
LoopFinder is five residues in length and resulted in an !PP variant with a TM of 28 °C. This is a 
significant improvement on the initial !PP design (TM < 20 °C). However, this is still not comparable 
to the stability of the oPP! counterpart suggesting !PP could be optimised further. 
Therefore, a more comprehensive study of loops selected by LoopFinder will be required to find an 
optimal !PP loop. A quantitative approach would help refine and select the best loops for synthesis 
Figure 5-16: Sedimentation-equilibrium AUC data (top, dots) and curves fitted to single-
ideal species model (lines) at 44 (blue), 52 (aqua), 56 (orange), and 60 (red) krpm. Bottom: 
Residuals for the above fits. (A) PP!PP: v̅ = 0.753 cm3 g-1. The fit returned a mass of 
5951 Da (1.1 " monomer mass), 95% confidence limits = 5932 – 5970 Da. (B) PP!PG: v̅ 
= 0.726 cm3 g-1. The fit returned a mass of 5919 Da (1.1 " monomer mass), 95% 
confidence limits = 5897 – 5941 Da. Conditions: 100 µM peptide, PBS, pH 7.4. 
 




from the large number (>1000) of loops outputted by LoopFinder. Parameters to be considered 
include RMSD with entering and exiting residues, hydrophobicity of loop specifically the 
hydrophobic moment, orientation of secondary structure either side of loop, loop rigidity, and ease 
of loop synthesis with regard to sequence.  
While LoopFinder offers a good starting point for selecting potential loops to connect secondary 
structure components together there are some drawbacks to this approach. LoopFinder assumes the 
loop will adopt the same conformation in the native protein environment as in its new miniprotein 
environment, which may not be the case. 
Overall, while an !PP topology that is comparable in folding and stability to that of oPP! (TM 51 °C) 
has not been delivered a reasonably well folded peptide with a TM of 28 °C (!PP-NPE-5) has been 
designed and characterised and has been taken forward to expand the PP! topology. Also, 
significant progress forward has been made compared to the initial !PP design which had a TM of 
< 20 °C. 
The NGGQG loop from !PP-NPE-5 is used in the design of PP!PP. PP!PP has similar levels of 
folding and thermal stability to oPP!. To determine the contribution of each interface to the overall 
stability of the topology two variants (PP!PG and PG!PP) are described with each helix interface 
knocked out in turn. The interface was removed by mutation of the Pro residues in the polyproline-
II helix to Gly. CD spectroscopy of these peptides revealed that the PP! interface in the PP!PP 
topology was significantly more dominant; PG!PP was essentially unfolded. 
The next stage of characterisation will seek to verify the structure through NMR spectroscopy. High 
resolution structural data will be required to determine whether the PP!PP peptide has formed the 
topology desired. NOEs between helices will help in determining whether the second polyproline-
II helix is interacting with the ! helix or not. 
Overall, two new topologies have been designed (!PP and PP!PP) that, to the best of our 
knowledge, have not been observed before in nature and thus help move us into the dark matter of 
protein space.33 Solution phase biophysical characterisation for the peptides discussed in this chapter 








Table 5-7: Combined solution-phase biophysical characterisation for the peptides discussed in this chapter.  
Entry Name Sequence and register 
              321321       efgabcd efgabcd efgabcd 
MRE222 (deg cm2 







1 oPP!         Ac- PPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY-NH2 -18319 48 51 1.0 
!PP        defgabc defgabc defgabc defgabc       123123123     
2 !PP-GDNAT            Ac-YEKELAA YEKELAA YEKELAA GDNAT PKKPKKPPG–NH2 -12046 32 < 20 1.0 
3 !PP-GDNAT-4h    Ac-YEKELAA YEKELAA YEKELAA YEKELAA GDNAT PKKPKKPKKPPG–NH2 -19601 50 49 1.0 
4 !PP-GSGSG            Ac-YEKELAA YEKELAA YEKELAA GSGSG PKKPKKPPG–NH2 -13826.8 36 20 1.0 
Capping Motifs               defgabc defgabc defgabc       123123     
5 !PP-NP         Ac-NP YEKELAA YEKELAA YEKELAA GNDAT PKKPKKPPG-NH2 -14910 39 15 1.0 
6 !PP-NPE        Ac-NPE YEKELAA YEKELAA YEKELAA GDNAT PKKPKKPPG-NH2 -16020 42 22 1.0 
7 !PP-NPELAA     Ac-NPELAA YEKELAA YEKELAA YEKELAA GDNAT PKKPKKPPG-NH2 -17057 44 20 1.0 
Loops             defgabc defgabc defgabc        123123     
8 !PP-NPE-4     Ac-NPE YEKELAA YEKELAA YEKELAA NPQG   PKKPKKPPG-NH2 -15395 40 18 1.0 
9 !PP-NPE-5     Ac-NPE YEKELAA YEKELAA YEKELAA NGGQG  PKKPKKPPG-NH2 -15789 41 28 1.0 
10 !PP-NPE-6     Ac-NPE YEKELAA YEKELAA YEKELAA QAKDQQ PKKPKKPPG-NH2 -15190 39 20 1.0 
PP!PP        321321       defgabc defgabc defgabc       123123     
11 PP!PP  Ac-PPKKPKKP GDNAT PYKLELY KYELELY KYELELY NGGQG PKKPKKPPG-NH2 -12818 33 48 1.1 
12 PP!PG  Ac-PPKKPKKP GDNAT PYKLELY KYELELY KYELELY NGGQG GKKGKKGGG-NH2 -12939 33 46 1.1 
13 PG!PP  Ac-GGKKGKKG GDNAT PYKLELY KYELELY KYELELY NGGQG PKKPKKPPG-NH2 -5283 14 n/a n/a 
a MRE222 from CD spectroscopy at 5 °C and 100 µM peptide in PBS. b The point of inflection in sigmoidal thermal denaturation curves, calculated from the maxima 




ards larger oPP! topologies 
 




Chapter 6! Modulating stability in oPP! through elongation and  
               cyclisation 
The cyclisation work described in this chapter was done in collaboration with Marcel Schmidt (MS) 
at EnzyPep, Netherlands. The work was conceived and designed by the author of this thesis (KPG), 
Prof. Dek Woolfson, and MS. MS performed the enzymatic cyclisation and KPG carried out the 
synthesis and biophysical characterisation. Dr Prasun Kumar performed the bioinformatics 
analysis. 
6.1! Chapter introduction 
6.1.1! Protein-protein interactions 
Miniproteins provide a compact and stable scaffold onto which functional motifs can be grafted 
including binding and recognition motifs that have the potential to disrupt protein-protein 
interactions.21, 59, 269 Both transient and long-lived, protein-protein interactions are important for 
controlling a diverse range of cellular functions.270-273 As a result, protein interfaces have become 
targets for perturbing cell function.274-275 Further, the use of miniproteins to disrupt protein-protein 
interactions in important cellular recognition domains offers exciting and challenging opportunities 
to develop miniprotein-based drug therapeutics.276-278 More-challenging motifs that have the 
potential to introduce catalytic function into the simplified miniprotein system are also being 
explored.61 
SH3 (Src homololgy region 3) and other domains such as EVH1 and WW domains have similar 
interfaces to that of PP!. SH3 domains are one of the most abundant molecular recognition domains 
in the proteome and are found in a wide variety of intracellular and membrane-associated proteins.279 
They play important roles in protein-protein interactions essential to cell function.280 The SH3 
domain has a characteristic fold consisting of five or six β strands arranged as two antiparallel β 
sheets. The surface of the domain has a hydrophobic ligand binding pocket with highly conserved 
aromatic residues in which Pro-rich sequences bind. The Pro-rich ligands contain a conserved PXXP 
binding motif and adopt a polyproline-II helix conformation (Figure 6-1A).281-286 In isolation, the 
Pro-rich ligands bind with modest affinity (5 -100 µM) and with little selectivity within families of 
SH3 domains; many SH3 domains bind multiple PXXP containing peptides.287-288 However, SH3 
domains are often found in association with other interaction domains (e.g. SH2 domains)  and work 
in a cooperative manner to give highly specific protein-protein interactions.289 
The avian pancreatic peptide (aPP) has been used as a scaffold whereby some residues on the 
polyproline-II helix have been replaced by a Pro-rich sequence motif (RP1) that interacts with the 
SH3 domain of abelson tyrosine kinase (Ab1-SH3) (Figure 6-1B).281 The binding of this new aPP 
mutant (APP-RP1) to Ab1-SH3 is comparable to the binding of RP1with Ab1-SH3. 
 











The aPP scaffold has been used in a similar way to bind to the polyproline-recognition domain 
EVH1. EVH1 domains are found in a large number of signalling proteins and are often involved in 
modulating the actin cytoskeleton or in signal transduction in postsynaptic compartments of 
chemical synapses.290 Optimisation of the polyproline-II helix of aPP produced a variant with high 
affinity for the ActA target protein in Listeria monocytogenes, EVH1 mena.56 The ! helix of aPP 
has also been optimised for sequence specific DNA recognition. A mutant of aPP named p007 
presents the !-helical recognition epitope found on the bZIP protein GCN4. The recognition epitope 
was grafted onto the solvent exposed face of the ! helix and subsequently binds DNA with 
nanomolar affinity.59 
6.1.2! Controlling the stability of protein-protein interactions 
Similar to aPP, the compact, well-folded nature of the oPP! miniprotein lends itself as a good 
scaffold for targeting and disrupting protein-protein interactions. The sequence-to-stability 
relationships established for the fold in Chapter 4 will help determine which residues are amenable 
to mutation. In complicated association-dissociation processes involving complex dynamics it will 
be important to be able to control and tune the stability and affinity of protein-protein interactions.  
One way to tune stability is to vary the length of the peptide components. The stability of !-helical 
coiled coils increases dramatically with peptide length in a direct but non-linear cooperative manner; 
the increase in stability on going from three to four heptads is greater than going from four to five 
heptads.291-292 As chain length increases, the importance of hydrophobic interactions in relation to 
stability decreases.291 The correlation between peptide chain length and stability has successfully 
been used to engineer and quantify a range of stabilities into heterodimeric coiled coils with 
micromolar to sub-nanomolar dissociation constants.203 Such peptides will be useful for applications 
in protein engineering and synthetic biology where protein-protein interactions with specific 
Figure 6-1: (A) Interaction of the SH3 domain of abelson kinase (Ab1-SH3) with a proline 
rich sequence motif called RP1 (PDB: 1BBZ). (B) Structural alignment of aPP (PDB: 
1PPT) with RP1 motif which is complexed to Ab1-SH3. Colour key: RP1(teal), Ab1-SH3 
(grey, aromatic residues highlighted in purple) and aPP (orange). 
 




stabilities are required. The effect of chain length on the stability of oPP! will therefore be examined 
in this chapter. 
As well as varying chain length to modulate peptide stability, miniproteins can also be stabilised by 
cyclisation. Cyclic miniproteins are particularly attractive for in vivo applications where the peptides 
will need to be resistant to proteolysis and degradation in the cellular environment.293 Linear peptide 
based drugs have limited resistance to proteolysis294 compared to cyclic variants which have much 
better metabolic stability due to their reduced sensitivity to proteolytic cleavage.295 A cyclic 
miniprotein also offers potentially enhanced binding properties as a result of its limited 
conformational flexibility which in turn reduces the entropic penalty upon binding. Given the 
importance of proteolytic stability for applications of miniproteins in vivo, and more ambitiously as 
drug therapeutics, cyclisation of oPP! has been explored and will be discussed herein. 
6.1.3! Peptide cyclisation strategies 
A peptide can be cyclised in four different ways: head-to-tail (C-terminus to N-terminus), head-to-
side chain, side chain-to-tail, or side chain-to-side chain.296 For each of these strategies various 
different synthetic methodologies have been explored. One strategy involves an azide-alkyne 
cycloaddition to introduce a 1,2,3-triazole into the peptide backbone, which are both thermally and 
physiologically stable.297-298 Further, the triazole is readily obtained by 1,3-dipolar cycloadditions 
between an azide and alkyne group. However, while the synthesis is synthetically facile a non-native 
peptide bond is generated at the ligation site. Another cyclisation strategy is the synthesis of larger 
more flexible peptide macrocycles followed by an intramolecular ring contraction to give the target 
structure.299-300 This has been demonstrated as an effective way to reduce the entropic penalty of 
macrocyclization, particularly for very small ring sizes. Ring closing metathesis has also been used 
to cyclise side chain protected peptides in anhydrous organic solvents.301-302 However, for many of 
these synthetic methodologies heavy dilution is required to prevent polymerisation; there are risks 
of epimerisation; and sidechain protected peptides can have poor solubility.303 
Native chemical ligation (NCL) is an alternative strategy often used to cyclise unprotected peptides 
in aqueous solution. This reaction utilises an N-terminal Cys and a C-terminal thioester that react to 
form a native amide bond through a trans-thioesterification followed by S-to-N acyl migration.304 
The strategy was initially developed to ligate peptide segments together to facilitate the synthesis of 
large peptides. However, by incorporating the N-terminal Cys and C-terminal thioester into the same 
peptide, cyclic peptides can readily be synthesised.305 However, this strategy usually requires the 
presence of a Cys in the peptide sequence although desulfurization methods have been  
developed.306-307 
6.1.3.1! Enzymatic cyclisation 
Enzymes offer an alternative to traditional synthetic methodologies for cyclisation. Examples of 
such  enzymes include sortases,308 trypsin,309 asparaginyl endoproteases (AEP),310-311 and subtilisin 
variants such as peptiligase.312 While these enzymes offer excellent stereo- and chemo- selectivity 
 




many suffer from incomplete ligation, low catalytic efficiency, and leave a “footprint” region. A 
footprint is an unavoidable enzyme recognition sequence at the coupling site. However, a peptiligase 
based enzyme variant named omniligase-1 has recently been reported to efficiently catalyse 
cyclisation and is footprint free.313-314 
Peptiligase is protein engineered from a stabilised cation independent variant of substilisin BPN’ 
(Sbt149).313 The calcium binding domain has been removed and 18 stabilising mutations made 
including the introduction of a disulfide bridge. Subsequently, the introduction of two further 
mutations (Ser212 to Cys and Pro216 to Ala) yields peptiligase. Omniligase-1 is an improved variant 
of peptiligase that has recently become commercially available.314 Schmidt et al (EnzyPep, 
Netherlands) demonstrate the use of omniligase-1 as a versatile enzyme for head-to-tail peptide 
cyclisation of linear peptides bearing a C-terminal ester (Figure 6-2). Omniligase-1 has been shown 




Omniligase-1 has six specific substrate recognition pockets: four recognise the C-terminal part of 
the peptide (S1-S4), and two are involved in binding the N-terminal acyl acceptor part of the peptide 
(S1’ and S2’ ).314 To ensure efficient ligation, hydrophobic amino acids are preferred at position 4 









Figure 6-2: Schematic showing cyclisation of linear peptide esters using omniligase-1. 
Figure 6-3: Schematic representation of the enzyme pocket of Omniligase-1 highlighting 
the substrate scope at each position. 
 




6.2! Effects of chain length on the formation and stability of the oPP! 
topology 
With the optimized PP! sequence in hand, the effect of chain length on the formation and stability 
of the oPP! topology was investigated. First, and simply, oPP! variants with 1-, 3- and 4- unit 
polyproline-II-helical repeats and correspondingly 2-, 4- and 5- heptad !-helical repeats were 
synthesised (Table 6-1). oPP! completes the series with two polyproline-II units and three !-helical 
repeats. For all sequences the final two Pro residues at the N terminus were maintained. 
 
The oPP!-X series of peptides were first analysed by CD spectroscopy (Figure 6-5). 
Unsurprisingly, the shortest peptide, oPP!-2, was the least folded in the series with an ! helicity of 
35 % at 5 °C, and a correspondingly low TM of 19 °C. The larger construct, oPP!-4, was significantly 
more folded and thermally stable than oPP! with a TM of 66 °C and the longest peptide, oPP!-5, 









Table 6-1: Sequences of the series of peptides with chain length ranging from 2 to 5 
heptads. 
 Peptide  Sequence and helical register 
  321321321321       efgabcd efgabcd efgabcd efgabcd efgabcd 
oPP!-2 Ac-         PPKKP GDNAT PEKLAAY EKELAAY-NH2          
oPP! Ac-      PPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY-NH2          
oPP!-4 Ac-   PPKKPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY EKELAAY-NH2          
oPP!-5 Ac-PPKKPKKPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY EKELAAY EKELAAY-NH2          
Figure 6-4: CD data showing the effect of chain length on the folding and stability in 
oPP!. (A) CD spectra recorded at 5 °C for the oPP!-X series: oPP!-2 (orange), oPP! 
(black), oPP!-4 (pink) and oPP!-5 (blue). Temperature dependence of the CD signal 
monitored at 222 nm for oPP!-X series, same colour scheme as for (A). Conditions: 100 
µM peptide, PBS, pH 7.4. 
 




Overall, stability increases with chain length in the oPP! topology. However, similar to what is 
observed for !-helical coiled coils, this occurs in a non-linear cooperative manner (Figure 6-5). The 
most significant increase in thermal stability is observed between oPP!-2 and oPP!-3 with an 
increase of 32 °C. A smaller increase in stability of 15 °C is seen between oPP!-3 and oPP!-4 while 











To determine the oligomeric state of the new longer oPP! constructs SE AUC experiments were 
performed. Experimental data for each peptide readily fitted to a single ideal species models and  




Peptide name MRE222 nm /  





oPP!-2 -12822 35 19 
oPP! -18319 48 51 
oPP!-4 -21356 54 66 
oPP!-5 -20670 52 72 
Figure 6-5: Effect of chain length on the folding and stability of oPP!. (Top) Table 
summarising the MRE222 at 5 °C, the % helicity and the TM for all the oPP!-X peptides. 
(Bottom) Plot of heptad length vs TM (blue) and MRE222 at 5 °C (red) for oPP!-X peptides. 
Dashed lines to help guide the eye.  
 





6.2.1! Periodicity mismatch in the oPP! topology 
In Crick’s model of !-helical coiled coils, the 7-residue repeating unit (heptad) of each helix spans 
the same distance and therefore alignment between the two helices is maintained along the coiled 
coil.135, 197 However, in oPP! the 3- and 7-residue repeats of the polyproline-II and ! helices do not 
quite match structurally. Polyproline-II helices have a rise per residue of approximately 3.1 Å and 
therefore span ≈ 9.3 Å per helical repeat; while ! helices have a rise per residue of approximately 
1.5 Å and span ≈ 10.5 Å per heptad repeat (Figure 6-7A&B). This could result in mismatches over 
the lengths of the helical rods of up to 6 Å for oPP!-5 which in turn could destabilize the helix–
helix interactions that we seek to optimize (Figure 6-7C). 
Figure 6-6: Sedimentation-equilibrium AUC data (top, dots) and fitted (lines) single-ideal 
species model curves at 44 (blue), 52 (aqua), 56 (orange), and 60 (red) krpm for oPPα-2, 
oPPα-4 and oPPα-5. Residuals (bottom) for the above fit using the same colour scheme. 
(A) oPPα-2 (v̅ = 0.742 cm3 g-1), (B) oPPα-4 (v̅ = 0.730 cm3 g-1),  (C) oPPα-5 (v̅ = 0.753 
cm3 g-1). The fits returned the following masses: oPPα-2, 2503 Da, (0.9 " monomer mass), 
95% confidence limits = 2491 – 2514 Da; oPPα-4, 4846 Da, (1.0 " monomer mass), 95% 
confidence limits = 4826 – 4867 Da; oPPα-5, 6402 Da, (1.0 " monomer mass), 95% 
confidence limits = 6375 – 6429 Da. Conditions for AUC: 130 µM, PBS, pH 7.4. 
 
 












Methods to reduce the mismatch in periodicities and realign the two helices were investigated. Skips, 
stutters and stammers are relatively prevalent in !-helical coiled coils.315-316 A skip is defined as the 
insertion of one reside into the heptad pattern, a stutter is the insertion of four residues and a stammer 
is the insertion of three residues. By the same logic, a skip can also be thought of as the insertion of 
two stutters. Stutters straighten the helices by decreasing the degree of supercoiling in a left handed 
coiled coil while stammers increase supercoiling.315 When stutters and stammers are repeated 
regularly along the helix, as opposed to just being local discontinuities, they lead to coiled coils that 
deviate globally from the Crick model and can lead to a range of periodicities. For example inclusion 
of stutters leads to hendecad repeats (7+4=11) and pentadecad repeats (7+4+4=15).118 The supercoil 
of these coiled coils is determined by the deviation of their periodicity from the 3.63 residues per 
turn of an undistorted coiled coil. Crick coiled coils with periodicities of 3.5 (7/2, heptad) are left-
handed, hendacads with 3.67 (11/3) are virtually straight, and pentadecads with 3.75 (15/4) are right-
handed. Stammers are less common in natural coiled coils since the super coil needs to compensate 
for their 3.3 periodicity (10/3). This imposes a lot of strain on the helix and is at the limit of allowed 
!-helical backbone conformation.118  
Translating this logic to oPP!, helix realignment could be achieved in two ways; either the 
introduction of  a stutter into the ! helix or a skip into the polyproline-II helix. Indeed the bacterial 
surface adhesin Ag I/II from S. mutans appears to adopt the latter in the form of a Pro skip 
(PXXPPXX) on the polyproline-II helix that intersperses the PXX repeat (Figure 6-8).166 The !-PP 
interface in AgI/II is three full polyproline-II helix repeat units before a skip is introduced therefore 
Peptide name PPII helix theoretical 
length / Å 
! Helix theoretical 
length / Å 
Mismatch 
/ Å 
oPP!-2 18.6 21 2.4 
oPP! 27.9 31.5 3.6 
oPP!-4 37.2 42 4.8 
oPP!-5 46.5 52.5 6 
Figure 6-7: Sequence repeats in !-helical coiled-coils and oPP!. (A) Heptad repeat in !-
helical coiled coil highlighting distance spanned (1.5 x 7 = 10.5 Å). (B) 3- and 7- residue 
repeats of the polyproline-II and ! helices highlighting distance spanned (polyproline-II 
helix 3.1 x 3 = 9.3 Å). (C) Table highlighting the mismatch in periodicities between the 
polyproline-II and ! helices at varying chain lengths.  
 




a Pro skip could improve the stability of the longest oPP!-5 peptide which has four full polyproline-
II helix repeat units. 
A skip was chosen to be incorporated onto the polyproline-II helix over a stutter on the ! helix since 
naturally related proteins use Pro skips on the polyproline-II helix. Also introduction of a stutter on 
the ! helix was anticipated to be more disruptive. As such, a Pro skip was introduced to the middle 
of the polyproline-II repeat of the oPP!-5 sequence (Table 6-2). 
 
oPP!-5-skip showed similar helicity to oPP!-5 at 5 °C but was slightly less thermally stable with a 
TM of 68 °C. This suggests that the oPP! fold is plastic in nature and can tolerate minor mismatches 
in periodicities without the need for helix realignment. However, this may not be the case for longer, 
fibrous-like assemblies such as AgI/II. The slightly reduced TM of oPP!-5 may also suggest that the 
skip position is not optimally placed. Future investigation is required to vary the position of the skip 




Peptide  Sequence and helical register 
    321321321321       efgabcd efgabcd efgabcd efgabcd efgabcd 
oPP!-5  Ac-PPKKPKKPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY EKELAAY EKELAAY-NH2          
oPP!-5-
skip 
Ac-PPKKPKKPPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY EKELAAY EKELAAY-NH2          
Table 6-2: Sequence of oPP!-5 with the incorporation of a skip on the polyproline-II helix. 
 
Figure 6-8: The bacterial surface adhesin (PDB: 3IOX) from S. mutans.  highlighting the 
interdigitation of the Pro and Tyr residues between the extended ! helix and polyproline-
II helix and the Pro skip on the polyproline-II helix breaking the PXX repeat. AgI/II is 
coloured blue to orange from N to C terminus. 
 















6.2.2! Helix capping in the oPP! topology 
As mentioned earlier oPP! possesses an N terminal PP. This double Pro was maintained across the 
various chain lengths. This was because the NMR structures of oPP! and PP! show the PP 
interacting with the C terminus of the ! helix suggesting PP is a good helix cap. To determine the 




Table 6-3: Sequence of oPP!-4 with the removal of the double Pro cap. 
Peptide  Sequence and helical register 
                      321321321       efgabcd efgabcd efgabcd efgabcd  
oPP!-4 Ac- PPKKPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY EKELAAY-NH2 
oPP!-4-
no-cap 
Ac-  PKKPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY EKELAAY-NH2          
Figure 6-9: Folding and stability of oPP!-5-skip. (A) CD spectra recorded at 5 °C for 
oPP! (black), oPP!-5:  (blue), and oPP!-5-skip (green). (B) Temperature dependence of 
the CD signal monitored at 222 nm. Same colour scheme as for (A). Conditions for CD 
experiments: 100 µM peptide, PBS, pH 7.4.(C) AUC Sedimentation-equilibrium data 
(top, dots) and fitted single-ideal species model curves (lines) at 44 (blue), 52 (aqua), 56 
(orange), and 60 (red) krpm for oPPα-5-skip. Bottom: Residuals for the above fits using 
the same colour scheme. oPP!-5-skip v̅ = 0.753 cm3 g-1. The fit returned a mass of 6085 
Da (1.0 " monomer mass), 95% confidence limits = 6126 – 8257 Da. Conditions for AUC: 
130 µM, PBS, pH 7.4. 
 




oPP!-4 and oPP!-4-nocap were similar in the CD spectra. oPP!-4-no-cap was marginally less 
folded at 5 °C compared to oPP!-4 and also slightly less thermally stable with a TM of 62 °C. This 
suggests that the double Pro cap helps anchor the N-terminus of the polyproline-II helix against the 


















Figure 6-10: Folding and stability of oPP!-4-no-cap. (A) CD spectra recorded at 5 °C for 
oPP! (black), oPP!-4:  (pink), and oPP!-4-no-cap (sky blue). (B) Temperature 
dependence of the CD signal monitored at 222 nm. Same colour scheme as for (A). 
Conditions for CD experiments: 100 µM peptide, PBS, pH 7.4.(C) AUC Sedimentation-
equilibrium data (top, dots) and curves fitted to a single-ideal species model (lines) at 44 
(blue), 52 (aqua), 56 (orange), and 60 (red) krpm for oPPα-4-no-cap. Bottom: Residuals 
for the above fits using the same colour scheme. oPP!-4-no-cap v̅ = 0.751 cm3 g-1. The 
fit returned a mass of 4488 Da (0.9 " monomer mass), 95% confidence limits = 4466 – 
4510 Da. Conditions for AUC: 130 µM, PBS, pH 7.4. 
 




6.2.3! Models and MD simulations of the oPP!-X series 
Models of the oPP!-X series of peptides were constructed in PyMol based on the bacterial surface 
adhesin AgI/II structure (PDB: 3IOX). Models were then energy minimised over 10 ns of MD 
simulations in water (Figure 6-11).  
While 10 ns is not long enough for the peptides to reach their most stable conformation or unfold, 
the short simulation gives an idea of the stability of the peptides. Also given the repetitive and 
degenerate nature of these sequences solving an NMR structure for them would be very challenging 
and therefore these MD simulations provide an initial model to help visualise these structures. All 
models were found to be well folded over the 10 ns trajectory and had relatively low RMSD values 





In brief summary, a set of oPP! variants have been presented ranging in length from two to five !-
helical heptads. The different lengths allow access to peptides with a range of stabilities. As observed 
for !-helical coiled coils, stability increases with chain length in a non-linear manner. For the lengths 
tested a skip region is not necessary in order to maintain a periodicity match between the two helices. 
The double PP at the N-terminus of the polyproline-II helix appears to act as a helix cap adding to 
the constructs stability. 
Table 6-4: RMSD between 0 and 10 ns timepoints for the oPP!-X series during MD 
simulations. 
Peptide  All atom RMSD /  Å Backbone RMSD /  Å 
oPP!-2 2.012 1.103 
oPP!-4 3.018 2.081 
oPP!-4-no-cap 2.056 1.063 
oPP!-5 2.835 1.690 
oPP!-5-skip 2.287 1.363 
Figure 6-11: Models of the oPP!-X Series after 10 ns of MD simulations in water. oPP!-
2 (orange), oPP! (NMR structure, state 8, black), oPP!-4 (pink), oPP!-4-no-cap (lilac), 
oPP!-5 (blue), oPP!-5-skip (green). 
 




6.3! Enzymatic cyclisation of oPP! with omniligase-1 
6.3.1! Cyclic oPP! design 
Next, the cyclisation of oPP! was explored as an alternative strategy to increase stability. The 
cyclisation strategy discussed in Section 6.1.3.1 was applied to oPP!. In order to cyclise oPP! a 
linker between the N-terminal end of the polyproline-II helix and the C-terminal end of the ! helix 
had to be introduced. Inspection of the oPP! NMR structure revealed the distance between the N-
terminal nitrogen of Pro1 and the C-terminal carboxyl carbon of Tyr34 is 8.4 ± 0.4 Å. This is similar 
to the distance between the C-terminal carboxyl carbon of Pro8 and the N-terminal nitrogen of Pro14 
(8.8 ±  0.4 Å) for which a five-residue loop connects the two secondary structure components 
(Figure 6-12A). Therefore, a similar length loop could be satisfactory in joining the N-terminal end 
of the polyproline-II helix and the C-terminal end of the ! helix while still maintaining the interface 
between the two helices. A loop of four to six residues in length was therefore deemed appropriate. 
The position of cyclisation was considered next. The cyclisation site could be part of the loop region 
or within either the polyproline-II or ! helix components. Given Pro should be avoided in the 
recognition sequence for omniligase-1 the polyproproline-II helix was discounted as a cyclisation 
site.  
Therefore, both cyclisation in the ! helix and loop region were investigated (Figure 6-12B). There 
were advantages and disadvantages to both cyclisation strategies. Loop cyclisation would allow a 
sequence to be selected that is most optimal for the enzyme and therefore give the cyclisation the 
best chance of success. !-Helix cyclisation requires a six residue sequence frame on the ! helix to 
be chosen that is compatible with omniligase-1. This could result in a sequence frame that is not 
fully optimal for omniligase-1 or require mutations that disrupt the oPP! assembly. However, the ! 
helix cyclisation strategy allows a sequence for Loop2 (Figure 6-12B) to be selected that is optimal 
for bridging the gap between the two secondary structure components without worrying about 
enzyme compatibility. Also, we anticipate that the peptide undergoing !-helix cyclisation would be 
partially unfolded before enzyme addition, as a result of the break in !-helical secondary structure, 
therefore facilitating formation of the enzyme-substrate intermediate and successful cyclisation. The 

















Based on unpublished work by Schmidt et al., a six residue loop sequence was selected based on its 
compatibility with omniligase-1. The P4P3P2P1P1’P2’sequence chosen was LSTKDL. The enzyme 
recognition sequence avoided Pro and ensured a hydrophobic residue at P4 (leucine). For cyclisation 
in the ! helix region, a six residue recognition sequence frame was selected as AYEKEL between 
heptad two and three ensuring P4 was a hydrophobic residue (Ala) (Table 6-5).  
 
 
Loop2, connecting the N-terminal end of the polyproline-II helix with the C-terminal end of the ! 
helix, was chosen based on a bioinformatics analysis of loop residues in the PDB. A Top8000 dataset 
from the Richardson lab317 was used. This dataset comprises 7957 high resolution structures. Only 
structures of the highest quality are selected to this dataset and criteria for selection include a crystal 
structure resolution of < 2 Å and a MolProbity318 score of  < 2. MolProbity is a structure validation 
web service that assesses the quality of a model at both the global and local level, for example 
ensuring Ramachandran outliers are limited. 




Loop oPP!-LSTKDL DL PPKKPKKP GDNAT PEKLAAY EKELAAY EKELAAY LSTK -OCam-L-OH 
 cPP!-LSTKDL  
! helix oPP!-GPQY ELAAY GPQY PPKKPKKP GDNAT PEKLAAY EKELAAY EK-OCam-L-OH 
 cPP!-GPQY  
Figure 6-12: oPP! and cyclic variant. (A) State 8 of NMR strucutre of oPP!. (B) Model 
of cyclic oPP! generated in ISAMBARD highlighting the two different cyclisation sites 
examined. Colour key: N-terminus (blue) and C-terminus (red). 
 




The Richardson dataset was further refined by culling PDB entries that had greater than 25% 
sequence identity using the Pisces Server.319 This yielded 3252 PDB files. From this dataset, 
structures containing an N-terminal ! helix connected to a C-terminal polyproline-II helix via a loop 
region were selected. The program Assignment of Secondary Structure in Proteins (ASSP)320 was 
used to assign secondary structure. The most common methods of secondary structure assignment 
such as Dictionary of Protein Secondary Structure (DSSP)321 and STRIDE322 were not used since 
they omit definitions for polyproline-II helices.323 
The ASSP method assigns secondary structure by first calculating local geometric parameters: twist, 
rise per residue, virtual torsion angle, and radius. The full length of the protein chain is scanned and 
parameters for blocks of four C! atoms are calculated. The continuity in the protein structure is 
checked based on these parameters and continuous stretches are further divided into secondary 
structure elements. Assignments include right- or left- handed ! helix, right- or left- handed 310 
helix, right- or left- handed # helix, left-handed polyproline-II helix, extended conformation ($-
strands). If a stretch of protein does not fall into any of these categories it is labelled as undefined. 
The minimum possible length for ! and polyproline-II helices are four and three residues 
respectively. 
In our analysis a loop region was specified by having ‘undefined’ secondary structure. 734 structures 
were obtained that had an N-terminal ! helix connected to a C-terminal polyproline-II helix by such 
a region. A range of loop lengths from zero to four residues were extracted (Table 6-6). 
Interestingly, no loops longer than four residues were found. This is likely a result of longer loop 
regions containing other regions of secondary structure and not just strictly ‘undefined’ peptide. 
Note that PP! is not present in the dataset since it does not have an N-terminal ! helix component; 





Since four-to-six residue loops were most desirable and there were no five or six residue loops 
identified, we focused on the four-residue loops in the dataset. Of the 116 structures 60 % were in a 
antiparallel conformation. The propensity for residues at each position in the four residue loop was 
then calculated (Figure 6-13). The most preferred residue at each position were (Gly/Asn, Gly/Pro, 
Pro/Gln, Gly/Tyr) equating to (Position 1, Position 2, Position 3, Position 4). Based on this analysis 
the four residue loop GPQY was selected for the cyclic structure in which the ligation site was 
located in the ! helix. 
Table 6-6: Frequency of loops of ranging lengths connecting N-terminal ! helix to C-
















6.3.2! Synthesis and biophysical characterisation of cyclic oPP! variants 
The linear peptides bearing C-terminal activated carboxyamidomethyl (Cam) ester were synthesised 
by SPPS and then enzymatically cyclised with omniligase-1 by Marcel Schmidt. Both cyclic oPP! 
variants were obtained, despite evidence of unwanted ester hydrolysis side reactions, with cPP!-
GPQY being the most facile. As anticipated, the pre-folded nature of the peptides, in particular 
cPP!-LSTKDL, may have inhibited the formation of the enzyme-substrate intermediate. 
By CD spectroscopy, both peptides appeared to be less folded at 5 °C compared to oPP!  (Figure 
6-14). However, thermal unfolding experiments of the far-UV CD revealed cPP!-GPQY and cPP!-
LSTKDL both underwent cooperative and fully reversible transitions with TM of 70 °C and 73 °C, 







We posit that some of the reduction in helicity of both cyclic peptides at 5 °C can be attributed to 
the introduction of either a four or six residue loop region which should not contribute to the !-
Figure 6-13: Barchart highlighting the propensity for the amino acid residues in the four 
residue loop connecting an ! helix to a polyproline-II helix.  
Figure 6-14: Folding and stability of cPP! variants. (A) CD spectra recorded at 5 °C for 
oPP! (black), cPP!-LSTKDL (red) and cPP!-GPQY (teal). (B) Temperature dependence 








helical CD signal however is included in the normalisation calculation. Therefore the data for the 
cyclic peptides were renormalised for the residues in oPP! only (i.e. 34 residues not 40 or 38 
residues for oPP!-LSTKDL and oPP!-GPQY, respectively). The renormalized CD spectra are 
shown in Figure 6-15. The degree of folding of cPP!-LSTKDL at 5 °C appears comparable to that 
of oPP!, while cPP!-GPQY remains less folded than oPP!. This suggests that a four residue loop 
is not long enough to bridge the gap between the ! helix and polyproline-II helix secondary structure 







SE AUC experiments confirmed that both cyclic peptides were monomeric in solution. 








Figure 6-15: Folding and stability of cPP! variants normalised for 34 oPP! residues only. 
(A) CD spectra recorded at 5 °C for oPP! (black), cPP!-LSTKDL (red) and cPP!-GPQY 
(teal). (B) Temperature dependence of the far-UV CD signal monitored at 222 nm. Same 
colour scheme as for (A). Conditions: 100 µM peptide, PBS. 
Figure 6-16: Sedimentation-equilibrium AUC data (top, dots) and fitted (lines) curves to 
single-ideal species model at 44 (blue), 52 (aqua), 56 (orange), and 60 (red) krpm for for 
cPPα- LSTKDL and cPPα-GPQY. Residuals (bottom) for the above fit. (A) oPPα-
LSTKDL (v̅ = 0.751 cm3 g-1). The fit returned the following mass: oPPα-LSTKDL, 4100 
Da, (0.9 x monomer mass), 95% confidence limits = 4079 – 4121 Da. (B) oPPα-GPQY (v̅ 
= 0.743 cm3 g-1). The fit returned the following mass: oPPα-GPQY, 4315 Da, (1.0 
monomer mass), 95% confidence limits = 4268 – 4365 Da. Conditions for AUC:  
130 µM, PBS, pH 7.4. 
 
 




6.4! Chapter conclusion 
Two strategies were explored for improving the stability of oPP!. Firstly, the chain length of oPP! 
was varied. A set of oPP! variants of ranging length from two to five !-helical heptads were 
designed with TMs ranging from 19 to 72 °C. Similar to what is observed in !-helical coiled coils 
the stability of these peptides increases with increasing chain length in a non-linear but cooperative 
manner.291-292 The greatest increase in stability is observed between oPP!-2 (TM 19 °C) and oPP! 
(TM 51 °C) with minimal increase in stability between the longest variants oPP!-4 and oPP!-5 (66 
to 72 °C). 
It was hypothesised that increasing the lengths of the helices may have led to a mismatch in the 
periodicities resulting from the different secondary structures. Therefore, a Pro skip was introduced 
to realign Pro and Tyr  side chains however this had little effect on the folding or thermal stability 
of oPP!-5. This suggests that for the lengths investigated the oPP! fold is plastic to some extent 
and can accommodate small mismatches in periodicities but this may not be the case for longer, 
fibrous like assemblies. 
This set of oPP! variants will be useful for applications in protein engineering and synthetic biology 
where protein-protein interactions of varying stabilities are required. They will also be useful in the 
emerging field of peptide origami.324 While the base complementarity of DNA has been exploited 
to rationally design artificial nanostructures that can arrange into 2D and 3D structures (DNA 
origami),325 the design of such peptide counterparts is significantly more challenging as a result of 
many cooperative and long range interactions. The first example is the self-assembly of a tetrahedral 
peptide fold designed from 12 orthogonal coiled-coil peptides joined by short flexible peptide 
linkers.151 Graph theory revealed that both parallel and antiparallel coiled-coil components are 
needed to form a single chain tetrahedron. While both orientations are present in nature significantly 
more parallel dimers have been isolated and designed. Therefore, these antiparallel oPP! peptides 
may be useful additions to the toolkit of coiled-coil peptide building blocks and will aid the design 
of future polyhedra and the construction of complex modular protein assemblies more generally. 
Secondly, successful enzymatic cyclisation of oPP! yielding two cyclic peptide variants with 
significantly enhanced thermal stabilities compared to the linear oPP! peptide. Both peptides had 
cooperative and fully reversible unfolding transitions with TMs of 70 and 73 °C. Future work will 
focus on obtaining a high resolution structure of the cPP! mutants. Given the enhanced thermal 
stability of the cyclic oPP! variants initial attempts were made to crystallise the peptides. 
Unfortunately crystal trays (laid using standard commercial screens at 20 °C) resulted in no crystals 
to date however further crystal trays will be laid at higher concentrations and lower temperatures to 
attempt to reach optimal crystallisation conditions.  
 




Further investigations are also required to determine the proteolytic stability of these cyclic peptides 
in a biological fluid. If proteolytic stability is high then these oPP! variants will be useful scaffolds 
for grafting recognition motifs to modulate protein-protein interactions in a cellular environment. 
More ambitiously they could have the potential to be good architectures for developing miniprotein 
based drug therapeutics.
 




Chapter 7! Conclusions and future work 
7.1! Overall conclusions 
Through the work described in this thesis, an optimised PP! miniprotein has been designed and 
fully characterised in solution. Sequence-to-stability relationships have been probed through 
mutagenesis studies. The newly designed oPP! has also been used as a foundation for building two 
new topologies, which, to the best of our knowledge, have not been observed before in nature: !PP 
and PP!PP. 
Firstly, the PP! minprotein, which is based on sequences from natural peptides, has been rationally 
redesigned into a completely de novo PP! framework. The redesign of PP! was inspired by design 
principles for !-helical coiled coils including knobs-into-holes packing, electrostatic interactions 
between helices, and !-helical propensity. The optimised PP! miniprotein has been extensively 
characterised in solution by a range of biophysical techniques including high-resolution NMR 
spectroscopy. The parent and optimised design have similar helicities at 5 °C. However, oPP! has 
significantly enhanced thermal stability. We attribute the enhanced stability of the peptide to a 
number of factors. While formal salt bridges are not observed between charged side chains on the ! 
and polyproline-II helices, electrostatic steering effects likely contribute to the elevated stability and 
general tightening of the structure. Furthermore, the number of CH–π interactions detected in the 
NMR structure of oPP! is increased, with an average of one extra CH–π interaction per ensemble 
state. 
To enhance our understanding of the oPP! fold, sequence-to-stability relationships have been 
investigated through a series of amino acid mutations to the a and g positions on the ! helix which 
are involved in KIH-type packing between the two helices. Studies found that the a position is 
tolerant of mutation to small hydrophobic residues Val and Ile as well as charged residue Lys. 
However, this position is not tolerant of Ala and Glu, which yield unfolded peptides. Overall, as 
observed in related natural peptides, Leu is the most favoured residue at the a position. A fully 
hydrophobic hole for accepting the Pro side chain has been investigated by placing Leu at both the 
a and g positions. While expanding the hydrophobic seam gives a peptide that is thermally very 
stable, concentration-dependent circular dichroism spectroscopy experiments combined with 
sedimentation equilibrium analytical ultracentrifugation experiments indicate this is at the cost of a 
discrete monomeric structure. Finally, Leu at a and Glu at g is preferred over Glu at a and Leu at g 
in the oPP! framework.  
Optimised PP! and the sequence-to-stability relationships determined in this thesis can be used as 
a foundation on which to build larger and more complex assemblies based on the PP! fold for 
 




applications in synthetic biology and protein engineering. Towards this goal, an iterative design 
process has been used to design a stable and folded !PP topology. Initial designs show that simply 
maintaining the interface between the two helices and joining them using a flexible or suboptimal 
loop region is not enough to form a stable !PP topology. Both N-terminal capping motifs and loop 
optimisation are important factors to be considered to give a folded and stable !PP topology. N-
terminal capping motifs were chosen based on the work by Richardson et al. and loops were selected 
using LoopFinder within the ISAMBARD framework.142, 225 While an !PP topology equivalent in 
folding and stability to that of oPP! has not been delivered, a reasonably well folded !PP variant 
has been designed and characterised. Further, significant progress has been made compared to the 
initial !PP design. oPP! and the new !PP topology were subsequently used in the design of a new 
extended PP!PP topology. PP!PP shows similar folding and stability compared to oPP!. 
Mutagenesis experiments reveal that the PP! interface of the topology is the more dominant 
compared to the !PP interface and when it is removed the stability of the topology is reduced 
dramatically. An NMR or X-ray crystal structure is needed to verify the structure and determine 
whether the PP!PP peptide has formed the desired topology. 
Finally, two strategies have been implemented to enhance the stability of oPP!: increasing chain 
length and peptide cyclisation. Consistent with observations for !-helical coiled-coils, the stability 
of oPP! increases with chain length in a non-linear cooperative manner. The greatest increase in 
stability is observed between variants with two and three !-helical heptad repeats, while a minimal 
increase in stability is observed between the longest variants of lengths four and five !-helical heptad 
repeats. It is hypothesised that increasing the lengths of the helices may lead to a mismatch in the 
periodicities between the different secondary structures. To test this, a Pro skip was introduced to 
realign Pro and Tyr side chains. However, this had little effect on the folding or thermal stability of 
the variant with five !-helical heptad repeats. This suggests the PP! fold is plastic enough to 
accommodate small mismatches in periodicities within the lengths tested. However, this may not be 
the case for longer, fibrous like assemblies. This set of oPP! variants will be useful for applications 
where protein-protein interactions of varying stabilities are required.  
Successful enzymatic cyclisation of oPP! has produced two cyclic peptide variants with 
significantly enhanced thermal stabilities compared to the linear oPP! peptide. Both have 
cooperative and fully reversible unfolding transitions with TMs exceeding that of oPP!. Such 
miniproteins are potentially useful scaffolds for grafting functional motifs for applications in vivo. 
7.2! Future work 
Two new topologies have been designed (!PP and PP!PP) that help protein design move into the 
dark matter of protein space.33 Future targets for expanding the PP! topology include !PP! and 
PP!PP!, given that the PP! component of PP!PP is the more dominant. Further, more ambitious 
 




targets include expanding oPP! to form circular 3D objects. For example, one can envisage forming 
a single chain hybrid polyproline-II-!-helical barrel structure with alternating polyproline-II and ! 
helices (Figure 7-1A). Alternatively an ‘inverted’ TIM-barrel type structure could be designed with 
! helices forming a central !-helical barrel with each helix connected by an external polyproline-II 
helix (Figure 7-1B-D).326  
Analogues to !-helical barrels (specifically CC-Hept), such single-chain barrels could find 
applications in catalysis and small-molecule binding.145, 152 Currently CC-Hept is a rudimentary 
hydrolase. However this is limited by the seven-fold symmetry; one mutation results in seven copies 
Figure 7-1: Design targets incorporating PP!. (A) Single chain hybrid polyproline-II-!-
helical barrel structure with alternating polyproline-II and ! helices. (B) An ‘inverted’ 
TIM-barrel type structure with ! helices forming a central !-helical barrel with each helix 
connected by an external polyproline-II helix. Loops not shown for (A) and (B). (C) Top-
down view of de novo designed TIM-barrel, PDB 5BVL. (D) Side view of TIM-barrel. 
 




across the assembly. A single-chain variant would allow point mutations to be made in the assembly 
and more sophisticated active sites within the lumen of the barrel to be designed. 
The compact and stable nature of the oPP! miniprotein makes it a useful scaffold for targeting and 
disrupting protein-protein interactions. Further the sequence-to-stability relationships established 
for the fold will help determine which residues are amenable to mutation. The set of oPP! variants 
of ranging lengths will be useful for controlling and tuning the stability and affinity of the protein-
protein interactions. This will be particularly important in systems with complex association-
dissociation dynamics. 
The cyclic variants will be good starting points for in vivo applications where the peptides will need 
to be resistant to proteolysis and degradation. Future work should focus on determining their 
proteolytic stability in a biological fluid. If proteolytic stability is high then these variants will be 
useful scaffolds for grafting recognition motifs for modulating protein-protein interactions in a 
cellular environment. Motifs could be grafted onto either solvent exposed face of the polyproline-II 
helix or the ! helix. The related natural pancreatic peptides have been used as scaffolds to present 
! helical and polyproline-II recognition epitopes.56, 59, 61 Further, and more ambitiously, the cyclic 
oPP! miniproteins could be good architectures for developing miniprotein-based therapeutics.
 




Chapter 8! Appendix 
8.1! HPLC traces and MALDI-TOF MS for the designed peptide sequences 













Figure 8-1: o-! - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass [M+H]+ =  
2440.242 Da, observed mass = 2440.904 Da. 
 
Figure 8-2: oPP! - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass [M+H]+ 
= 3799.009 Da, observed mass = 3800.901 Da. 
 
 



















Figure 8-4: oPP!-Phe - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass [M+H]+ 
= 3752.024 Da, observed mass = 3752.826 Da. 
Figure 8-3: oPP!-E%K - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 3802.219 Da, observed mass = 3802.219 Da. 
 























Figure 8-5: oPP!-I@a - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass [M+H]+ 
= 3752.024 Da, observed mass = 3752.826 Da. 
Figure 8-6: oPP!-V@a - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass [M+H]+ 
= 3752.024 Da, observed mass = 3752.826 Da. 
Figure 8-7: oPP!-E@a - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 3752.024 Da, observed mass = 3752.826 Da. 
 











Figure 8-8: oPP!-K@a - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 3846.374 Da, observed mass = 3846.239 Da. 
Figure 8-9: oPP!-A@a - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 3675.393 Da, observed mass = 3675.088 Da. 
Figure 8-10: oPP!-L@a-L@g - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 3941.109 Da, observed mass = 3946.465 Da. 
 












Figure 8-11: oPP!-L@a-A@g - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 3857.015 Da, observed mass = 3863.115 Da. 
Figure 8-12: oPP!-A@a-L@g - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 3857.015 Da, observed mass = 3860.997 Da. 
Figure 8-13: oPP!-a%g - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass [M+H]+ = 
3799.099 Da, observed mass = 3800.896 Da. 
 












Figure 8-16: oPP!-GDNAT - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 3888.020 Da, observed mass = 3889.910 Da. 
Figure 8-14: PPII - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass [M+H]+ = 
864.460 Da, observed mass = 865.969 Da. 
Figure 8-15: oPP!-GSGSG - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 3777.265 Da, observed mass = 3777.630 Da. 
 













Figure 8-18: oPP!-NP - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass [M+H]+ 
= 4101.601 Da, observed mass = 4103.111 Da. [M+H]2+ also visible. 
Figure 8-17: oPP!-GDNAT-4 - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 4951.624 Da, observed mass = 4954.896 Da. [M+H]2+ also visible. 
Figure 8-19: oPP!-NPE - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 4230.716 Da, observed mass = 4231.905 Da. 
 










Figure 8-20: oPP!-NPELAA - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 4486.033 Da, observed mass = 4486.418 Da. 
Figure 8-21: oPP!-NPE-4 - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 4168.691 Da, observed mass = 4168.664 Da. 
Figure 8-22: oPP!-NPE-5 - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 4185.678 Da, observed mass = 4187.968 Da. 
 

















Figure 8-24: PP!PP - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass [M+H]+ 
= 5575.464 Da, observed mass = 5579.034 Da. [M+H]2+ also visible. 
Figure 8-25: PP!PG - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass [M+H]+ 
= 5415.205 Da, observed mass = 5418.360 Da. [M+H]2+ also visible. 
Figure 8-23: oPP!-NPE-6 - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 4471.021 Da, observed mass = 4473.628 Da. 
 























Figure 8-26: PG!PP - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass [M+H]+ 
= 5415.205  Da, observed mass = 5418.926 Da. [M+H]2+ also visible. 
 




















Figure 8-27: oPP!-2 - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass [M+H]+ 
= 4863.574 Da, observed mass = 4863.025 Da. 
Figure 8-28: oPP!-4-nocap - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 4863.574 Da, observed mass = 4863.025 Da. 
Figure 8-29: oPP!-4 - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass [M+H]+ 
= 4960.690 Da, observed mass = 4961.102 Da. [M+H]2+ also visible. 
 










Figure 8-30: oPP!-5 - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass [M+H]+ 
= 6119.050 Da, observed mass = 6119.708 Da. Observed mass [M+H]2+ = 3059.692. 
Figure 8-32: cPP!-GPQY - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 4185.18 Da, observed mass = 4190.124 Da. [M+H]2+ also visible. 
Figure 8-31: oPP!-5-skip - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 6211.45 Da, observed mass = 6215.346 Da. [M+H]2+ also visible. 
 















Figure 8-33: cPP!-LSTKDL - HPLC traces (left) and MALDI-TOF MS (right). Calculated mass 
[M+H]+ = 4397.35 Da, observed mass = 4404.301 Da.  
 




8.2! Circular dichroism data for designed peptide sequences 










Figure 8-34: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for o-!. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt (black), 
cool (dashed line). 
 
Figure 8-35: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!. Conditions: 100 µM peptide, PBS , pH 7.4. Key: melt (black), 
cool (dashed line). 
 


























Figure 8-37: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-Phe. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
Figure 8-36: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-E%K. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 





























































































































































































Figure 8-38: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-I@a. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
 
Figure 8-39: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-V@a. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 






























Figure 8-41: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-K@a. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
Figure 8-40: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-E@a. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
Figure 8-42: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-A@a. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
 



















Figure 8-43: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-L@a-L@g. Conditions: 100 µM peptide, PBS, pH 7.4. Key: 
melt (black), cool (dashed line). 
 
Figure 8-44: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-L@a-A@g. Conditions: 100 µM peptide, PBS, pH 7.4. Key: 
melt (black), cool (dashed line). 
 
Figure 8-45: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-A@a-L@g. Conditions: 100 µM peptide, PBS, pH 7.4.  
 
 





















































































Figure 8-46: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-a%g. Conditions: 100 µM peptide, PBS, pH 7.4.  
 











































Figure 8-47: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for PPII. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt (black), 
cool (dashed line). 
 
Figure 8-48: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for !PP-GSGSG. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
 































Figure 8-49: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for !PP-GDNAT. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
Figure 8-50: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for !PP-GDNAT-4. Conditions: 100 µM peptide, PBS, pH 7.4. Key: 
melt (black), cool (dashed line). 
 
Figure 8-51: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for !PP-GDNAT-NP. Conditions: 100 µM peptide, PBS, pH 7.4. Key: 
melt (black), cool (dashed line). 
 
 






















Figure 8-52: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for !PP-GDNAT-NPE. Conditions: 100 µM peptide, PBS, pH 7.4. Key: 
melt (black), cool (dashed line). 
 
Figure 8-53: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for !PP-GDNAT-NPELAA. Conditions: 100 µM peptide, PBS, pH 7.4. 
Key: melt (black), cool (dashed line). 
 
Figure 8-54: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for !PP-NPE-4. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
 










































Figure 8-55: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for !PP-NPE-5. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
Figure 8-56: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for !PP-NPE-6. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
Figure 8-57: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for PP!PP. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt (black), 
cool (dashed line). 
 
 























Figure 8-58: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for PP!PG. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
Figure 8-59: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for PG!PP. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt (black), 
cool (dashed line). 
 
 


























































Figure 8-60: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-2. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt (black), 
cool (dashed line). 
 
Figure 8-61: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-4-nocap. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
 




















Figure 8-63: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-5. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
Figure 8-64: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-5-skip. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
Figure 8-62: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored 
at 222 nm (right) for oPP!-4. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt (black), 
cool (dashed line). 
 
 


















Figure 8-66: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored at 
222 nm (right) for cPP!-GPQY. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
Figure 8-65: CD spectrum at 5°C (left) and temperature dependent CD signal, monitored at 
222 nm (right) for cPP!-LSTKDL. Conditions: 100 µM peptide, PBS, pH 7.4. Key: melt 
(black), cool (dashed line). 
 
 




8.3! Analytical ultracentrifugation data for designed peptide sequences 













Figure 8-67: AUC data for o-! (v̅ = 0.747 cm3 g-1). Sedimentation equilibrium data (top, 
dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 (orange), 60 
(red) krpm. The fit returns a molecular weight of 2928 Da (1.2 " monomer mass, 95 % 
confidence limits 2880 – 2917 Da). Bottom: Residuals for the above fit (same colour 
scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
Figure 8-68: AUC data for oPP! (v̅ = 0.748 cm3 g-1). Sedimentation equilibrium data 
(top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 (orange), 
60 (red) krpm. The fit returns a molecular weight of 3854 Da (1.0 " monomer mass, 95 % 
confidence limits 3839 – 3869 Da). Bottom: Residuals for the above fit (same colour 
scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 










































Figure 8-69: AUC data for oPP!-E%K (v̅ = 0.748 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 35454 Da (0.9 " monomer 
mass, 95 % confidence limits 3511 – 3581Da). Bottom: Residuals for the above fit (same 
colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
Figure 8-70: AUC data for oPP!-Phe (v̅ = 0.756 cm3 g-1). Sedimentation equilibrium data 
(top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 (orange), 
60 (red) krpm. The fit returns a molecular weight of 3771 Da (1.0 " monomer mass, 95 % 
confidence limits 3742 – 3801 Da). Bottom: Residuals for the above fit (same colour 
scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
 































Figure 8-71: AUC data for oPP!-I@a (v̅ = 0.748 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 3074 Da (1.0 " monomer 
mass, 95 % confidence limits 3037 – 3111 Da). Bottom: Residuals for the above fit (same 
colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
Figure 8-72: AUC data for oPP!-V@a (v̅ = 0.743 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 3702 Da (1.0 " monomer 
mass, 95 % confidence limits 3683 – 3722 Da). Bottom: Residuals for the above fit (same 
colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 






































Figure 8-73: AUC data for oPP!-K@a (v̅ = 0.742 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 3692 Da (1.0 " monomer 
mass, 95 % confidence limits 3680 – 3703 Da). Bottom: Residuals for the above fit 
(same colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
Figure 8-74: AUC data for oPP!-A@a (v̅ = 0.733 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 3510 Da (1.0 " monomer 
mass, 95 % confidence limits 3495 – 3526 Da). Bottom: Residuals for the above fit 
(same colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
 


























Figure 8-75: AUC data for oPP!-L@a-L@g (v̅ = 0.754 cm3 g-1). Sedimentation 
equilibrium data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 
(aqua), 56 (orange), 60 (red) krpm. The fit returns a molecular weight of 4912 Da (1.2 " 
monomer mass, 95 % confidence limits 4899 – 4926 Da). Bottom: Residuals for the above 
fit (same colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
Figure 8-76: AUC data for oPP!-L@a-A@g (v̅ = 0.745 cm3 g-1). Sedimentation 
equilibrium data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 
(aqua), 56 (orange), 60 (red) krpm. The fit returns a molecular weight of 4019 Da (1.0 " 
monomer mass, 95 % confidence limits 4006 – 4030 Da). Bottom: Residuals for the above 
fit (same colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 

















Figure 8-77: AUC data for oPP!-A@a-L@g (v̅ = 0.745 cm3 g-1). Sedimentation 
equilibrium data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 
(aqua), 56 (orange), 60 (red) krpm. The fit returns a molecular weight of 4101 Da (1.1 
" monomer mass, 95 % confidence limits 4089 – 4113 Da). Bottom: Residuals for the 
above fit (same colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 
°C. 
Figure 8-78: AUC data for oPP!-a%g (v̅ = 0.748 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 4079 Da (1.1 " monomer 
mass, 95 % confidence limits 4065 – 4093 Da). Bottom: Residuals for the above fit 
(same colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 























































Figure 8-79: AUC data for αPP-GSGSG (v̅ = 0.744 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 3864 Da (1.0 " monomer 
mass, 95 % confidence limits 3851 – 3878 Da). Bottom: Residuals for the above fit (same 
colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
Figure 8-80: AUC data for αPP-GDNAT (v̅ = 0.743 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 3860 Da (1.0 " monomer 
mass, 95 % confidence limits 3850 – 3870 Da). Bottom: Residuals for the above fit (same 
colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
 











































Figure 8-81: AUC data for αPP-GDNAT-4 (v̅ = 0.747 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 4979 Da (1.0 " monomer 
mass, 95 % confidence limits 4956 – 5002 Da). Bottom: Residuals for the above fit (same 
colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
Figure 8-82: AUC data for αPP-NP (v̅ = 0.740 cm3 g-1). Sedimentation equilibrium data 
(top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 (orange), 
60 (red) krpm. The fit returns a molecular weight of 3936 Da (1.0 " monomer mass, 95 % 
confidence limits 3920 – 3951 Da). Bottom: Residuals for the above fit (same colour 
scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
 





















































































































































































Figure 8-83: AUC data for αPP-NPE (v̅ = 0.738 cm3 g-1). Sedimentation equilibrium data 
(top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 (orange), 
60 (red) krpm. The fit returns a molecular weight of 4296 Da (1.0 " monomer mass, 95 % 
confidence limits 4284 – 4308 Da). Bottom: Residuals for the above fit (same colour 
scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
Figure 8-84: AUC data for αPP-NPELAA (v̅ = 0.742 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 4646 Da (1.0 " monomer 
mass, 95 % confidence limits 4628 – 4664 Da). Bottom: Residuals for the above fit (same 
colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
 













































Figure 8-85: AUC data for αPP-NPE-4 (v̅ = 0.741 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 4172 Da (1.0 " monomer 
mass, 95 % confidence limits 4160 – 4184 Da). Bottom: Residuals for the above fit (same 
colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
Figure 8-86: AUC data for αPP-NPE-5 (v̅ = 0.737 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 4180 Da (1.0 " monomer 
mass, 95 % confidence limits 4166 – 4195 Da). Bottom: Residuals for the above fit (same 
colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
 











































Figure 8-87: AUC data for αPP-NPE-6 (v̅ = 0.739 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 4562 Da (1.0 " monomer 
mass, 95 % confidence limits 4548 – 4576 Da). Bottom: Residuals for the above fit (same 
colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
Figure 8-88: AUC data for PPαPP (v̅ = 0.753 cm3 g-1). Sedimentation equilibrium data 
(top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 (orange), 
60 (red) krpm. The fit returns a molecular weight of 5951 Da (1.0 " monomer mass, 95 % 
confidence limits 5932 – 5970 Da). Bottom: Residuals for the above fit (same colour 
scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
 





























Figure 8-89: AUC data for PPαPG (v̅ = 0.726 cm3 g-1). Sedimentation equilibrium data 
(top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 (orange), 
60 (red) krpm. The fit returns a molecular weight of 5919 Da (1.0 " monomer mass, 95 % 
confidence limits 5897 – 5941 Da). Bottom: Residuals for the above fit (same colour 
scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
 










































Figure 8-90: AUC data for oPPα-2 (v̅ = 0.742 cm3 g-1). Sedimentation equilibrium data 
(top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 (orange), 
60 (red) krpm. The fit returns a molecular weight of 2503 Da (1.0 " monomer mass, 95 % 
confidence limits 2491 – 2514 Da). Bottom: Residuals for the above fit (same colour 
scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
Figure 8-91: AUC data for oPPα-4-nocap (v̅ = 0.751 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 4488 Da (1.0 " monomer 
mass, 95 % confidence limits 4466 – 4510 Da). Bottom: Residuals for the above fit (same 
colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
 












































Figure 8-92: AUC data for oPPα-4 (v̅ = 0.730 cm3 g-1). Sedimentation equilibrium data 
(top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 (orange), 
60 (red) krpm. The fit returns a molecular weight of 4846 Da (1.0 " monomer mass, 95 % 
confidence limits 4826 – 4867 Da). Bottom: Residuals for the above fit (same colour 
scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
Figure 8-93: AUC data for oPPα-5 (v̅ = 0.753 cm3 g-1). Sedimentation equilibrium data 
(top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 (orange), 
60 (red) krpm. The fit returns a molecular weight of 6402 Da (1.0 " monomer mass, 95 % 
confidence limits 6375 – 6429 Da). Bottom: Residuals for the above fit (same colour 
scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
 







































Figure 8-95: AUC data for cPP!-LSTKDL (v̅ = 0.751 cm3 g-1). Sedimentation 
equilibrium data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 
(aqua), 56 (orange), 60 (red) krpm. The fit returns a molecular weight of 4100 Da (0.9 " 
monomer mass, 95 % confidence limits 4079 – 4121 Da). Bottom: Residuals for the above 
fit (same colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
Figure 8-94: AUC data for oPPα-5-skip (v̅ = 0.753 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 6085 Da (1.0 " monomer 
mass, 95 % confidence limits 6126 – 8257 Da). Bottom: Residuals for the above fit (same 
colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
 





















Figure 8-96: AUC data for cPP!-GPQY (v̅ = 0.743 cm3 g-1). Sedimentation equilibrium 
data (top, dots) and fitted single-ideal species model curves at 44 (blue), 52 (aqua), 56 
(orange), 60 (red) krpm. The fit returns a molecular weight of 4315 Da (1.0 " monomer 
mass, 95 % confidence limits 4268 – 4365 Da). Bottom: Residuals for the above fit (same 
colour scheme as above). Conditions: 130 µM peptide, PBS, pH 7.4, 20 °C. 
 
 




8.4! NMR assignments, structure calculations and validation statistics for 
structural ensembles. 
! oPPα! PPα!900MHz! PPα!700MHz!
Degree!of!Assignment! ! ! !
H!(%)! 95.8! 87! 87!
Heavy!atoms!(N!and!C)!(%)! 29.3! 32.4! 32.4!
Number!of!Restraints! ! ! !
Total!Distance!restraints! 624! 583! 459!
IntraBresidue!(|iBj|=0)! 260! 245! 228!
Sequential!(|iBj|=1)! 118! 103! 121!
Medium!Range!(2!≤!|iBj|!<!5)! 77! 67! 11!
Long!Range!(|iBj|!≥!5)! 39! 35! 20!
Ambiguous! 130! 133! 79!
Dihedral!angle!restraints! 48! 55! 43!
Restraints!statisticsa! ! ! !
Rms!of!distance!violations!(Å)! 0.029!±!0.011! 0.062±0.019! 0.092±0.028!
Rms!of!dihedral!violations!(Å)! 0.030!±!0.060! 0.03!±0.036! 0.09±0.097!
Violations!>!0.5!Å! 0! 0! 0!
Violations!>!0.3!Å! 1.75!±!1.4! 5.65!±!1.52! 2.2±1.6!
Violations!>!0.1!Å! 7.1!±!1.9! 12.45±1.63! 4.6±2.1!







Angles!(o)! 0.42±0.01! 0.429!±!0.010! 0.42±0.01!
Impropers!(o)! 1.01±0.07! 0.932!±!0.084! 0.98±0.10!
Structural!qualityc! ! ! !
Ramachandran!Plotd! ! ! !
Most!favoured!regions!(%)! 99.4! 96.8! 97.0!
Allowed!regions!(%)! 0.6! 3.2! 3.0!
Generously!allowed(%)! 0! 0! 0!
Disallowed!regions!(%)! 0! 0! 0!
Verify3D!ZBscore! B1.61! B2.89! B2.73!
Table 8-1: Comparison of NMR data between PPα!and!oPPα. 
 




ProsaII!ZB!score! 2.07! 1.08! 1.28!
Procheck!ZB!score!(Φ/Ψ)! 2.05! 1.97! 1.61!
Procheck!ZBscore!(all)! 2.25! 1.54! 0.470!
MolProbility!ZB!score! 0.86! 0.13! 0.30!
No!of!close!contacts! 0! 1! 0!
Coordinate!precision!rmsd!(Å)! ! ! !
All!backbone!atoms!(Å)! 0.52±0.13! 0.514!±!0.121! 0.67±0.15!


























Table 8-2: CH–# interactions in oPP!. 87 interactions (4.35 ±! 1.13! per ensemble 
structure). 
Model CH donor CH acceptor 



























































































































donor total = 5 i.e. 0.25 CH–π interactions per structure.  
Leu donor total = 25 i.e. 1.25 CH–π interactions per structure.  
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